QUARTERLY REPORT

Q1 2026 — Quarterly report on Form 10-Q

Q1 2026PDF · 156 pages5.0 MB
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-Q
(Mark One)
☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended April 3, 2026
OR
☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from 	to
Commission File Number: 001-02217
COCA COLA CO
(Exact name of Registrant as specified in its charter)
Delaware 	58-0628465
(State or other jurisdiction of incorporation or organization) 	(I.R.S. Employer Identification No.)
One Coca-Cola Plaza
Atlanta, Georgia 	30313
(Address of principal executive offices) 	(Zip Code)
Registrant’s telephone number, including area code: (404) 676-2121
Securities registered pursuant to Section 12(b) of the Act:
Title of each class 	Trading Symbol(s) 	Name of each exchange on which registered
Common Stock, $0.25 Par Value 	KO 	New York Stock Exchange
1.875% Notes Due 2026 	KO26 	New York Stock Exchange
0.750% Notes Due 2026 	KO26C 	New York Stock Exchange
1.125% Notes Due 2027 	KO27 	New York Stock Exchange
0.125% Notes Due 2029 	KO29A 	New York Stock Exchange
0.125% Notes Due 2029 	KO29B 	New York Stock Exchange
0.400% Notes Due 2030 	KO30B 	New York Stock Exchange
1.250% Notes Due 2031 	KO31 	New York Stock Exchange
3.125% Notes Due 2032 	KO32 	New York Stock Exchange
0.375% Notes Due 2033 	KO33 	New York Stock Exchange
0.500% Notes Due 2033 	KO33A 	New York Stock Exchange
1.625% Notes Due 2035 	KO35 	New York Stock Exchange
1.100% Notes Due 2036 	KO36 	New York Stock Exchange
0.950% Notes Due 2036 	KO36A 	New York Stock Exchange
3.375% Notes Due 2037 	KO37 	New York Stock Exchange
0.800% Notes Due 2040 	KO40B 	New York Stock Exchange
1.000% Notes Due 2041 	KO41 	New York Stock Exchange
3.500% Notes Due 2044 	KO44 	New York Stock Exchange
3.750% Notes Due 2053 	KO53 	New York Stock Exchange

-- 1 of 156 --

Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding
12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
Yes ☒ No ☐
Indicate by check mark whether the Registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T
(§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the Registrant was required to submit such files). Yes ☒ No ☐
Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth
company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer 	☒ 	Accelerated filer 	☐
Non-accelerated filer 	☐ 	Smaller reporting company 	☐
Emerging growth company 	☐
If an emerging growth company, indicate by check mark if the Registrant has elected not to use the extended transition period for complying with any new or
revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. 	☐
Indicate by check mark if the Registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒
Indicate the number of shares outstanding of each of the issuer’s classes of common stock as of the latest practicable date.
Class of Common Stock 	Shares Outstanding as of April 28, 2026
$0.25 Par Value 	4,302,482,418

-- 2 of 156 --

THE COCA-COLA COMPANY AND SUBSIDIARIES
Table of Contents
Page
Forward-Looking Statements 	1
Part I. Financial Information
Item 1. 	Financial Statements 	2
Consolidated Statements of Income — Three Months Ended April 3, 2026 and March 28, 2025 	2
Consolidated Statements of Comprehensive Income — Three Months Ended April 3, 2026 and
March 28, 2025 	3
Consolidated Balance Sheets — April 3, 2026 and December 31, 2025 	4
Consolidated Statements of Cash Flows — Three Months Ended April 3, 2026 and March 28, 2025 	5
Notes to Consolidated Financial Statements 	6
Item 2. 	Management’s Discussion and Analysis of Financial Condition and Results of Operations 	26
Item 3. 	Quantitative and Qualitative Disclosures About Market Risk 	37
Item 4. 	Controls and Procedures 	38
Part II. Other Information
Item 1. 	Legal Proceedings 	38
Item 1A. 	Risk Factors 	40
Item 2. 	Unregistered Sales of Equity Securities and Use of Proceeds 	40
Item 5. 	Other Information 40
Item 6. 	Exhibits 	41
Signatures 	45

-- 3 of 156 --

FORWARD-LOOKING STATEMENTS
This report contains information that may constitute “forward-looking statements.” Generally, the words “believe,” “expect,” “intend,” “estimate,” “anticipate,” “project,”
“will” and similar expressions identify forward-looking statements, which generally are not historical in nature. However, the absence of these words or similar expressions
does not mean that a statement is not forward-looking. All statements that address operating performance, events or developments that we expect or anticipate will occur in the
future are forward-looking statements. Management believes that these forward-looking statements are reasonable as and when made. However, caution should be taken not to
place undue reliance on any such forward-looking statements because such statements speak only as of the date when made. Our Company undertakes no obligation to publicly
update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law. In addition, forward-looking
statements are subject to certain risks and uncertainties that could cause our Company’s actual results to differ materially from historical experience and our present
expectations or projections. These risks and uncertainties include, but are not limited to, the possibility that the assumptions used to calculate our estimated aggregate
incremental tax and interest liability related to the potential unfavorable outcome of the ongoing tax dispute with the United States Internal Revenue Service could significantly
change; those described in Part II, “Item 1A. Risk Factors” and elsewhere in this report and in our Annual Report on Form 10-K for the year ended December 31, 2025; and
those described from time to time in our future reports filed with the Securities and Exchange Commission.
1

-- 4 of 156 --

Part I. Financial Information
Item 1. Financial Statements
THE COCA-COLA COMPANY AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF INCOME
(In millions except per share data)
Three Months Ended
April 3,
2026 March 28,
2025
Net Operating Revenues 	$ 	12,472 $ 	11,129
Cost of goods sold 	4,620 	4,163
Gross Profit 	7,852 	6,966
Selling, general and administrative expenses 	3,472 	3,234
Other operating charges 	21 	73
Operating Income 	4,359 	3,659
Interest income 	222 	180
Interest expense 	375 	387
Equity income (loss) — net 	384 	351
Other income (loss) — net 	21 	254
Income Before Income Taxes 	4,611 	4,057
Income taxes 	645 	722
Consolidated Net Income 	3,966 	3,335
Less: Net income (loss) attributable to noncontrolling interests 	42 	5
Net Income Attributable to Shareowners of The Coca-Cola Company 	$ 	3,924 $ 	3,330
Basic Net Income Per Share 	$ 	0.91 $ 	0.77
Diluted Net Income Per Share $ 	0.91 $ 	0.77
Average Shares Outstanding — Basic 	4,302 	4,302
Effect of dilutive securities 	12 	11
Average Shares Outstanding — Diluted 	4,314 	4,313
Calculated based on net income attributable to shareowners of The Coca-Cola Company.
Refer to Notes to Consolidated Financial Statements.
1
1
1
2

-- 5 of 156 --

THE COCA-COLA COMPANY AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
(In millions)
Three Months Ended
April 3,
2026 March 28,
2025
Consolidated Net Income 	$ 	3,966 $ 	3,335
Other Comprehensive Income:
Net foreign currency translation adjustments 	(42) 	619
Net gains (losses) on derivatives 	71 	(257)
Net change in unrealized gains (losses) on available-for-sale debt securities 	(11) 	13
Net change in pension and other postretirement benefit liabilities 	29 	19
Total Comprehensive Income 	4,013 	3,729
Less: Comprehensive income (loss) attributable to noncontrolling interests 	(2) 	38
Total Comprehensive Income Attributable to Shareowners of The Coca-Cola Company 	$ 	4,015 $ 	3,691
Refer to Notes to Consolidated Financial Statements.
3

-- 6 of 156 --

THE COCA-COLA COMPANY AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS
(In millions except par value)
April 3,
2026
December 31,
2025
ASSETS
Current Assets
Cash and cash equivalents 	$ 	10,574 $ 	10,270
Short-term investments 	509 	3,602
Total Cash, Cash Equivalents and Short-Term Investments 	11,083 	13,872
Marketable securities 	2,737 	1,934
Trade accounts receivable, less allowances of $489 and $495, respectively 	3,675 	3,038
Inventories 	4,730 	4,425
Prepaid expenses and other current assets 	2,953 	2,433
Assets held for sale 	5,212 	5,342
Total Current Assets 	30,390 	31,044
Equity method investments 	20,403 	20,235
Deferred income tax assets 	1,141 	1,206
Property, plant and equipment, less accumulated depreciation of $9,202 and $9,119, respectively 	9,522 	9,613
Trademarks with indefinite lives 	12,463 	12,531
Goodwill 	15,411 	15,491
Other noncurrent assets 	14,887 	14,696
Total Assets 	$ 	104,217 $ 	104,816
LIABILITIES AND EQUITY
Current Liabilities
Accounts payable and accrued expenses 	$ 	14,409 $ 	14,813
Loans and notes payable 	332 	1,551
Current maturities of long-term debt 	4,493 	1,822
Accrued income taxes 	717 	525
Liabilities held for sale 	2,427 	2,570
Total Current Liabilities 	22,378 	21,281
Long-term debt 	39,065 	42,119
Other noncurrent liabilities 	4,425 	4,735
Deferred income tax liabilities 	2,615 	2,406
The Coca-Cola Company Shareowners’ Equity
Common stock, $0.25 par value; authorized — 11,200 shares; issued — 7,040 shares 	1,760 	1,760
Capital surplus 	20,634 	20,581
Reinvested earnings 	82,026 	80,382
Accumulated other comprehensive income (loss) 	(14,040) 	(14,131)
Treasury stock, at cost — 2,737 and 2,738 shares, respectively 	(56,747) 	(56,423)
Equity Attributable to Shareowners of The Coca-Cola Company 	33,633 	32,169
Equity attributable to noncontrolling interests 	2,101 	2,106
Total Equity 	35,734 	34,275
Total Liabilities and Equity 	$ 	104,217 $ 	104,816
Refer to Notes to Consolidated Financial Statements.
4

-- 7 of 156 --

THE COCA-COLA COMPANY AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS
(In millions)
Three Months Ended
April 3,
2026 March 28,
2025
Operating Activities
Consolidated net income 	$ 	3,966 $ 	3,335
Adjustments to reconcile consolidated net income to net cash provided by operating activities:
Depreciation and amortization 	264 	267
Stock-based compensation expense 	56 	63
Deferred income taxes 	205 	95
Equity (income) loss — net of dividends 	(375) 	(264)
Foreign currency adjustments 	33 	50
Significant (gains) losses — net 	10 	(331)
Other operating charges 	10 	—
Other items 	115 	104
Net change in operating assets and liabilities 	(2,263) 	(8,521)
Net Cash Provided by (Used in) Operating Activities 	2,021 	(5,202)
Investing Activities
Purchases of investments 	(1,459) 	(2,507)
Proceeds from disposals of investments 	3,503 	1,005
Acquisitions of businesses, equity method investments and nonmarketable securities 	(37) 	(42)
Proceeds from disposals of businesses, equity method investments and nonmarketable securities 	— 	748
Purchases of property, plant and equipment 	(266) 	(309)
Proceeds from disposals of property, plant and equipment 	2 	8
Collateral (paid) received associated with hedging activities — net 	(20) 	(15)
Other investing activities 	23 	45
Net Cash Provided by (Used in) Investing Activities 	1,746 	(1,067)
Financing Activities
Issuances of loans, notes payable and long-term debt 	— 	5,436
Payments of loans, notes payable and long-term debt 	(1,262) 	(1,599)
Issuances of stock 	155 	159
Purchases of stock for treasury 	(477) 	(370)
Dividends 	(2,281) 	(89)
Other financing activities 	(3) 	(105)
Net Cash Provided by (Used in) Financing Activities 	(3,868) 	3,432
Effect of Exchange Rate Changes on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 	86 	163
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents
Net increase (decrease) in cash, cash equivalents, restricted cash and restricted cash equivalents during the period 	(15) 	(2,674)
Cash, cash equivalents, restricted cash and restricted cash equivalents at beginning of period 	11,010 	11,488
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents at End of Period 	10,995 	8,814
Less: Restricted cash and restricted cash equivalents at end of period 	421 	397
Cash and Cash Equivalents at End of Period 	$ 	10,574 $ 	8,417
Refer to Notes to Consolidated Financial Statements.
5

-- 8 of 156 --

THE COCA-COLA COMPANY AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
NOTE 1: SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Basis of Presentation
The accompanying unaudited consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (“U.S.
GAAP”) for interim financial information and with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X. They do not include all information and notes required by
U.S. GAAP for complete financial statements. However, except as disclosed herein, there has been no material change in the information disclosed in the Notes to Consolidated
Financial Statements included in the Annual Report on Form 10-K of The Coca-Cola Company for the year ended December 31, 2025. Certain other amounts in the prior years’
consolidated financial statements and notes have been revised to conform to the current year presentation.
When used in these notes, the terms “The Coca-Cola Company,” “Company,” “we,” “us” and “our” mean The Coca-Cola Company and all entities included in our consolidated
financial statements. In the opinion of management, all adjustments (including normal recurring accruals) considered necessary for a fair presentation have been included.
Operating results for the three months ended April 3, 2026 are not necessarily indicative of the results that may be expected for the year ending December 31, 2026. Sales of
our ready-to-drink beverages are somewhat seasonal, with the second and third calendar quarters typically accounting for the highest sales volumes. The volume of sales in the
beverage business may be affected by weather conditions.
Each of our quarterly reporting periods, other than the fourth quarter, ends on the Friday closest to the last day of the corresponding quarterly calendar period. The first quarter
of 2026 and the first quarter of 2025 ended on April 3, 2026 and March 28, 2025, respectively. Our fourth quarter and our fiscal year end on December 31 regardless of the day
of the week on which December 31 falls.
Advertising Costs
The Company’s accounting policy related to advertising costs for annual reporting purposes is to expense production costs of print, radio, television and other advertisements as
of the first date the advertisements take place. All other marketing expenditures are expensed in the annual period in which the expenditure is incurred.
For quarterly reporting purposes, we allocate our estimated full year marketing expenditures that benefit multiple quarters to each of those quarters. We use the proportion of
each quarter’s actual unit case volume to the estimated full year unit case volume as the basis for the allocation. This methodology results in our marketing expenditures being
recognized at a standard rate per unit case. At the end of each quarter, we review our estimated full year unit case volume and our estimated full year marketing expenditures
that benefit multiple quarters in order to evaluate if a change in estimate is necessary. The impact of any change in the full year estimate is recognized in the quarter in which
the change in estimate occurs. Our full year marketing expenditures are not impacted by this interim accounting policy.
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents
We classify time deposits and other investments that are highly liquid and have maturities of three months or less at the date of purchase as cash equivalents or restricted cash
equivalents, as applicable. Restricted cash and restricted cash equivalents generally consist of amounts held by our captive insurance companies, which are included in the line
item other noncurrent assets in our consolidated balance sheet, and when applicable, cash and cash equivalents related to assets held for sale are included in the line item assets
held for sale in our consolidated balance sheet. We manage our exposure to counterparty credit risk through specific minimum credit standards, diversification of counterparties
and procedures to monitor our concentrations of credit risk. Refer to Note 2 for additional information on our assets held for sale and Note 4 for additional information on our
captive insurance companies.
The following tables provide a summary of cash, cash equivalents, restricted cash and restricted cash equivalents that constitute the total amounts shown in our consolidated
statements of cash flows (in millions):
April 3,
2026
December 31,
2025
Cash and cash equivalents 	$ 	10,574 $ 	10,270
Restricted cash and restricted cash equivalents 	421 	740
Cash, cash equivalents, restricted cash and restricted cash equivalents 	$ 	10,995 $ 	11,010
6

-- 9 of 156 --

March 28,
2025
December 31,
2024
Cash and cash equivalents 	$ 	8,417 $ 	10,828
Restricted cash and restricted cash equivalents 	397 	660
Cash, cash equivalents, restricted cash and restricted cash equivalents 	$ 	8,814 $ 	11,488
NOTE 2: ACQUISITIONS AND DIVESTITURES
Acquisitions
Our Company’s acquisitions of businesses, equity method investments and nonmarketable securities totaled $37 million and $42 million during the three months ended April 3,
2026 and March 28, 2025, respectively. The activity during the three months ended April 3, 2026 and March 28, 2025 included $32 million and $30 million, respectively, of
investments in alternative energy limited partnerships. Refer to Note 14 for additional information on these investments.
Divestitures
Proceeds from disposals of businesses, equity method investments and nonmarketable securities totaled $748 million during the three months ended March 28, 2025. In March
2025, the Company sold a portion of our ownership interest in Coca-Cola Europacific Partners plc (“CCEP”), an equity method investee, for which we received cash proceeds
of $741 million and recognized a net gain of $331 million, which was recorded in the line item other income (loss) — net in our consolidated statement of income.
Assets and Liabilities Held for Sale
In October 2025, the Company entered into a definitive agreement to sell a portion of our interest in our bottling operations in Africa to Coca-Cola HBC AG (“CCHBC”), an
equity method investee. Closing is subject to various regulatory approvals and is expected by the end of 2026, upon which we will deconsolidate these bottling operations. We
have also agreed to a separate option arrangement for CCHBC to acquire the Company’s remaining 25% ownership interest within a six-year period from closing. As these
operations met the criteria to be classified as held for sale, during the year ended December 31, 2025, we were required to record the related assets and liabilities at the lower of
carrying value or fair value less any costs to sell based on the estimated proceeds. This resulted in an impairment charge of $1,274 million, primarily due to the negative net
foreign currency translation adjustments that will be reclassified to income upon sale. During the three months ended April 3, 2026, we recorded an additional impairment
charge of $10 million based on management’s revised estimates. These charges were recorded in the line item other income (loss) — net in our consolidated statement of
income.
7

-- 10 of 156 --

The following table presents information related to the major classes of assets and liabilities that were classified as held for sale in our consolidated balance sheets (in millions):
April 3,
2026
December 31,
2025
Cash, cash equivalents and short-term investments 	$ 	172 $ 	178
Trade accounts receivable, less allowances 	363 	389
Inventories 	436 	466
Prepaid expenses and other current assets 	161 	147
Equity method investments 	6 	5
Deferred income tax assets 	46 	46
Property, plant and equipment — net 	1,953 	1,964
Trademarks with indefinite lives 	2 	2
Goodwill 	3,284 	3,350
Other noncurrent assets 	64 	60
Allowance for reduction of assets held for sale 	(1,275) 	(1,265)
Assets held for sale 	$ 	5,212 $ 	5,342
Accounts payable and accrued expenses 	$ 	668 $ 	816
Loans and notes payable 	169 	187
Current maturities of long-term debt 	398 	398
Accrued income taxes 	35 	5
Long-term debt 	838 	850
Other noncurrent liabilities 	148 	154
Deferred income tax liabilities 	171 	160
Liabilities held for sale 	$ 	2,427 $ 	2,570
NOTE 3: NET OPERATING REVENUES
The following table presents net operating revenues disaggregated between the United States and International and further by line of business (in millions):
United States 	International 	Total
Three Months Ended April 3, 2026
Concentrate operations 	$ 	2,188 $ 	5,197 $ 	7,385
Finished product operations 	2,557 	2,530 	5,087
Total 	$ 	4,745 $ 	7,727 $ 	12,472
Three Months Ended March 28, 2025
Concentrate operations 	$ 	1,975 $ 	4,619 $ 	6,594
Finished product operations 	2,278 	2,257 	4,535
Total 	$ 	4,253 $ 	6,876 $ 	11,129
Refer to Note 16 for disclosures of net operating revenues by operating segment and Corporate.
8

-- 11 of 156 --

NOTE 4: INVESTMENTS
Equity Securities
The carrying values of our equity securities were included in the following line items in our consolidated balance sheets (in millions):
Fair Value with Changes
Recognized in Income
Measurement Alternative
— No Readily
Determinable Fair Value
April 3, 2026
Marketable securities 	$ 	484 $ 	—
Other noncurrent assets 	2,397 	43
Total equity securities 	$ 	2,881 $ 	43
December 31, 2025
Marketable securities 	$ 	489 $ 	—
Other noncurrent assets 	2,100 	44
Total equity securities 	$ 	2,589 $ 	44
The calculation of net unrealized gains and losses recognized during the period related to equity securities still held at the end of the period is as follows (in millions):
Three Months Ended
April 3,
2026
March 28,
2025
Net gains (losses) recognized during the period related to equity securities 	$ 	(17) $ 	(15)
Less: Net gains (losses) recognized during the period related to equity securities sold
during the period 	16 	8
Net unrealized gains (losses) recognized during the period related to equity securities
still held at the end of the period 	$ 	(33) $ 	(23)
Debt Securities
Our debt securities consisted of the following (in millions):
Gross Unrealized 	Estimated
Fair Value	Cost 	Gains 	Losses
April 3, 2026
Trading securities $ 	48 $ 	1 $ 	— $ 	49
Available-for-sale securities 2,639 	20 	(78) 	2,581
Total debt securities $ 	2,687 $ 	21 $ 	(78) $ 	2,630
December 31, 2025
Trading securities $ 	49 $ 	1 $ 	— $ 	50
Available-for-sale securities 1,816 	23 	(65) 	1,774
Total debt securities $ 	1,865 $ 	24 $ 	(65) $ 	1,824
The estimated fair value as of April 3, 2026 includes $2,015 million of Brazilian government bonds with a cost of $2,075 million and gross unrealized losses of $60 million and, as of
December 31, 2025, includes $1,207 million of Brazilian government bonds with a cost of $1,255 million, gross unrealized gains of $1 million and gross unrealized losses of $49 million.
The carrying values of our debt securities were included in the following line items in our consolidated balance sheets (in millions):
April 3, 2026 	December 31, 2025
Trading Securities Available-for-Sale
Securities 	Trading Securities Available-for-Sale
Securities
Marketable securities $ 	49 $ 	2,204 	$ 	50 $ 	1,395
Other noncurrent assets — 	377 	— 	379
Total debt securities 	$ 	49 $ 	2,581 	$ 	50 $ 	1,774
1
1
1
9

-- 12 of 156 --

The contractual maturities of these available-for-sale debt securities as of April 3, 2026 were as follows (in millions):
Cost
Estimated
Fair Value
Within 1 year 	$ 	363 $ 	363
After 1 year through 5 years 	2,061 	2,011
After 5 years through 10 years 	39 	44
After 10 years 	176 	163
Total 	$ 	2,639 $ 	2,581
The Company expects that actual maturities may differ from the contractual maturities above because borrowers have the right to call or prepay certain obligations.
The sale and/or maturity of available-for-sale debt securities resulted in the following realized activity (in millions):
Three Months Ended
April 3,
2026
March 28,
2025
Gross gains 	$ 	1 $ 	1
Gross losses 	(1) 	(2)
Proceeds 	197 	137
Captive Insurance Companies
In accordance with local insurance regulations, our consolidated captive insurance companies are required to meet and maintain minimum solvency capital requirements. The
Company elected to invest a majority of its solvency capital in a portfolio of marketable equity and debt securities. These securities are included in the disclosures above. The
Company uses one of our consolidated captive insurance companies to reinsure group annuity insurance contracts that cover the obligations of certain of our European and
Canadian pension plans. This captive’s solvency capital funds included total equity and debt securities of $2,667 million and $2,356 million as of April 3, 2026 and
December 31, 2025, respectively, which were classified in the line item other noncurrent assets in our consolidated balance sheets because the assets were not available to
satisfy our current obligations.
NOTE 5: INVENTORIES
Inventories consisted of the following (in millions):
April 3,
2026
December 31,
2025
Raw materials and packaging 	$ 	2,959 $ 	2,708
Finished goods 	1,420 	1,375
Other 	351 	342
Total inventories 	$ 	4,730 $ 	4,425
10

-- 13 of 156 --

NOTE 6: HEDGING TRANSACTIONS AND DERIVATIVE FINANCIAL INSTRUMENTS
The following table presents the fair values of the Company’s derivative instruments that were designated and qualified as part of a hedging relationship (in millions):
Fair Value
Derivatives Designated as Hedging Instruments 	Financial Statement Line Item Impacted
April 3,
2026
December 31,
2025
Assets:
Foreign currency contracts 	Prepaid expenses and other current assets 	$ 	170 $ 	125
Foreign currency contracts 	Other noncurrent assets 	64 	31
Interest rate contracts 	Other noncurrent assets 	132 	142
Total assets 	$ 	366 $ 	298
Liabilities:
Foreign currency contracts 	Accounts payable and accrued expenses 	$ 	136 $ 	205
Foreign currency contracts 	Other noncurrent liabilities 	33 	28
Commodity contracts 	Accounts payable and accrued expenses 	26 	9
Interest rate contracts 	Accounts payable and accrued expenses 	40 	17
Interest rate contracts 	Other noncurrent liabilities 	717 	700
Total liabilities 	$ 	952 $ 	959
All of the Company’s derivative instruments are carried at fair value in our consolidated balance sheets after considering the impact of legally enforceable master netting agreements and cash
collateral held or placed with the same counterparties, as applicable. Current disclosure requirements mandate that derivatives must also be disclosed without reflecting the impact of master
netting agreements and cash collateral. Refer to Note 15 for the net presentation of the Company’s derivative instruments.
Refer to Note 15 for additional information related to the estimated fair value.
The following table presents the fair values of the Company’s derivative instruments that were not designated as hedging instruments (in millions):
Fair Value
Derivatives Not Designated as Hedging Instruments 	Financial Statement Line Item Impacted
April 3,
2026 	December 31, 2025
Assets:
Foreign currency contracts 	Prepaid expenses and other current assets 	$ 	129 $ 	115
Foreign currency contracts 	Other noncurrent assets 	18 	18
Foreign currency contracts 	Assets held for sale 	2 	—
Commodity contracts 	Prepaid expenses and other current assets 	78 	7
Commodity contracts 	Other noncurrent assets 	2 	—
Commodity contracts 	Assets held for sale 	10 	3
Other derivative instruments 	Prepaid expenses and other current assets 	5 	—
Total assets 	$ 	244 $ 	143
Liabilities:
Foreign currency contracts 	Accounts payable and accrued expenses 	$ 	76 $ 	66
Foreign currency contracts 	Other noncurrent liabilities 	7 	5
Foreign currency contracts 	Liabilities held for sale 	2 	5
Commodity contracts 	Accounts payable and accrued expenses 	2 	10
Commodity contracts 	Other noncurrent liabilities 	— 	1
Commodity contracts 	Liabilities held for sale 	— 	1
Other derivative instruments 	Accounts payable and accrued expenses 	2 	2
Total liabilities 	$ 	89 $ 	90
All of the Company’s derivative instruments are carried at fair value in our consolidated balance sheets after considering the impact of legally enforceable master netting agreements and cash
collateral held or placed with the same counterparties, as applicable. Current disclosure requirements mandate that derivatives must also be disclosed without reflecting the impact of master
netting agreements and cash collateral. Refer to Note 15 for the net presentation of the Company’s derivative instruments.
Refer to Note 15 for additional information related to the estimated fair value.
1,2
1
1
2
1,2
1
1
2
11

-- 14 of 156 --

Credit Risk Associated with Derivatives
We have established strict counterparty credit guidelines and enter into transactions only with financial institutions of investment grade or better. We monitor counterparty
exposures regularly and review any downgrade in credit rating immediately. If a downgrade in the credit rating of a counterparty were to occur, we have provisions requiring
collateral for substantially all of our transactions. To mitigate pre-settlement risk, minimum credit standards become more stringent as the duration of the derivative financial
instrument increases. In addition, the Company’s master netting agreements reduce credit risk by permitting the Company to net settle for transactions with the same
counterparty. To minimize the concentration of credit risk, we enter into derivative transactions with a portfolio of financial institutions. Furthermore, for certain derivative
financial instruments, the Company has agreements with counterparties that require collateral to be exchanged based on changes in the fair value of the instruments. The
Company classifies collateral payments and receipts as investing cash flows when the collateral account is in an asset position and as financing cash flows when the collateral
account is in a liability position. As a result of these factors, we consider the risk of counterparty default to be minimal.
Cash Flow Hedging Strategy
The Company uses cash flow hedges to minimize the variability in cash flows of assets or liabilities or forecasted transactions caused by fluctuations in foreign currency
exchange rates, commodity prices or interest rates. The changes in the fair values of derivatives designated as cash flow hedges are recorded in accumulated other
comprehensive income (loss) (“AOCI”) and are reclassified into the line item in our consolidated statement of income in which the hedged items are recorded in the same
period the hedged items affect earnings. The changes in the fair values of hedges that are determined to be ineffective are immediately reclassified from AOCI into income. The
maximum length of time for which the Company hedges its exposure to the variability in future cash flows is typically three years.
The Company maintains a foreign currency cash flow hedging program to reduce the risk that our U.S. dollar net cash inflows from sales outside the United States and U.S.
dollar net cash outflows from procurement activities will be adversely affected by fluctuations in foreign currency exchange rates. We enter into forward contracts and purchase
foreign currency options and collars (principally euro, British pound and Japanese yen) to hedge certain portions of forecasted cash flows denominated in foreign currencies.
When the U.S. dollar strengthens against the foreign currencies, the decline in the present value of future foreign currency cash flows is partially offset by gains in the fair value
of the derivative instruments. Conversely, when the U.S. dollar weakens, the increase in the present value of future foreign currency cash flows is partially offset by losses in
the fair value of the derivative instruments. The total notional values of derivatives that were designated and qualified for the Company’s foreign currency cash flow hedging
program were $10,447 million and $9,760 million as of April 3, 2026 and December 31, 2025, respectively.
The Company uses cross-currency swaps to hedge the changes in cash flows of certain of its foreign currency denominated debt and other monetary assets or liabilities due to
fluctuations in foreign currency exchange rates. For this hedging program, the Company recognizes in earnings each period the changes in carrying values of these foreign
currency denominated assets and liabilities due to fluctuations in exchange rates. The changes in fair values of the cross-currency swap derivatives are recorded in AOCI with
an immediate reclassification into income for the changes in fair values attributable to fluctuations in foreign currency exchange rates. The total notional value of derivatives
that were designated as cash flow hedges for the Company’s foreign currency denominated assets and liabilities was $557 million as of both April 3, 2026 and December 31,
2025.
The Company has entered into commodity futures contracts and other derivative instruments on various commodities to mitigate the price risk associated with forecasted
purchases of materials used in our manufacturing process. These derivative instruments were designated as part of the Company’s commodity cash flow hedging program. The
objective of this hedging program is to reduce the variability of cash flows associated with future purchases of certain commodities. The total notional values of derivatives that
were designated and qualified for this program were $33 million and $53 million as of April 3, 2026 and December 31, 2025, respectively.
Our Company monitors our mix of short-term debt and long-term debt regularly. We manage our risk related to interest rate fluctuations through the use of derivative financial
instruments. From time to time, the Company has entered into interest rate swap agreements and has designated these instruments as part of the Company’s interest rate cash
flow hedging program. The objective of this hedging program is to mitigate the risk of adverse changes in benchmark interest rates on the Company’s future interest payments.
The total notional values of derivatives that were designated and qualified for this program were $778 million and $1,786 million as of April 3, 2026 and December 31, 2025,
respectively.
12

-- 15 of 156 --

The following table presents the pretax impact that changes in the fair values of derivatives designated as cash flow hedges had on other comprehensive income (“OCI”), AOCI
and income (in millions):
Gain (Loss)
Recognized
in OCI Financial Statement Line Item Impacted Gain (Loss) Reclassified
from AOCI into Income
Three Months Ended April 3, 2026
Foreign currency contracts 	$ 	53 Net operating revenues 	$ 	(71)
Foreign currency contracts 	11 Cost of goods sold 	2
Foreign currency contracts 	— Interest expense 	(1)
Foreign currency contracts 	(9) Other income (loss) — net 	(12)
Commodity contracts 	(12) Cost of goods sold 	5
Interest rate contracts 	(2) Interest expense 	(1)
Total 	$ 	41 	$ 	(78)
Three Months Ended March 28, 2025
Foreign currency contracts 	$ 	(269) Net operating revenues 	$ 	41
Foreign currency contracts 	(7) Cost of goods sold 	3
Foreign currency contracts 	— Interest expense 	(1)
Foreign currency contracts 	(4) Other income (loss) — net 	24
Commodity contracts 	3 Cost of goods sold 	3
Interest rate contracts 	— Interest expense 	(1)
Total 	$ 	(277) 	$ 	69
As of April 3, 2026, the Company estimates that it will reclassify into income during the next 12 months net losses of $97 million from the pretax amount recorded in AOCI as
the anticipated cash flows occur.
Fair Value Hedging Strategy
The Company uses interest rate swap agreements designated as fair value hedges to minimize exposure to changes in the fair value of fixed-rate debt that result from
fluctuations in benchmark interest rates. The Company also uses cross-currency interest rate swaps to hedge the changes in the fair value of foreign currency denominated debt
relating to fluctuations in foreign currency exchange rates and benchmark interest rates. The changes in the fair values of derivatives designated as fair value hedges and the
offsetting changes in the fair values of the hedged items are recognized in earnings. As a result, any difference is reflected in earnings as ineffectiveness. When a derivative is
no longer designated as a fair value hedge for any reason, including termination and maturity, the remaining unamortized difference between the carrying value of the hedged
item at that time and the face value of the hedged item is amortized to earnings over the remaining life of the hedged item, or immediately if the hedged item has matured or has
been extinguished. The total notional values of derivatives that were designated and qualified as fair value hedges of this type were $13,501 million and $13,674 million as of
April 3, 2026 and December 31, 2025, respectively.
The following table summarizes the pretax impact that changes in the fair values of derivatives designated as fair value hedges had on income (in millions):
Hedging Instruments and Hedged Items 	Financial Statement Line Item Impacted
Gain (Loss) Recognized in Income
Three Months Ended
April 3,
2026
March 28,
2025
Interest rate contracts 	Interest expense 	$ 	(49) $ 	80
Fixed-rate debt 	Interest expense 	57 	(76)
Net impact of fair value hedging instruments 	$ 	8 $ 	4
13

-- 16 of 156 --

The following table summarizes the amounts recorded in our consolidated balance sheets related to hedged items in fair value hedging relationships (in millions):
Cumulative Amount of Fair Value Hedging Adjustments
Carrying Values of
Hedged Items Included in the Carrying Values of Hedged
Items Remaining for Which Hedge Accounting Has
Been Discontinued
Balance Sheet Location of Hedged Items
April 3,
2026
December 31,
2025
April 3,
2026
December 31,
2025
April 3,
2026
December 31,
2025
Current maturities of long-term debt 	$ 	3,187 $ 	1,491 	$ 	(36) $ 	(10) 	$ 	3 $ 	—
Long-term debt 	9,718 	11,648 	(727) 	(705) 	85 	97
Cumulative amount of fair value hedging adjustments does not include changes due to foreign currency exchange rate fluctuations.
Hedges of Net Investments in Foreign Operations Strategy
The Company uses forward contracts and a portion of its foreign currency denominated debt, a non-derivative financial instrument, to protect the value of our net investments
in a number of foreign operations. In 2025, the Company changed its method for assessing the effectiveness of derivative financial instruments designated as net investment
hedges to include only the changes in fair value attributable to changes in foreign currency spot rates. The changes in the fair values of the effective portion of the derivative
financial instruments are recognized in net foreign currency translation adjustments, a component of AOCI, to offset the changes in the values of the net investments being
hedged. The initial value, and subsequent changes in fair value of the excluded component, are amortized into earnings over the life of the hedging instrument. For non-
derivative financial instruments that are designated and qualify as hedges of net investments in foreign operations, the changes in the carrying values of the designated portions
of the non-derivative financial instruments due to fluctuations in foreign currency exchange rates are recorded in net foreign currency translation adjustments. Any ineffective
portions of net investment hedges are reclassified from AOCI into income during the period of change.
The following table summarizes the notional values and pretax impact of changes in the fair values of instruments designated as net investment hedges (in millions):
Notional Values 	Gain (Loss) Recognized in OCI
as of 	Three Months Ended
April 3,
2026
December 31,
2025
April 3,
2026
March 28,
2025
Foreign currency contracts 	$ 	2,226 $ 	1,067 	$ 	(1) $ 	(1)
Foreign currency denominated debt 	14,705 	14,998 	294 	(605)
Total 	$ 	16,931 $ 	16,065 	$ 	293 $ 	(606)
The Company did not reclassify any gains or losses during the three months ended April 3, 2026, nor the three months ended March 28, 2025. The cash inflows and outflows
associated with the Company’s derivative contracts designated as net investment hedges are classified in the line item other investing activities in our consolidated statement of
cash flows.
Economic (Non-Designated) Hedging Strategy
In addition to derivative instruments that have been designated and qualify for hedge accounting, the Company also uses certain derivatives as economic hedges of foreign
currency, interest rate and commodity exposure. Although these derivatives were not designated and/or did not qualify for hedge accounting, they are effective economic
hedges. The changes in the fair values of economic hedges are immediately recognized in earnings.
The Company uses foreign currency economic hedges to offset the earnings impact that fluctuations in foreign currency exchange rates have on certain monetary assets and
liabilities denominated in nonfunctional currencies. The changes in the fair values of economic hedges used to offset those monetary assets and liabilities are immediately
recognized in earnings in the line item other income (loss) — net in our consolidated statement of income. In addition, we use foreign currency economic hedges to minimize
the variability in cash flows associated with fluctuations in foreign currency exchange rates, including those related to certain acquisition and divestiture activities. The changes
in the fair values of economic hedges used to offset the variability in U.S. dollar net cash flows are immediately recognized in earnings in the line items net operating revenues,
cost of goods sold or other income (loss) — net in our consolidated statement of income, as applicable. The total notional values of derivatives related to our foreign currency
economic hedges were $10,207 million and $9,744 million as of April 3, 2026 and December 31, 2025, respectively.
The Company also uses certain derivatives as economic hedges to mitigate the price risk associated with the purchase of materials used in the manufacturing process and
vehicle fuel. The changes in the fair values of these economic hedges are
1
1
14

-- 17 of 156 --

immediately recognized in earnings in the line items net operating revenues, cost of goods sold, or selling, general and administrative expenses in our consolidated statement of
income, as applicable. The total notional values of derivatives related to our economic hedges of this type were $528 million and $482 million as of April 3, 2026 and
December 31, 2025, respectively.
The following table presents the pretax impact that changes in the fair values of derivatives not designated as hedging instruments had on income (in millions):
Derivatives Not Designated as Hedging Instruments 	Financial Statement Line Item Impacted
Gain (Loss)
Recognized in Income
Three Months Ended
April 3,
2026
March 28,
2025
Foreign currency contracts 	Net operating revenues 	$ 	(39) $ 	(71)
Foreign currency contracts 	Cost of goods sold 	6 	21
Foreign currency contracts 	Other income (loss) — net 	25 	29
Commodity contracts 	Cost of goods sold 	67 	4
Other derivative instruments 	Selling, general and administrative expenses 	— 	1
Total 	$ 	59 $ 	(16)
NOTE 7: SUPPLY CHAIN FINANCE PROGRAM
Our current payment terms with the majority of our suppliers are 120 days. Certain financial institutions offer a voluntary supply chain finance (“SCF”) program, which enables
our suppliers, at their sole discretion, to sell their receivables from the Company to these financial institutions on a non-recourse basis at a rate that leverages our credit rating
and thus may be more beneficial to them. The SCF program is available to suppliers of goods and services included in cost of goods sold and selling, general and administrative
expenses in our consolidated statement of income. The Company and our suppliers agree on contractual terms for the goods and services we procure, including prices,
quantities and payment terms, regardless of whether the supplier elects to participate in the SCF program. The suppliers sell goods or services, as applicable, to the Company
and issue the associated invoices to the Company based on the agreed-upon contractual terms. Then, if they are participating in the SCF program, our suppliers sell their
invoices to the financial institutions. Our suppliers’ voluntary participation in the SCF program has no bearing on our payment terms. No guarantees are provided by the
Company or any of our subsidiaries under the SCF program. We have no economic interest in a supplier’s decision to participate in the SCF program, and we have no direct
financial relationship with the financial institutions, as it relates to the SCF program. Accordingly, amounts due to our suppliers that elected to participate in the SCF program
are included in the line item accounts payable and accrued expenses and liabilities held for sale in our consolidated balance sheet, as applicable. All activity related to amounts
due to suppliers that elected to participate in the SCF program is reflected within the operating activities section of our consolidated statement of cash flows. As of April 3, 2026
and December 31, 2025, the amount of obligations outstanding that the Company has confirmed as valid to the financial institutions under the SCF program was $1,262 million
and $1,363 million, respectively. As of April 3, 2026 and December 31, 2025, these amounts included $32 million and $37 million, respectively, of confirmed obligations
outstanding related to our bottling operations in Africa that are currently held for sale. Refer to Note 2.
NOTE 8: DEBT AND BORROWING ARRANGEMENTS
Loans and notes payable consist primarily of commercial paper issued in the United States. As of April 3, 2026 and December 31, 2025, we had $250 million and
$1,495 million, respectively, in outstanding commercial paper borrowings.
NOTE 9: COMMITMENTS AND CONTINGENCIES
Guarantees
As of April 3, 2026, we were contingently liable for guarantees of indebtedness owed by third parties of $837 million, of which $63 million was related to variable interest
entities. Our guarantees are primarily related to third-party customers, bottlers and vendors and have arisen through the normal course of business. These guarantees have
various terms, and none of these guarantees is individually significant. These amounts represent the maximum potential future payments that we could be required to make
under the guarantees. However, management has concluded that the likelihood of any significant amounts being paid by our Company under these guarantees is remote.
Concentrations of Credit Risk
We believe our exposure to concentrations of credit risk is limited due to the diverse geographic areas covered by our operations.
15

-- 18 of 156 --

Legal Contingencies
The Company is involved in various legal proceedings. We establish reserves for specific legal proceedings when we determine that the likelihood of an unfavorable outcome is
probable and the amount of loss can be reasonably estimated. Management has also identified certain other legal matters where we believe an unfavorable outcome is
reasonably possible and/or for which no estimate of possible losses can be made. Management believes that the total liabilities of the Company that may arise as a result of
currently pending legal proceedings (excluding tax audit claims) will not have a material adverse effect on the Company taken as a whole.
Tax Audits
The Company is involved in various tax matters, with respect to some of which the outcome is uncertain. These uncertain tax matters may result in the assessment of additional
taxes.
On September 17, 2015, the Company received a Statutory Notice of Deficiency (“Notice”) from the United States Internal Revenue Service (“IRS”) seeking approximately
$3.3 billion of additional federal income tax for years 2007 through 2009. In the Notice, the IRS stated its intent to reallocate over $9 billion of income to the U.S. parent
company from certain of its foreign affiliates that the U.S. parent company licensed to manufacture, distribute, sell, market and promote its products in certain non-U.S.
markets.
The Notice concerned the Company’s transfer pricing between its U.S. parent company and certain of its foreign affiliates. IRS rules governing transfer pricing require arm’s-
length pricing of transactions between related parties such as the Company’s U.S. parent and its foreign affiliates.
To resolve the same transfer pricing issue for the tax years 1987 through 1995, the Company and the IRS had agreed in 1996 on an arm’s-length methodology for determining
the amount of U.S. taxable income that the U.S. parent company would report as compensation from its foreign licensees. The Company and the IRS memorialized this accord
in a closing agreement resolving that dispute (“Closing Agreement”). The Closing Agreement provided that, absent a change in material facts or circumstances or relevant
federal tax law, in calculating the Company’s income taxes going forward, the Company would not be assessed penalties by the IRS for using the agreed-upon tax calculation
methodology that the Company and the IRS agreed would be used for the 1987 through 1995 tax years.
The IRS audited and confirmed the Company’s compliance with the agreed-upon Closing Agreement methodology in five successive audit cycles for tax years 1996 through
2006.
The September 17, 2015 Notice from the IRS retroactively rejected the previously agreed-upon methodology for the 2007 through 2009 tax years in favor of an entirely
different methodology, without prior notice to the Company. Using the new tax calculation methodology, the IRS reallocated over $9 billion of income to the U.S. parent
company from its foreign licensees for tax years 2007 through 2009. Consistent with the Closing Agreement, the IRS did not assert penalties, and it has yet to do so.
The IRS designated the Company’s matter for litigation on October 15, 2015. Litigation designation is an IRS determination that forecloses to a company any and all alternative
means for resolution of a tax dispute. As a result of the IRS’ designation of the Company’s matter for litigation, the Company was forced to either accept the IRS’ newly
imposed tax assessment and pay the full amount of the asserted tax or litigate the matter in the federal courts. The matter remains subject to the IRS’ litigation designation,
preventing the Company from any attempt to settle or otherwise mutually resolve the matter with the IRS.
The Company consequently initiated litigation by filing a petition in the U.S. Tax Court (“Tax Court”) in December 2015, challenging the tax adjustments enumerated in the
Notice.
Prior to trial, the IRS increased its transfer pricing adjustment by $385 million, resulting in an additional tax adjustment of $135 million. The Company obtained a summary
judgment in its favor on a different matter related to Mexican foreign tax credits, which thereafter effectively reduced the IRS’ potential tax adjustment by $138 million.
The trial was held in the Tax Court from March through May 2018, and final post-trial briefs were filed and exchanged in April 2019.
On November 18, 2020, the Tax Court issued an opinion (“Opinion”) in which it predominantly sided with the IRS but agreed with the Company that dividends previously paid
by the foreign licensees to the U.S. parent company in reliance upon the Closing Agreement should continue to be allowed to offset royalties, including those that would
become payable to the Company in accordance with the Opinion. On November 8, 2023, the Tax Court issued a supplemental opinion (together with the original Tax Court
opinion, “Opinions”), siding with the IRS in concluding both that certain U.S. tax regulations (known as the blocked-income regulations) that address the effect of certain
Brazilian legal restrictions on royalty payments by the Company’s licensee in Brazil apply to the Company’s operations and that the Tax Court opinion in 3M Co. & Subs. v.
Commissioner (February 9, 2023) (“3M case”) controlled as to the validity of those regulations. On October 1, 2025, the U.S.
16

-- 19 of 156 --

Court of Appeals for the Eighth Circuit issued an opinion reversing the judgment of the Tax Court in the 3M case. In its decision, the court concluded that the blocked-income
regulation was inconsistent with Internal Revenue Code (“IRC”) Section 482 and that the IRS therefore could not reallocate income from 3M’s subsidiary in Brazil to 3M in
contravention of Brazilian restrictions on the payment of royalties. Further, the U.S. Court of Appeals for the Eighth Circuit specifically rejected the IRS’ argument that the
ability of 3M’s subsidiary in Brazil to pay dividends, rather than royalties, meant that royalty income should not be treated as blocked. Both of these conclusions are highly
supportive of the Company’s position in its case and reinforce its prior conclusions.
The Company believes that the IRS and the Tax Court misinterpreted and misapplied the applicable regulations in reallocating income earned by the Company’s foreign
licensees to increase the Company’s U.S. tax. Moreover, the Company believes that the retroactive imposition of such tax liability using a calculation methodology different
from that previously agreed upon by the IRS and the Company, and audited by the IRS for over a decade, is unconstitutional. The Company intends to assert its claims on
appeal and vigorously defend its positions. In addition, for its litigation with the IRS and for purposes of its appeal of the Tax Court decision, the Company continues to
evaluate the implications of several significant administrative law cases recently decided by the U.S. Supreme Court, most notably Loper Bright v. Raimondo, which overruled
Chevron U.S.A., Inc. v. NRDC (“Chevron case”). Since 1984, the Chevron case had required that courts defer to agency interpretations of statutes and agency action. In Ohio v.
EPA and Garland v. Cargill, two of the recent decisions, the U.S. Supreme Court demonstrated how courts are to rule on agency interpretations and actions without the
deference previously required by the Chevron case.
On August 2, 2024, the Tax Court entered a decision reflecting additional federal income tax of $2.7 billion for the 2007 through 2009 tax years. With applicable interest, the
total liability for the 2007 through 2009 tax years resulting from the Tax Court’s decision is $6.0 billion, for which the IRS issued the Company invoices on September 3, 2024.
The Company paid those invoices (“IRS Tax Litigation Deposit”) on September 10, 2024, which stopped interest from accruing on the additional tax due for the 2007 through
2009 tax years. That amount, plus interest earned, would be refunded in full or in part if the Company’s tax positions are ultimately sustained on appeal. For the three months
ended April 3, 2026 and March 28, 2025, the Company recorded net interest income of $55 million and $53 million, respectively, related to this tax payment in the line item
income taxes in our consolidated statements of income, in accordance with our accounting policy. The payment of the IRS invoices and the related accrued interest were
recorded in the line item other noncurrent assets in our consolidated balance sheets as of April 3, 2026 and December 31, 2025. On October 22, 2024, the Company appealed
the Tax Court’s decision to the U.S. Court of Appeals for the Eleventh Circuit. The Company filed its principal appellate brief with the U.S. Court of Appeals for the Eleventh
Circuit on March 12, 2025. The IRS filed its appellate brief on July 7, 2025. The Company filed its reply brief on August 27, 2025.
In determining the amount of tax reserve to be recorded as of December 31, 2020, the Company completed the required two-step evaluation process prescribed by Accounting
Standards Codification 740, Accounting for Income Taxes. In doing so, we consulted with outside advisors, and we reviewed and considered relevant laws, rules, and
regulations, including, but not limited to, the Opinions and relevant caselaw. We also considered our intention to vigorously defend our positions and assert our various well-
founded legal claims via every available avenue of appeal. We concluded, based on the technical and legal merits of the Company’s tax positions, that it is more likely than not
the Company’s tax positions will ultimately be sustained on appeal. In addition, we considered a number of alternative transfer pricing methodologies, including the
methodology asserted by the IRS and affirmed in the Opinions (“Tax Court Methodology”), that could be applied by the courts upon final resolution of the litigation. Based on
the required probability analysis, we determined the methodologies we believe the federal courts could ultimately order to be used in calculating the Company’s tax. As a result
of this analysis, we recorded a tax reserve of $438 million during the year ended December 31, 2020 related to the application of the resulting methodologies as well as the
different tax treatment applicable to dividends originally paid to the U.S. parent company by its foreign licensees, in reliance upon the Closing Agreement, that would be
recharacterized as royalties in accordance with the Opinions and the Company’s analysis.
The Company’s conclusion that it is more likely than not the Company’s tax positions will ultimately be sustained on appeal is unchanged as of April 3, 2026. However, based
on the required probability analysis and the accrual of interest through the current reporting period, we updated our tax reserve as of April 3, 2026 to $520 million.
While the Company strongly disagrees with the IRS’ positions and the portions of the Opinions affirming such positions, it is possible that some portion or all of the
adjustments proposed by the IRS and sustained by the Tax Court could ultimately be upheld. In that event, the Company would not receive a refund of the applicable portion or
all of the $6.0 billion it paid in response to the IRS invoices issued in September 2024 and the related accrued interest receivable of $457 million as of April 3, 2026.
Additionally, the Company would likely be subject to significant additional liabilities for subsequent years, which could have a material adverse impact on the Company’s
financial position, results of operations and cash flows.
The Company calculated the potential impact of applying the Tax Court Methodology to reallocate income from foreign licensees potentially covered within the scope of the
Opinions for the 2010 through 2025 tax years, assuming such methodology were to be ultimately upheld by the courts, and the IRS were to decide to apply that methodology to
subsequent years, with
17

-- 20 of 156 --

consent of the federal courts. This impact would include taxes and interest accrued through December 31, 2025. The calculations incorporated the estimated impact of
correlative adjustments to the previously accrued transition tax payable under the 2017 Tax Cuts and Jobs Act. The Company estimates that the potential aggregate remaining
incremental tax and interest liability for the tax years 2010 through 2025 could be approximately $14 billion as of December 31, 2025. Additional income tax and interest on
any unpaid potential liabilities for the 2010 through 2025 tax years would continue to accrue until the time any such potential liability, or portion thereof, were to be paid. The
Company estimates the impact of the continued application of the Tax Court Methodology for the three months ended April 3, 2026 would increase the potential aggregate
incremental tax and interest liability by approximately $450 million. We currently project the continued application of the Tax Court Methodology in 2026, assuming similar
facts and circumstances as of December 31, 2025 and reflecting changes enacted under the One Big Beautiful Bill Act effective in 2026, would result in an incremental annual
tax liability that would increase the Company’s effective tax rate by approximately 3.8%.
Risk Management Programs
The Company has numerous global insurance programs in place to help protect the Company from the risk of loss. In general, we are self-insured for large portions of many
different types of claims; however, we do use commercial insurance above our self-insured retentions to reduce the Company’s risk of catastrophic loss. Our reserves for the
Company’s self-insured losses are estimated using actuarial methods and assumptions of the insurance industry, adjusted for our specific expectations based on our claims
history. Our self-insurance reserves totaled $159 million and $155 million as of April 3, 2026 and December 31, 2025, respectively.
NOTE 10: OTHER COMPREHENSIVE INCOME
AOCI attributable to shareowners of The Coca-Cola Company is separately presented in our consolidated balance sheet as a component of shareowners’ equity, which also
includes our proportionate share of equity method investees’ AOCI. OCI attributable to noncontrolling interests is allocated to, and included in, our consolidated balance sheet
as part of the line item equity attributable to noncontrolling interests.
AOCI attributable to shareowners of The Coca-Cola Company consisted of the following, net of tax (in millions):
April 3,
2026
December 31,
2025
Net foreign currency translation adjustments 	$ 	(12,671) $ 	(12,673)
Accumulated net gains (losses) on derivatives 	(173) 	(244)
Unrealized net gains (losses) on available-for-sale debt securities 	(37) 	(26)
Adjustments to pension and other postretirement benefit liabilities 	(1,159) 	(1,188)
Accumulated other comprehensive income (loss) 	$ 	(14,040) $ 	(14,131)
The following table summarizes the allocation of total comprehensive income between shareowners of The Coca-Cola Company and noncontrolling interests (in millions):
Three Months Ended April 3, 2026
Shareowners of
The Coca-Cola Company
Noncontrolling
Interests 	Total
Consolidated net income 	$ 	3,924 $ 	42 $ 	3,966
Other comprehensive income:
Net foreign currency translation adjustments 	2 	(44) 	(42)
Net gains (losses) on derivatives 	71 	— 	71
Net change in unrealized gains (losses) on available-for-sale debt securities 	(11) 	— 	(11)
Net change in pension and other postretirement benefit liabilities 	29 	— 	29
Total comprehensive income (loss) 	$ 	4,015 $ 	(2) $ 	4,013
Refer to Note 6 for additional information related to the net gains or losses on derivative instruments.
Refer to Note 4 for additional information related to the net unrealized gains or losses on available-for-sale debt securities.
1
2
1
2
18

-- 21 of 156 --

The following tables present OCI attributable to shareowners of The Coca-Cola Company, including our proportionate share of equity method investees’ OCI (in millions):
Three Months Ended April 3, 2026 	Before-Tax Amount 	Income Tax After-Tax Amount
Foreign currency translation adjustments:
Translation adjustments arising during the period 	$ 	250 $ 	20 $ 	270
Gains (losses) on intra-entity transactions that are of a long-term investment nature 	(490) 	— 	(490)
Gains (losses) on net investment hedges arising during the period 	293 	(71) 	222
Net foreign currency translation adjustments 	$ 	53 $ 	(51) $ 	2
Derivatives:
Gains (losses) arising during the period 	$ 	22 $ 	(10) $ 	12
Reclassification adjustments recognized in net income 	78 	(19) 	59
Net gains (losses) on derivatives 	$ 	100 $ 	(29) $ 	71
Available-for-sale debt securities:
Unrealized gains (losses) arising during the period 	$ 	(15) $ 	4 $ 	(11)
Net change in unrealized gains (losses) on available-for-sale debt securities 	$ 	(15) $ 	4 $ 	(11)
Pension and other postretirement benefit liabilities:
Net pension and other postretirement benefit liabilities arising during the period 	$ 	14 $ 	(1) $ 	13
Reclassification adjustments recognized in net income 	21 	(5) 	16
Net change in pension and other postretirement benefit liabilities 	$ 	35 $ 	(6) $ 	29
Other comprehensive income (loss) attributable to shareowners of The Coca-Cola
Company 	$ 	173 $ 	(82) $ 	91
Refer to Note 6 for additional information related to the net gains or losses on derivative instruments.
Refer to Note 4 for additional information related to the net unrealized gains or losses on available-for-sale debt securities.
Three Months Ended March 28, 2025 	Before-Tax Amount 	Income Tax After-Tax Amount
Foreign currency translation adjustments:
Translation adjustments arising during the period 	$ 	8 $ 	(9) $ 	(1)
Reclassification adjustments recognized in net income 	34 	(2) 	32
Gains (losses) on intra-entity transactions that are of a long-term investment nature 	1,010 	— 	1,010
Gains (losses) on net investment hedges arising during the period 	(606) 	151 	(455)
Net foreign currency translation adjustments 	$ 	446 $ 	140 $ 	586
Derivatives:
Gains (losses) arising during the period 	$ 	(274) $ 	69 $ 	(205)
Reclassification adjustments recognized in net income 	(69) 	17 	(52)
Net gains (losses) on derivatives 	$ 	(343) $ 	86 $ 	(257)
Available-for-sale debt securities:
Unrealized gains (losses) arising during the period 	$ 	16 $ 	(4) $ 	12
Reclassification adjustments recognized in net income 	1 	— 	1
Net change in unrealized gains (losses) on available-for-sale debt securities 	$ 	17 $ 	(4) $ 	13
Pension and other postretirement benefit liabilities:
Net pension and other postretirement benefit liabilities arising during the period 	$ 	(17) $ 	10 $ 	(7)
Reclassification adjustments recognized in net income 	33 	(7) 	26
Net change in pension and other postretirement benefit liabilities 	$ 	16 $ 	3 $ 	19
Other comprehensive income (loss) attributable to shareowners of The Coca-Cola
Company 	$ 	136 $ 	225 $ 	361
Refer to Note 6 for additional information related to the net gains or losses on derivative instruments.
Refer to Note 4 for additional information related to the net unrealized gains or losses on available-for-sale debt securities.
1
1
2
1
2
1
1
2
1
2
19

-- 22 of 156 --

The following table presents the amounts and line items in our consolidated statement of income where adjustments reclassified from AOCI into income were recorded
(in millions):
Amount Reclassified from
AOCI
into Income
Description of AOCI Component 	Financial Statement Line Item Impacted
Three Months Ended April 3,
2026
Derivatives:
Foreign currency contracts 	Net operating revenues 	$ 	71
Foreign currency and commodity contracts 	Cost of goods sold 	(7)
Foreign currency and interest rate contracts 	Interest expense 	2
Foreign currency contracts 	Other income (loss) — net 	12
Income before income taxes 	78
Income taxes 	(19)
Consolidated net income 	$ 	59
Pension and other postretirement benefit liabilities:
Amortization of net actuarial loss (gain) 	Other income (loss) — net 	$ 	21
Income before income taxes 	21
Income taxes 	(5)
Consolidated net income 	$ 	16
NOTE 11: CHANGES IN EQUITY
The following tables provide a reconciliation of the beginning and ending carrying amounts of total equity, equity attributable to shareowners of The Coca-Cola Company and
equity attributable to noncontrolling interests (in millions):
Shareowners of The Coca-Cola Company
Three Months Ended April 3, 2026 Common Shares
Outstanding 	Total Reinvested
Earnings
Accumulated Other
Comprehensive
Income (Loss) Common Stock Capital Surplus 	Treasury Stock Non-controlling
Interests
December 31, 2025 	4,302 $ 	34,275 $ 	80,382 $ 	(14,131) $ 	1,760 $ 	20,581 $ 	(56,423) $ 	2,106
Comprehensive income (loss) 	— 	4,013 	3,924 	91 	— 	— 	— 	(2)
Dividends paid/payable to
shareowners of The Coca-Cola
Company ($0.53 per share) 	— 	(2,280) 	(2,280) 	— 	— 	— 	— 	—
Dividends paid to noncontrolling
interests 	— 	(3) 	— 	— 	— 	— 	— 	(3)
Purchases of treasury stock 	(5) 	(361) 	— 	— 	— 	— 	(361) 	—
Impact related to stock-based
compensation plans 	6 	90 	— 	— 	— 	53 	37 	—
April 3, 2026 	4,303 $ 	35,734 $ 	82,026 $ 	(14,040) $ 	1,760 $ 	20,634 $ 	(56,747) $ 	2,101
20

-- 23 of 156 --

Shareowners of The Coca-Cola Company
Three Months Ended March 28, 2025
Common Shares
Outstanding 	Total
Reinvested
Earnings
Accumulated Other
Comprehensive
Income (Loss) Common Stock Capital Surplus 	Treasury Stock
Non-controlling
Interests
December 31, 2024 	4,302 $ 	26,372 $ 	76,054 $ 	(16,843) $ 	1,760 $ 	19,801 $ 	(55,916) $ 	1,516
Comprehensive income (loss) 	— 	3,729 	3,330 	361 	— 	— 	— 	38
Dividends paid/payable to
shareowners of The Coca-Cola
Company ($0.51 per share) 	— 	(2,195) 	(2,195) 	— 	— 	— 	— 	—
Dividends paid to noncontrolling
interests 	— 	(2) 	— 	— 	— 	— 	— 	(2)
Purchases of treasury stock 	(4) 	(279) 	— 	— 	— 	— 	(279) 	—
Impact related to stock-based
compensation plans 	6 	129 	— 	— 	— 	72 	57 	—
March 28, 2025 	4,304 $ 	27,754 $ 	77,189 $ 	(16,482) $ 	1,760 $ 	19,873 $ 	(56,138) $ 	1,552
NOTE 12: SIGNIFICANT OPERATING AND NONOPERATING ITEMS
Other Operating Charges
During the three months ended April 3, 2026, the Company recorded other operating charges of $21 million. These charges included $10 million related to an indemnification
agreement entered into as a part of the refranchising of certain of our bottling operations, $4 million related to North America modernization initiatives, $4 million for the
amortization of noncompete agreements related to the BA Sports Nutrition, LLC (“BodyArmor”) acquisition in 2021 and $3 million related to tax litigation expense.
During the three months ended March 28, 2025, the Company recorded other operating charges of $73 million. These charges consisted of $47 million related to the
remeasurement of our contingent consideration liability to fair value in conjunction with our acquisition of fairlife, LLC (“fairlife”) in 2020, which brought the total liability to
$6,173 million and was paid in March 2025. Additionally, other operating charges included $11 million related to the Company’s productivity and reinvestment program,
$9 million related to an indemnification agreement entered into as a part of the refranchising of certain of our bottling operations, $3 million for the amortization of noncompete
agreements related to the BodyArmor acquisition and $3 million related to tax litigation expense.
Refer to Note 9 for additional information on the tax litigation.
Other Nonoperating Items
Equity Income (Loss) — Net
During the three months ended April 3, 2026 and March 28, 2025, the Company recorded net charges of $33 million and $8 million, respectively. These amounts represent the
Company’s proportionate share of significant operating and nonoperating items recorded by certain of our equity method investees.
Other Income (Loss) — Net
During the three months ended April 3, 2026, the Company recognized a net loss of $19 million related to realized and unrealized gains and losses on equity securities and
trading debt securities as well as realized gains and losses on available-for-sale debt securities. The Company also recorded an impairment charge of $10 million related to our
bottling operations in Africa, which are held for sale.
During the three months ended March 28, 2025, the Company recognized a gain of $331 million related to the sale of a portion of our ownership interest in CCEP, an
impairment charge of $25 million related to an equity method investee in Latin America and a net loss of $19 million related to realized and unrealized gains and losses on
equity securities and trading debt securities as well as realized gains and losses on available-for-sale debt securities. The Company also recorded charges of $25 million and
$11 million for special termination benefits and a curtailment loss, respectively, related to non-U.S. pension activity.
Refer to Note 2 for additional information on our bottling operations in Africa and the sale of our ownership interest in CCEP. Refer to Note 4 for additional information on
equity and debt securities. Refer to Note 13 for additional information on the non-U.S. pension curtailment and special termination benefits. Refer to Note 15 for additional
information on the impairment charges.
21

-- 24 of 156 --

NOTE 13: PENSION AND OTHER POSTRETIREMENT BENEFIT PLANS
Net periodic benefit cost or income for our pension and other postretirement benefit plans consisted of the following (in millions):
Pension Plans
Other Postretirement
Benefit Plans
Three Months Ended
April 3,
2026 March 28,
2025 April 3,
2026 March 28,
2025
Service cost 	$ 	26 $ 	26 	$ 	1 $ 	1
Interest cost 	76 	75 	2 	3
Expected return on plan assets 	(98) 	(104) 	(1) 	(1)
Amortization of prior service cost (credit) 	1 	— 	(1) 	(1)
Amortization of net actuarial loss (gain) 	21 	25 	— 	—
Curtailment loss (gain) 	— 	11 	— 	—
Special termination benefits 	— 	25 	— 	—
Net periodic benefit cost (income) 	$ 	26 $ 	58 	$ 	1 $ 	2
The weighted-average expected long-term rates of return on plan assets used in computing 2026 net periodic benefit cost (income) were 6.25% for pension plans and 6.75% for other
postretirement benefit plans.
The curtailment loss and special termination benefits were primarily related to the benefit uplifts provided by the Company to active participants pursuant to the group annuity purchase (“buy-
in”) for a non-U.S. defined benefit plan. The Company intends to convert the buy-in to a buy-out in the future, at which time the insurer would assume full responsibility for the plan obligations.
All of the amounts in the table above, other than service cost, were recorded in the line item other income (loss) — net in our consolidated statements of income. During the
three months ended April 3, 2026, the Company contributed $9 million to our pension trusts. We anticipate making additional contributions of approximately $18 million
during the remainder of 2026. The Company contributed $11 million to our pension trusts, offset by a $61 million transfer of surplus non-U.S. plan assets from pension trusts to
general assets of the Company during the three months ended March 28, 2025.
NOTE 14: INCOME TAXES
The Company recorded income taxes of $645 million (14.0% effective tax rate) and $722 million (17.8% effective tax rate) during the three months ended April 3, 2026 and
March 28, 2025, respectively.
The Company’s effective tax rates for the three months ended April 3, 2026 and March 28, 2025 vary from the statutory U.S. federal tax rate of 21.0%, primarily due to the tax
impact of significant operating and nonoperating items, as described in Note 12, along with the tax benefits of having significant earnings generated outside of the United States
and significant earnings generated in investments accounted for under the equity method, both of which are generally taxed at rates lower than the statutory U.S. federal tax
rate.
The Company’s effective tax rate for the three months ended April 3, 2026 included $279 million of net tax benefits related to various discrete tax items, including net interest
income of $55 million related to the IRS Tax Litigation Deposit recorded in the line item income taxes in our consolidated statement of income, in accordance with our
accounting policy, and a tax benefit of $194 million, primarily related to return to provision adjustments.
The Company’s effective tax rate for the three months ended March 28, 2025 included $143 million of net tax benefits related to various discrete tax items, including net
interest income of $53 million related to the IRS Tax Litigation Deposit recorded in the line item income taxes in our consolidated statement of income, in accordance with our
accounting policy, and a tax benefit of $85 million related to a change in the Company’s indefinite reinvestment assertion for certain foreign entities.
During the three months ended April 3, 2026, the Company invested $32 million in limited partnerships that receive tax credits and other tax benefits by constructing, owning
and operating alternative energy generation facilities. During the three months ended April 3, 2026, the Company received tax credits and other income tax benefits of
$3 million and recognized amortization expense of $2 million related to all of our investments of this nature. The amount of non-income tax-related activity and other returns
related to these investments was not material during the three months ended April 3, 2026.
During the three months ended March 28, 2025, the Company invested $30 million in limited partnerships that receive tax credits and other tax benefits by constructing,
owning and operating alternative energy generation facilities. During the three months ended March 28, 2025, the Company received tax credits and other income tax benefits
of $9 million and recognized amortization expense of $7 million related to all of our investments of this nature. The amount of non-income tax-related activity and other returns
related to these investments was not material during the three months ended March 28, 2025.
1
2
2
1
2
22

-- 25 of 156 --

As of April 3, 2026 and December 31, 2025, the carrying values of these investments were $30 million and $32 million, respectively. The Company has no unfunded
commitments related to these investments as of April 3, 2026. The Company recorded $32 million of unfunded commitments related to these investments in the line item
accounts payable and accrued expenses in our consolidated balance sheet as of December 31, 2025.
We are currently in litigation with the IRS for tax years 2007 through 2009. Refer to Note 9.
NOTE 15: FAIR VALUE MEASUREMENTS
Recurring Fair Value Measurements
The following tables summarize assets and liabilities measured at fair value on a recurring basis (in millions):
April 3, 2026 	Level 1 	Level 2 	Level 3 	Other
Netting
Adjustment
Fair Value
Measurements
Assets:
Equity securities with readily determinable values 	$ 	2,131 $ 	493 $ 	70 	$ 	187 $ 	— 	$ 	2,881
Debt securities 	— 	2,630 	— 	— 	— 	2,630
Derivatives 	— 	610 	— 	— 	(506) 	104
Total assets 	$ 	2,131 $ 	3,733 $ 	70 	$ 	187 $ 	(506) 	$ 	5,615
Liabilities:
Derivatives 	$ 	26 $ 	1,015 $ 	— 	$ 	— $ 	(999) 	$ 	42
Total liabilities 	$ 	26 $ 	1,015 $ 	— 	$ 	— $ 	(999) 	$ 	42
Refer to Note 4 for additional information related to the composition of our equity securities with readily determinable values and debt securities.
Refer to Note 6 for additional information related to the composition of our derivatives portfolio.
Certain investments that are measured at fair value using the net asset value per share (or its equivalent) practical expedient have not been categorized in the fair value hierarchy but are included
to reconcile to the amounts presented in Note 4.
Amounts represent the impact of legally enforceable master netting agreements that allow the Company to settle net positive and negative positions and also cash collateral held or placed with
the same counterparties. There were no amounts subject to legally enforceable master netting agreements that management has chosen not to offset or that do not meet the offsetting
requirements. Refer to Note 6.
The Company is obligated to return $60 million in cash collateral it has netted against its derivative position.
The Company has the right to reclaim $551 million in cash collateral it has netted against its derivative position.
The Company’s derivative financial instruments were recorded at fair value in our consolidated balance sheet as follows: $12 million in the line item assets held for sale, $92 million in the line
item other noncurrent assets, $2 million in the line item liabilities held for sale and $40 million in the line item other noncurrent liabilities. Refer to Note 6 for additional information related to the
composition of our derivatives portfolio.
3 	4
1
1
2 	5 	7
2 	6 	7
1
2
3
4
5
6
7
23

-- 26 of 156 --

December 31, 2025 	Level 1 	Level 2 	Level 3 	Other
Netting
Adjustment
Fair Value
Measurements
Assets:
Equity securities with readily determinable values 	$ 	2,148 $ 	237 $ 	61 	$ 	143 $ 	— 	$ 	2,589
Debt securities 	— 	1,824 	— 	— 	— 	1,824
Derivatives 	— 	441 	— 	— 	(403) 	38
Total assets 	$ 	2,148 $ 	2,502 $ 	61 	$ 	143 $ 	(403) 	$ 	4,451
Liabilities:
Derivatives 	$ 	9 $ 	1,040 $ 	— 	$ 	— $ 	(954) 	$ 	95
Total liabilities 	$ 	9 $ 	1,040 $ 	— 	$ 	— $ 	(954) 	$ 	95
Refer to Note 4 for additional information related to the composition of our equity securities with readily determinable values and debt securities.
Refer to Note 6 for additional information related to the composition of our derivatives portfolio.
Certain investments that are measured at fair value using the net asset value per share (or its equivalent) practical expedient have not been categorized in the fair value hierarchy but are included
to reconcile to the amounts presented in Note 4.
Amounts represent the impact of legally enforceable master netting agreements that allow the Company to settle net positive and negative positions and also cash collateral held or placed with
the same counterparties. There were no amounts subject to legally enforceable master netting agreements that management has chosen not to offset or that do not meet the offsetting
requirements. Refer to Note 6.
The Company was obligated to return $48 million in cash collateral it had netted against its derivative position.
The Company had the right to reclaim $597 million in cash collateral it had netted against its derivative position.
The Company’s derivative financial instruments were recorded at fair value in our consolidated balance sheet as follows: $3 million in the line item assets held for sale, $35 million in the line
item other noncurrent assets, $5 million in the line item liabilities held for sale and $90 million in the line item other noncurrent liabilities. Refer to Note 6 for additional information related to the
composition of our derivatives portfolio.
Gross realized and unrealized gains and losses on Level 3 assets and liabilities were not significant for the three months ended April 3, 2026. Gross realized and unrealized
gains and losses on Level 3 assets and liabilities, excluding the remeasurement of the fairlife contingent consideration liability, were not significant for the three months ended
March 28, 2025. Refer to Note 12 for additional information on the fairlife contingent consideration liability.
The Company recognizes transfers between levels within the hierarchy as of the beginning of the reporting period. Gross transfers between levels within the hierarchy were not
significant for the three months ended April 3, 2026 and March 28, 2025.
Nonrecurring Fair Value Measurements
During the three months ended April 3, 2026, the Company recorded an impairment charge of $10 million related to our bottling operations in Africa, which are held for sale,
based on Level 3 inputs. Refer to Note 2. During the three months ended March 28, 2025, the Company recorded an other-than-temporary impairment charge of $25 million
related to a joint venture in Latin America. This impairment charge was derived using Level 3 inputs and was due to the joint venture’s restructuring and planned liquidation.
These charges were recorded in the line item other income (loss) — net in our consolidated statements of income.
Other Fair Value Disclosures
The carrying values of cash and cash equivalents, short-term investments, trade accounts receivable, accounts payable and accrued expenses, and loans and notes payable
approximate their fair values because of the relatively short-term maturities of these financial instruments. The fair value of our long-term debt is estimated using Level 2 inputs
based on quoted prices for those instruments. Where quoted prices are not available, the fair value is estimated using discounted cash flows and market-based expectations for
interest rates, credit risk and the contractual terms of the debt instruments. As of April 3, 2026, the carrying value and fair value of our long-term debt, including the current
portion, were $43,558 million and $40,088 million, respectively. As of December 31, 2025, the carrying value and fair value of our long-term debt, including the current
portion, were $43,941 million and $39,385 million, respectively.
3 	4
1
1
2 	5 	7
2 	6 	7
1
2
3
4
5
6
7
24

-- 27 of 156 --

NOTE 16: OPERATING SEGMENTS
Our organizational structure consists of the following five operating segments: Europe, Middle East and Africa (“EMEA”), Latin America, North America, Asia Pacific, and
Bottling Investments. Information about our Company’s operations by operating segment and Corporate is as follows (in millions):
EMEA Latin
America North
America 	Asia Pacific Bottling
Investments Operating
Segments Total 	Corporate 	Eliminations 	Consolidated
Three Months Ended April 3, 2026
Net operating revenues:
Third party 	$ 	2,807 $ 	1,678 $ 	4,891 $ 	1,426 $ 	1,638 $ 	12,440 $ 	32 $ 	— $ 	12,472
Intersegment 	205 	— 	2 	82 	2 	291 	— 	(291) 	—
Total net operating revenues 	3,012 	1,678 	4,893 	1,508 	1,640 	12,731 	32 	(291) 	12,472
Cost of goods sold 	769 	274 	2,332 	517 	1,111 	5,003 	(92) 	(291) 	4,620
Selling, general and administrative expenses 	984 	366 	951 	455 	338 	3,094 	378 	— 	3,472
Other operating charges 	— 	— 	4 	— 	— 	4 	17 	— 	21
Operating income (loss) 	$ 	1,259 $ 	1,038 $ 	1,606 $ 	536 $ 	191 $ 	4,630 $ 	(271) $ 	— $ 	4,359
Interest income 	222
Interest expense 	375
Equity income (loss) — net 	384
Other income (loss) — net 	21
Income before income taxes 	$ 	4,611
Other segment information:
Capital expenditures 	$ 	53 $ 	— $ 	83 $ 	1 $ 	74 $ 	211 $ 	55 $ 	— $ 	266
Depreciation and amortization 	48 	8 	99 	11 	83 	249 	15 	— 	264
Three Months Ended March 28, 2025
Net operating revenues:
Third party 	$ 	2,481 $ 	1,477 $ 	4,359 $ 	1,325 $ 	1,461 $ 	11,103 $ 	26 $ 	— $ 	11,129
Intersegment 	176 	— 	2 	96 	2 	276 	— 	(276) 	—
Total net operating revenues 	2,657 	1,477 	4,361 	1,421 	1,463 	11,379 	26 	(276) 	11,129
Cost of goods sold 	759 	274 	2,106 	390 	1,010 	4,539 	(100) 	(276) 	4,163
Selling, general and administrative expenses 	833 	299 	914 	407 	334 	2,787 	447 	— 	3,234
Other operating charges 	— 	— 	— 	— 	— 	— 	73 	— 	73
Operating income (loss) 	$ 	1,065 $ 	904 $ 	1,341 $ 	624 $ 	119 $ 	4,053 $ 	(394) $ 	— $ 	3,659
Interest income 	180
Interest expense 	387
Equity income (loss) — net 	351
Other income (loss) — net 	254
Income before income taxes 	$ 	4,057
Other segment information:
Capital expenditures 	$ 	41 $ 	— $ 	115 $ 	1 $ 	105 $ 	262 $ 	47 $ 	— $ 	309
Depreciation and amortization 	44 	7 	81 	12 	76 	220 	47 	— 	267
Effective March 31, 2026, our Company’s chief operating decision maker (“CODM”) is our Chief Executive Officer. Information about total assets by segment is not disclosed
because such information is not regularly provided to, or used by, our CODM.
25

-- 28 of 156 --

During the three months ended April 3, 2026 and March 28, 2025, our operating segments and Corporate were impacted by acquisition and divestiture activities. Refer to
Note 2. Additionally, during the three months ended April 3, 2026 and March 28, 2025, our operating segments and Corporate were impacted by certain significant operating
and nonoperating items. Refer to Note 12.
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
When used in this report, the terms “The Coca-Cola Company,” “Company,” “we,” “us” and “our” mean The Coca-Cola Company and all entities included in our consolidated
financial statements.
CRITICAL ACCOUNTING POLICIES AND ESTIMATES
Recoverability of Equity Method Investments and Indefinite-Lived Intangible Assets
Our Company faces many uncertainties and risks related to various economic, political and regulatory environments in the countries and territories in which we operate,
particularly in developing and emerging markets. Refer to the headings “Item 1A. Risk Factors” in Part I and “Our Business — Challenges and Risks” in Part II of our Annual
Report on Form 10-K for the year ended December 31, 2025, as well as the heading “Operations Review” below, for additional information related to our present business
environment. As a result, management must make numerous assumptions, which involve a significant amount of judgment, when performing impairment tests of equity method
investments and indefinite-lived intangible assets in various regions around the world. The performance of impairment tests involves critical accounting estimates. These
estimates require significant management judgment and include inherent uncertainties. Factors that management must estimate include, among others, the economic lives of the
assets, sales volume, pricing, royalty rates, cost of raw materials, delivery costs, long-term growth rates, discount rates, marketing spending, foreign currency exchange rates,
tax rates, capital spending and proceeds from the sale of assets. The variability of these factors depends on a number of conditions, and thus our accounting estimates may
change from period to period. These factors are even more difficult to estimate given the highly volatile global financial markets. As these factors are often interdependent and
may not change in isolation, we do not believe it is practicable or meaningful to present the impact of changing a single factor.
During the three months ended December 31, 2025, the operating results related to our BodyArmor sports performance and hydration beverage business, combined with lower
expectations of future performance compared to the original forecasts, triggered the need to update the Company’s impairment analysis, including a reassessment of the
business projections for the trademark. Based on this assessment, the Company concluded that the fair value of the trademark was less than its carrying value and recorded an
impairment charge of $960 million. The decrease in fair value was primarily driven by the revised projections of future operating results, including a slowing of the projected
long-term growth rate for the category, an intensifying competitive environment, and more focused innovation and international rollout plans. The remaining carrying value of
the trademark is $2,440 million. As of April 3, 2026, the fair value of this trademark approximates its carrying value. If the near-term operating results of this trademark do not
achieve our revised financial projections, or if the macroeconomic conditions change, causing the discount rate to increase without an offsetting increase in the operating
results, it is likely that we would be required to recognize an additional impairment charge. Management will continue to monitor the fair value of this trademark in future
periods.
OPERATIONS REVIEW
Sales of our ready-to-drink beverages are somewhat seasonal, with the second and third calendar quarters typically accounting for the highest sales volumes. The volume of
sales in the beverage business may be affected by weather conditions.
While our operations are primarily local, we remain subject to global trade dynamics, which may impact certain components of our cost structure as well as the cost structures
of our bottlers and our customers and may affect consumer sentiment across our markets.
Structural Changes, Acquired Brands and Newly Licensed Brands
In order to continually improve upon the Company’s operating performance, from time to time we engage in buying and selling ownership interests in bottling partners and
other manufacturing operations. In addition, we periodically acquire brands and their related operations or enter into license agreements for certain brands to supplement our
beverage offerings. These items impact our operating results and certain key metrics used by management in assessing the Company’s performance.
Unit case volume growth is a key metric used by management to evaluate the Company’s performance because it measures demand for our products at the consumer level. The
Company’s unit case volume represents the number of unit cases (or unit case equivalents) of Company beverage products directly or indirectly sold by the Company and its
bottling partners (“Coca-Cola system”) to customers or consumers and, therefore, reflects unit case volume for both consolidated and unconsolidated bottlers. Refer to the
heading “Beverage Volume” below.
26

-- 29 of 156 --

Concentrate sales volume represents the amount of concentrates, syrups, source waters and powders/minerals (in all instances expressed in unit case equivalents) sold by, or
used in finished products sold by, the Company to its bottling partners or other customers. For our Costa non-ready-to-drink beverage products, concentrate sales volume
represents the amount of beverages, primarily measured in number of transactions (in all instances expressed in unit case equivalents), sold by the Company to customers or
consumers. Refer to the heading “Beverage Volume” below.
When we analyze our net operating revenues, we generally consider the following factors: (1) volume growth (concentrate sales volume or unit case volume, as applicable); (2)
changes in price/mix; (3) foreign currency exchange rate fluctuations; and (4) acquisitions and divestitures (including structural changes as defined below), as applicable. Refer
to the heading “Net Operating Revenues” below. The Company sells concentrates and syrups to both consolidated and unconsolidated bottling partners. The ownership
structure of our bottling partners impacts the timing of recognizing concentrate revenue and concentrate sales volume. When we sell concentrates or syrups to our consolidated
bottling partners, we do not recognize the concentrate revenue or concentrate sales volume until the bottling partner has sold finished products manufactured from the
concentrates or syrups to a third party. When we sell concentrates or syrups to our unconsolidated bottling partners, we recognize the concentrate revenue and concentrate sales
volume when the concentrates or syrups are sold to the bottling partner. The subsequent sale of the finished products manufactured from the concentrates or syrups to a third
party does not impact the timing of recognizing the concentrate revenue or concentrate sales volume. When we account for an unconsolidated bottling partner as an equity
method investment, we eliminate the intercompany profit related to concentrate sales to the extent of our ownership interest, until the equity method investee has sold finished
products manufactured from the concentrates or syrups to a third party. We typically report unit case volume when finished products manufactured from the concentrates or
syrups are sold to a third party, regardless of our ownership interest in the bottling partner, if any.
We generally refer to acquisitions and divestitures of bottling operations as “structural changes,” which are a component of acquisitions and divestitures. Typically, structural
changes do not impact the Company’s unit case volume on a consolidated basis or at the geographic operating segment level. We recognize unit case volume for all sales of
Company beverage products, regardless of our ownership interest in the bottling partner, if any. However, the unit case volume reported by our Bottling Investments operating
segment is generally impacted by structural changes because it only includes the unit case volume of our consolidated bottling operations. Refer to Note 2 of Notes to
Consolidated Financial Statements for additional information on the Company’s acquisitions and divestitures.
“Acquired brands” refers to brands acquired during the past 12 months. Typically, the Company has not reported unit case volume or recognized concentrate sales volume
related to acquired brands in periods prior to the closing of a transaction. Therefore, the unit case volume and concentrate sales volume related to an acquired brand are
incremental to prior year volume. We generally do not consider the acquisition of a brand to be a structural change.
“Licensed brands” refers to brands not owned by the Company but for which we hold certain rights, generally including, but not limited to, distribution rights, and from which
we derive an economic benefit when the related products are sold. Typically, the Company has not reported unit case volume or recognized concentrate sales volume related to
a licensed brand in periods prior to the beginning of the term of a license agreement. Therefore, in the year that a license agreement is entered into, the unit case volume and
concentrate sales volume related to a licensed brand are incremental to prior year volume. We generally do not consider the licensing of a brand to be a structural change.
In May 2025, the Company refranchised our bottling operations in certain territories in India. The impact of this refranchising has been included as a structural change in our
analysis of net operating revenues on a consolidated basis as well as for the Bottling Investments and Asia Pacific operating segments for the three months ended April 3, 2026.
Additionally, in October 2025, the Company sold our finished product operations in Nigeria. The impact of this sale has been included as a divestiture in our analysis of net
operating revenues on a consolidated basis as well as for the EMEA operating segment for the three months ended April 3, 2026.
Beverage Volume
We measure the volume of Company beverage products sold in two ways: (1) unit cases of finished products and (2) concentrate sales. As used in this report, “unit case” means
a unit of measurement equal to 192 U.S. fluid ounces of finished beverage (24 eight-ounce servings), with the exception of unit case equivalents for Costa non-ready-to-drink
beverage products, which are primarily measured in number of transactions; and “unit case volume” means the number of unit cases (or unit case equivalents) of Company
beverage products directly or indirectly sold by the Company and its bottling partners to customers or consumers. Unit case volume primarily consists of beverage products
bearing Company trademarks. Also included in unit case volume are certain brands licensed to, or distributed by, our Company, and brands owned by Coca-Cola system bottlers
for which our Company provides marketing support and from the sale of which we derive an economic benefit. In addition, unit case volume includes sales by certain joint
ventures in which the Company has an ownership interest. We believe unit case volume is one of the indicators of the underlying strength of the Coca-Cola system because it
measures demand for our products at the consumer level. The unit case volume numbers used in this report are derived based on estimates received by the
27

-- 30 of 156 --

Company from its bottling partners and distributors. Concentrate sales volume represents the amount of concentrates, syrups, source waters and powders/minerals (in all
instances expressed in unit case equivalents) sold by, or used in finished beverages sold by, the Company to its bottling partners or other customers. For Costa non-ready-to-
drink beverage products, concentrate sales volume represents the amount of beverages, primarily measured in number of transactions (in all instances expressed in unit case
equivalents), sold by the Company to customers or consumers. Unit case volume and concentrate sales volume growth rates are not necessarily equal during any given period.
Factors such as seasonality, bottlers’ inventory practices, supply point changes, timing of price increases, new product introductions and changes in product mix can create
differences between unit case volume and concentrate sales volume growth rates. In addition to these items, the impact of unit case volume from certain joint ventures in which
the Company has an ownership interest, but to which the Company does not sell concentrates, syrups, source waters or powders/minerals, may give rise to differences between
unit case volume and concentrate sales volume growth rates.
Information about our volume growth worldwide and for each of our operating segments is as follows:
Percent Change 2026 versus 2025
Three Months Ended
April 3, 2026
Unit Cases 	Concentrate Sales
Worldwide 	3% 	8%
EMEA 	2 	5
Latin America 	1 	7
North America 	4 	11
Asia Pacific 	5 	10
Bottling Investments 	1 	N/A
Bottling Investments operating segment data reflects unit case volume growth for consolidated bottlers only.
Geographic operating segment data reflects unit case volume growth for all bottlers, both consolidated and unconsolidated, and distributors in the applicable geographic areas. Unit case volume
growth for Costa retail stores is reflected in the EMEA operating segment data.
Unit case volume percent change is based on average daily sales. Unit case volume growth based on average daily sales is computed by comparing the average daily sales in each of the
corresponding periods. Average daily sales are the unit cases sold during the period divided by the number of days in the period.
Concentrate sales volume represents the amount of concentrates, syrups, source waters and powders/minerals (in all instances expressed in unit case equivalents) sold by, or used in finished
beverages sold by, the Company to its bottling partners or other customers and is not based on average daily sales. For Costa non-ready-to-drink beverage products, concentrate sales volume
represents the amount of beverages, primarily measured in number of transactions (in all instances expressed in unit case equivalents), sold by the Company to customers or consumers and is not
based on average daily sales. Each of our quarters, other than the fourth quarter, ends on the Friday closest to the last day of the corresponding quarterly calendar period. As a result, the first
quarter of 2026 had six additional days when compared to the first quarter of 2025, and the fourth quarter of 2026 will have six fewer days when compared to the fourth quarter of 2025.
After considering the impact of structural changes, unit case volume for Bottling Investments for the three months ended April 3, 2026 increased 4%.
Unit Case Volume
Although a significant portion of our Company’s net operating revenues is not based directly on unit case volume, we believe unit case volume performance is one of the
indicators of the underlying strength of the Coca-Cola system because it measures demand for our products at the consumer level.
Unit case volume in EMEA increased 2%, which included 4% growth in both sparkling flavors and water, sports, coffee and tea, as well as growth in energy drinks, partially
offset by a 15% decline in juice, value-added dairy and plant-based beverages, which was primarily driven by the impact of the sale of our finished product operations in
Nigeria. Unit case volume in Trademark Coca-Cola was even. The operating segment’s volume performance included an increase in unit case volume of 3% in the Africa
operating unit, 2% in the Eurasia and Middle East operating unit and 1% in the Europe operating unit.
Unit case volume in Latin America increased 1%, which included 3% growth in water, sports, coffee and tea, 2% growth in sparkling flavors, as well as growth in energy
drinks. Unit case volume in Trademark Coca-Cola and in juice, value-added dairy and plant-based beverages was even. The operating segment’s volume performance included
2% growth in Brazil, partially offset by declines of 5% in Argentina and 1% in Mexico.
Unit case volume in North America increased 4%, which included 5% growth in both Trademark Coca-Cola and water, sports, coffee and tea, 2% growth in sparkling flavors,
as well as growth in energy drinks. Unit case volume in juice, value-added dairy and plant-based beverages was even.
1,2,3 	4
5
1
2
3
4
5
28

-- 31 of 156 --

Unit case volume in Asia Pacific increased 5%, which included 8% growth in water, sports, coffee and tea, 5% growth in Trademark Coca-Cola, 4% growth in sparkling
flavors, 2% growth in juice, value-added dairy and plant-based beverages, as well as growth in energy drinks. The operating segment’s volume performance included 8%
growth in the Greater China and Mongolia operating unit, 5% growth in both the India and Southwest Asia operating unit and the Japan and South Korea operating unit and 3%
growth in the ASEAN and South Pacific operating unit.
Unit case volume for Bottling Investments increased 1%, primarily driven by growth in Africa, partially offset by the impact of refranchising certain territories of our bottling
operations in India.
Concentrate Sales Volume
During the three months ended April 3, 2026, worldwide concentrate sales volume increased 8% and unit case volume increased 3% compared to the three months ended
March 28, 2025. Concentrate sales volume growth is calculated based on the amount sold during the reporting periods, which is impacted by the number of days. Conversely,
unit case volume growth is calculated based on average daily sales, which is not impacted by the number of days in the reporting periods. The first quarter of 2026 had six
additional days when compared to the first quarter of 2025, which contributed to the differences between concentrate sales volume and unit case volume growth rates on a
consolidated basis and for the individual operating segments. Additionally, the differences between concentrate sales volume and unit case volume growth rates for the
operating segments were impacted by the timing of concentrate shipments. We expect the differences between concentrate sales volume and unit case volume growth rates to be
minimal on a full year basis.
Net Operating Revenues
During the three months ended April 3, 2026, net operating revenues were $12,472 million, compared to $11,129 million during the three months ended March 28, 2025, an
increase of $1,343 million, or 12%.
The following table illustrates, on a percentage basis, the estimated impact of the factors resulting in the increase (decrease) in net operating revenues on a consolidated basis
and for each of our operating segments:
Percent Change 2026 versus 2025
Volume 	Price/Mix Foreign Currency
Fluctuations Acquisitions &
Divestitures 	Total
Consolidated 	8% 	2% 	3% 	(1)% 	12%
EMEA 	5 	5 	6 	(3) 	13
Latin America 	7 	1 	5 	— 	14
North America 	11 	1 	— 	— 	12
Asia Pacific 	10 	(6) 	2 	— 	6
Bottling Investments 	11 	(1) 	4 	(2) 	12
Note: Certain rows may not add due to rounding.
Represents the percent change in net operating revenues attributable to the increase (decrease) in concentrate sales volume for our geographic operating segments (expressed in unit case
equivalents) after considering the impact of acquisitions and divestitures, if any. For our Bottling Investments operating segment, this represents the percent change in net operating revenues
attributable to the increase (decrease) in unit case volume computed by comparing the total sales (rather than the average daily sales) in each of the corresponding periods after considering the
impact of structural changes, if any. Our Bottling Investments operating segment data reflects unit case volume growth for consolidated bottlers only after considering the impact of structural
changes, if any. Refer to the heading “Beverage Volume” above.
Includes structural changes, if any. Refer to the heading “Structural Changes, Acquired Brands and Newly Licensed Brands” above.
Refer to the heading “Beverage Volume” above for additional information related to changes in our unit case and concentrate sales volumes.
“Price/mix” refers to the change in net operating revenues caused by factors such as pricing actions taken by the Company and, where applicable, our bottling partners; the mix
of categories, products and packages sold; and the mix of channels and geographic territories where the sales occurred. Management believes that providing investors with
price/mix enhances their understanding about the combined impact that these items had on the Company’s net operating revenues. The impact of price/mix is calculated by
subtracting the change in net operating revenues resulting from volume increases or decreases, fluctuations in foreign currency exchange rates, and acquisitions and divestitures
from the total change in net operating revenues. Management uses this measure in making financial, operating and planning decisions and in evaluating the Company’s
performance.
1 	2
1
2
29

-- 32 of 156 --

Price/mix had a 2% favorable impact on our consolidated net operating revenues. Price/mix was impacted by a variety of factors and events including, but not limited to, the
following:
• EMEA — favorable pricing initiatives, including inflationary pricing, and favorable mix;
• Latin America — favorable pricing initiatives, including inflationary pricing, partially offset by unfavorable mix;
• North America — favorable pricing initiatives, partially offset by unfavorable mix;
• Asia Pacific — unfavorable mix and affordability initiatives; and
• Bottling Investments — unfavorable mix, partially offset by favorable pricing initiatives.
Fluctuations in foreign currency exchange rates, including the effects of our hedging activities, favorably impacted our consolidated net operating revenues by 3%. Net
operating revenues were favorably impacted by a weaker U.S. dollar compared to certain foreign currencies, including the euro, Mexican peso, South African rand and British
pound, which had a favorable impact on our EMEA, Latin America and Bottling Investments operating segments. The favorable impact of a weaker U.S. dollar compared to the
currencies listed above was partially offset by the impact of a stronger U.S. dollar compared to certain other foreign currencies, including the Argentine peso, Turkish lira and
Indian rupee, which had an unfavorable impact on our Latin America, EMEA, Asia Pacific and Bottling Investments operating segments. Refer to the heading “Liquidity,
Capital Resources and Financial Position — Foreign Exchange” below.
“Acquisitions and divestitures” generally refers to acquisitions and divestitures of brands or businesses, some of which the Company considers to be structural changes. The
impact of acquisitions and divestitures is the difference between the change in net operating revenues and the change in what our net operating revenues would have been if we
removed the net operating revenues associated with an acquisition or a divestiture from either the current year or the prior year, as applicable. Management believes that
quantifying the impact that acquisitions and divestitures had on the Company’s net operating revenues provides investors with useful information to enhance their
understanding of the Company’s net operating revenue performance by improving their ability to compare our period-to-period results. Management considers the impact of
acquisitions and divestitures when evaluating the Company’s performance. Refer to the heading “Structural Changes, Acquired Brands and Newly Licensed Brands” above for
additional information related to acquisitions and divestitures.
Net operating revenue growth rates are impacted by sales volume; price/mix; foreign currency exchange rate fluctuations; and acquisitions and divestitures. The size and timing
of acquisitions and divestitures are not consistent from period to period. Based on current spot rates and our hedging coverage in place, we expect foreign currency exchange
rate fluctuations will have a favorable impact on our full year 2026 net operating revenues.
Gross Profit Margin
Gross profit margin is a ratio calculated by dividing gross profit by net operating revenues. Management believes gross profit margin provides investors with useful information
related to the profitability of our business prior to considering all of the selling, general and administrative expenses and other operating charges incurred. Management uses
this measure in making financial, operating and planning decisions and in evaluating the Company’s performance.
Our gross profit margin increased to 63.0% for the three months ended April 3, 2026, compared to 62.6% for the three months ended March 28, 2025. The increase was
primarily due to the favorable impact of pricing initiatives and foreign currency exchange rate fluctuations, as well as the impact of the sale of our finished product operations
in Nigeria, partially offset by higher commodity costs.
Selling, General and Administrative Expenses
During the three months ended April 3, 2026, selling, general and administrative expenses were $3,472 million, compared to $3,234 million during the three months ended
March 28, 2025, an increase of $238 million, or 7%. The increase was primarily due to increased marketing spending, partially offset by lower annual incentive expense and the
impact of the sale of our finished product operations in Nigeria.
During the three months ended April 3, 2026, foreign currency exchange rate fluctuations increased selling, general and administrative expenses by 4%. Advertising expenses
for the three months ended April 3, 2026 and March 28, 2025 were $1,377 million and $1,089 million, respectively.
30

-- 33 of 156 --

Other Operating Charges
Other operating charges incurred by our operating segments and Corporate were as follows (in millions):
Three Months Ended
April 3,
2026 March 28,
2025
EMEA 	$ 	— $ 	—
Latin America 	— 	—
North America 	4 	—
Asia Pacific 	— 	—
Bottling Investments 	— 	—
Corporate 	17 	73
Total 	$ 	21 $ 	73
During the three months ended April 3, 2026, the Company recorded other operating charges of $21 million. These charges consisted of $10 million related to an
indemnification agreement entered into as a part of the refranchising of certain of our bottling operations, $4 million related to North America modernization initiatives,
$4 million for the amortization of noncompete agreements related to the BodyArmor acquisition and $3 million related to tax litigation expense.
During the three months ended March 28, 2025, the Company recorded other operating charges of $73 million. These charges consisted of $47 million related to the
remeasurement of our contingent consideration liability to fair value in conjunction with our acquisition of fairlife in 2020, which brought the total liability to $6,173 million
and was paid in March 2025. Additionally, other operating charges included $11 million related to the Company’s productivity and reinvestment program, $9 million related to
an indemnification agreement entered into as a part of the refranchising of certain of our bottling operations, $3 million for the amortization of noncompete agreements related
to the BodyArmor acquisition and $3 million related to tax litigation expense.
Refer to Note 9 of Notes to Consolidated Financial Statements for additional information on the tax litigation.
Operating Income and Operating Margin
Information about our operating income contribution by operating segment and Corporate on a percentage basis is as follows:
Three Months Ended
April 3,
2026 March 28,
2025
EMEA 	28.9% 	29.1%
Latin America 	23.8 	24.7
North America 	36.8 	36.7
Asia Pacific 	12.3 	17.1
Bottling Investments 	4.4 	3.2
Corporate 	(6.2) 	(10.8)
Total 	100.0% 	100.0%
Operating margin is a ratio calculated by dividing operating income by net operating revenues. Management believes operating margin provides investors with useful
information related to the profitability of our business after considering all of the selling, general and administrative expenses and other operating charges
incurred. Management uses this measure in making financial, operating and planning decisions and in evaluating the Company’s performance.
31

-- 34 of 156 --

Information about our operating margin on a consolidated basis and for each of our operating segments and Corporate is as follows:
Three Months Ended
April 3,
2026 March 28,
2025
Consolidated 	35.0% 	32.9%
EMEA 	44.8 	42.9
Latin America 	61.9 	61.2
North America 	32.8 	30.8
Asia Pacific 	37.6 	47.1
Bottling Investments 	11.7 	8.1
Corporate 	* 	*
* Calculation is not meaningful.
During the three months ended April 3, 2026, operating income was $4,359 million, compared to $3,659 million during the three months ended March 28, 2025, an increase of
$700 million, or 19%. The increase was driven by an increase in concentrate sales volume of 8%, favorable price/mix, lower operating expenses, lower other operating charges
and a favorable foreign currency exchange rate impact of 4%, partially offset by increased marketing spending and higher commodity costs.
Fluctuations in foreign currency exchange rates, including the effects of our hedging activities, favorably impacted consolidated operating income by 4% due to a weaker U.S.
dollar compared to certain foreign currencies, including the Mexican peso and euro, which had a favorable impact on our Latin America and EMEA operating segments. The
favorable impact of a weaker U.S. dollar compared to the currencies listed above was partially offset by the impact of a stronger U.S. dollar compared to certain other foreign
currencies, including the Argentine peso and Turkish lira, which had an unfavorable impact on our Latin America and EMEA operating segments. Refer to the heading
“Liquidity, Capital Resources and Financial Position — Foreign Exchange” below.
The EMEA operating segment reported operating income of $1,259 million and $1,065 million for the three months ended April 3, 2026 and March 28, 2025, respectively. The
increase in operating income was primarily driven by an increase in concentrate sales volume of 5%, favorable price/mix and a favorable foreign currency exchange rate impact
of 6%, partially offset by increased marketing spending and higher operating expenses.
Latin America reported operating income of $1,038 million and $904 million for the three months ended April 3, 2026 and March 28, 2025, respectively. The increase in
operating income was primarily driven by an increase in concentrate sales volume of 7%, favorable price/mix, lower commodity costs and a favorable foreign currency
exchange rate impact of 5%, partially offset by increased marketing spending.
Operating income for North America for the three months ended April 3, 2026 and March 28, 2025 was $1,606 million and $1,341 million, respectively. The increase in
operating income was primarily driven by an increase in concentrate sales volume of 11%, favorable price/mix and lower operating expenses, partially offset by increased
marketing spending and higher commodity costs.
Asia Pacific’s operating income for the three months ended April 3, 2026 and March 28, 2025 was $536 million and $624 million, respectively. The decrease in operating
income was primarily driven by unfavorable price/mix, higher commodity costs and increased marketing spending, partially offset by an increase in concentrate sales volume of
10% and a favorable foreign currency exchange rate impact of 3%.
Bottling Investments’ operating income for the three months ended April 3, 2026 and March 28, 2025 was $191 million and $119 million, respectively. The increase in
operating income was primarily driven by an increase in unit case volume of 11%, lower commodity costs, lower operating expenses and a favorable foreign currency exchange
rate impact of 12%, partially offset by unfavorable price/mix and the impact of refranchising certain territories of our bottling operations in India.
Corporate’s operating loss for the three months ended April 3, 2026 and March 28, 2025 was $271 million and $394 million, respectively. This decrease is primarily a result of
lower annual incentive expense and lower other operating charges.
Based on current spot rates and our hedging coverage in place, we expect foreign currency exchange rate fluctuations will have a favorable impact on our full year 2026
operating income.
32

-- 35 of 156 --

Interest Income
During the three months ended April 3, 2026, interest income was $222 million, compared to $180 million during the three months ended March 28, 2025, an increase of
$42 million, or 23%. The increase was primarily driven by higher average investment balances.
Interest Expense
During the three months ended April 3, 2026, interest expense was $375 million, compared to $387 million during the three months ended March 28, 2025, a decrease of
$12 million, or 3%. The decrease was primarily due to lower average short-term debt balances.
Equity Income (Loss) — Net
During the three months ended April 3, 2026, equity income was $384 million, compared to equity income of $351 million during the three months ended March 28, 2025, an
increase of $33 million, or 9%. This increase reflects, among other items, the impact of more favorable operating results reported by certain of our equity method investees in
the current year and a favorable foreign currency exchange rate impact. These favorable impacts were partially offset by the impact of the sale of our ownership interests in
certain equity method investees in 2025, and a $25 million increase in net charges resulting from the Company’s proportionate share of significant operating and nonoperating
items recorded by certain of our equity method investees.
Other Income (Loss) — Net
During the three months ended April 3, 2026, other income (loss) — net was income of $21 million. The Company recognized a net loss of $19 million related to realized and
unrealized gains and losses on equity securities and trading debt securities as well as realized gains and losses on available-for-sale debt securities, dividend income of
$33 million and net foreign currency exchange gains of $30 million. Other income (loss) — net also included $13 million of costs related to our trade accounts receivable
factoring program and an impairment charge of $10 million related to our bottling operations in Africa, which are held for sale.
During the three months ended March 28, 2025, other income (loss) — net was income of $254 million. The Company recognized a gain of $331 million related to the sale of a
portion of our ownership interest in CCEP, an impairment charge of $25 million related to an equity method investee in Latin America and a net loss of $19 million related to
realized and unrealized gains and losses on equity securities and trading debt securities as well as realized gains and losses on available-for-sale debt securities. Additionally,
the Company recognized net foreign currency exchange losses of $16 million, $24 million of costs related to our trade accounts receivable factoring program and dividend
income of $55 million. Other income (loss) — net also included expense of $33 million related to the non-service cost components of net periodic benefit cost, which included
charges of $25 million and $11 million for special termination benefits and a curtailment loss, respectively, related to non-U.S. pension activity.
Refer to Note 2 of Notes to Consolidated Financial Statements for additional information on the sale of our ownership interest in CCEP. Refer to Note 4 of Notes to
Consolidated Financial Statements for additional information on equity and debt securities. Refer to Note 13 of Notes to Consolidated Financial Statements for additional
information on net periodic benefit cost or income. Refer to Note 15 of Notes to Consolidated Financial Statements for additional information on the impairment charges.
Income Taxes
The Company recorded income taxes of $645 million (14.0% effective tax rate) and $722 million (17.8% effective tax rate) during the three months ended April 3, 2026 and
March 28, 2025, respectively.
The Company’s effective tax rates for the three months ended April 3, 2026 and March 28, 2025 vary from the statutory U.S. federal tax rate of 21.0%, primarily due to the tax
impact of significant operating and nonoperating items, as described in Note 12 of Notes to Consolidated Financial Statements, along with the tax benefits of having significant
earnings generated outside of the United States and significant earnings generated in investments accounted for under the equity method, both of which are generally taxed at
rates lower than the statutory U.S. federal tax rate.
The Company’s effective tax rate for the three months ended April 3, 2026 included $279 million of net tax benefits related to various discrete tax items, including net interest
income of $55 million related to the IRS Tax Litigation Deposit recorded in the line item income taxes in our consolidated statement of income, in accordance with our
accounting policy, and a tax benefit of $194 million, primarily related to return to provision adjustments.
The Company’s effective tax rate for the three months ended March 28, 2025 included $143 million of net tax benefits related to various discrete tax items, including net
interest income of $53 million related to the IRS Tax Litigation Deposit recorded in
33

-- 36 of 156 --

the line item income taxes in our consolidated statement of income, in accordance with our accounting policy, and a tax benefit of $85 million related to a change in the
Company’s indefinite reinvestment assertion for certain foreign entities.
We are currently in litigation with the IRS for tax years 2007 through 2009. Refer to Note 9 of Notes to Consolidated Financial Statements for additional information on the tax
litigation.
At the end of each quarter, we make our best estimate of the effective tax rate expected to be applicable for the full fiscal year. This estimate reflects, among other items, our
best estimate of operating results and foreign currency exchange rates. Based on current tax laws, including the impact of several countries enacting global minimum tax
regulations, the Company’s effective tax rate in 2026 is expected to be approximately 19.9% before considering the potential impact of any significant operating and
nonoperating items that may affect our effective tax rate. This rate does not include the impact of the ongoing tax litigation with the IRS, if the Company were not to prevail.
Many jurisdictions have enacted legislation and adopted policies resulting from the Organization for Economic Co-operation and Development’s (“OECD”) Anti-Base Erosion
and Profit Shifting project. The OECD is currently coordinating a two-pillared project on behalf of the Group of Twenty (G20) and other participating countries which would
grant additional taxing rights over profits earned by multinational enterprises to the countries in which their products are sold and services rendered. Pillar One would allow
countries to reallocate a portion of profits earned by multinational businesses with an annual global revenue exceeding €20 billion and a profit margin of over 10% to applicable
market jurisdictions. While the OECD issued draft language for the international implementation of Pillar One in October 2023, both the substantive rules and implementation
process remain under discussion at the OECD, so the timetable for any implementation remains uncertain.
In December 2021, the OECD issued Pillar Two model rules which would establish a global per-country minimum tax of 15%, and the European Union has approved a
directive requiring member states to incorporate similar provisions into their respective domestic laws. The directive requires, with certain limited exceptions, the rules to
initially become effective for fiscal years starting on or after December 31, 2023. Numerous countries have enacted legislation that implemented certain aspects of Pillar Two
effective January 1, 2024, or adopted legislation that became effective in 2025, while additional jurisdictions may enact similar legislation in the future. In June 2025, the Group
of Seven (G7) released a statement announcing an understanding of a potential side-by-side system approach to the Pillar Two framework that would exclude U.S.-parented
groups from certain Pillar Two provisions in recognition of existing U.S. minimum tax rules. In January 2026, the OECD issued further administrative guidance introducing a
side‑by‑side framework under Pillar Two, largely exempting U.S.-headquartered companies from the application of Pillar Two. The OECD and implementing countries are
expected to continue to make further revisions to their legislation and release additional guidance intended to adopt this side-by-side framework into law in each of the member
countries. The Company will continue to monitor developments to determine any potential impact in the countries in which we operate.
LIQUIDITY, CAPITAL RESOURCES AND FINANCIAL POSITION
We believe our ability to generate cash flows from operating activities is one of the fundamental strengths of our business. Refer to the heading “Cash Flows from Operating
Activities” below. The Company does not typically raise capital through the issuance of stock. Instead, we use debt financing to lower our overall cost of capital and increase
our return on shareowners’ equity. Refer to the heading “Cash Flows from Financing Activities” below. We have a history of borrowing funds both domestically and
internationally at reasonable interest rates, and we expect to be able to continue to borrow funds at reasonable rates over the long term. Our debt financing also includes the use
of a commercial paper program. We currently have the ability to borrow funds in this market at levels that are consistent with our debt financing strategy, and we expect to
continue to be able to do so in the future. The Company regularly reviews its optimal mix of short-term and long-term debt.
The Company’s cash, cash equivalents, short-term investments and marketable securities totaled $13.8 billion as of April 3, 2026. In addition to these funds, our commercial
paper program, and our ability to issue long-term debt, we had $6.6 billion in unused backup lines of credit for general corporate purposes as of April 3, 2026. These backup
lines of credit expire at various times through 2031.
Our current payment terms with the majority of our suppliers are 120 days. Certain financial institutions offer a voluntary supply chain finance program which enables our
suppliers, at their sole discretion, to sell their receivables from the Company to these financial institutions on a non-recourse basis at a rate that leverages our credit rating and
thus may be more beneficial to them. We do not believe there is a risk that our payment terms will be shortened in the near future. Refer to Note 7 of Notes to Consolidated
Financial Statements for additional information.
34

-- 37 of 156 --

The Company has a trade accounts receivable factoring program in certain countries. Under this program, we can elect to sell trade accounts receivables to unaffiliated financial
institutions at a discount. In these factoring arrangements, for ease of administration, the Company collects customer payments related to the factored receivables and remits
those payments to the financial institutions. The Company sold $3,271 million and $5,034 million of trade accounts receivables under this program during the three months
ended April 3, 2026 and March 28, 2025, respectively. The costs of factoring such receivables were $13 million and $24 million for the three months ended April 3, 2026 and
March 28, 2025, respectively. The cash received from the financial institutions is reflected within the operating activities section of our consolidated statement of cash flows.
Our current capital allocation priorities are as follows: investing wisely to support our business operations, continuing to grow our dividend payment, enhancing our beverage
portfolio and capabilities through consumer-centric acquisitions, and using excess cash to repurchase shares over time. We currently expect 2026 capital expenditures to be
approximately $2.2 billion. During 2026, we expect to repurchase shares to offset dilution resulting from employee stock-based compensation.
We are currently in litigation with the IRS for tax years 2007 through 2009. On November 18, 2020, the Tax Court issued the Opinion in which it predominantly sided with the
IRS. On November 8, 2023, the Tax Court issued a supplemental opinion, siding with the IRS in concluding both that certain U.S. tax regulations (known as the blocked-
income regulations) that address the effect of certain Brazilian legal restrictions on royalty payments by the Company’s licensee in Brazil apply to the Company’s operations
and that the Tax Court opinion in the 3M case controlled as to the validity of those regulations. On October 1, 2025, the U.S. Court of Appeals for the Eighth Circuit issued an
opinion reversing the judgment of the Tax Court in the 3M case. In its decision, the court concluded that the blocked-income regulation was inconsistent with IRC Section 482
and that the IRS therefore could not reallocate income from 3M’s subsidiary in Brazil to 3M in contravention of Brazilian restrictions on the payment of royalties. Further, the
U.S. Court of Appeals for the Eighth Circuit specifically rejected the IRS’ argument that the ability of 3M’s subsidiary in Brazil to pay dividends, rather than royalties, meant
that royalty income should not be treated as blocked. Both of these conclusions are highly supportive of the Company’s position in its case and reinforce its prior conclusions.
On August 2, 2024, the Tax Court entered a decision reflecting additional federal income tax of $2.7 billion for the 2007 through 2009 tax years. With applicable interest, the
total liability for the 2007 through 2009 tax years resulting from the Tax Court’s decision is $6.0 billion, for which the IRS issued the Company invoices on September 3, 2024.
The Company paid the IRS Tax Litigation Deposit on September 10, 2024, which stopped interest from accruing on the additional tax due for the 2007 through 2009 tax years.
That amount, plus interest earned, would be refunded in full or in part if the Company’s tax positions are ultimately sustained on appeal. For the three months ended April 3,
2026 and March 28, 2025, the Company recorded net interest income of $55 million and $53 million, respectively, related to this tax payment in the line item income taxes in
our consolidated statements of income, in accordance with our accounting policy. The payment of the IRS invoices and the related accrued interest were recorded in the line
item other noncurrent assets in our consolidated balance sheets as of April 3, 2026 and December 31, 2025. On October 22, 2024, the Company appealed the Tax Court’s
decision to the U.S. Court of Appeals for the Eleventh Circuit. The Company filed its principal appellate brief with the U.S. Court of Appeals for the Eleventh Circuit on March
12, 2025. The IRS filed its appellate brief on July 7, 2025. The Company filed its reply brief on August 27, 2025. The Company strongly disagrees with the IRS’ positions and
the portions of the Opinions affirming such positions and intends to vigorously defend our positions utilizing every available avenue of appeal. While the Company believes
that it is more likely than not that we will ultimately prevail in this litigation upon appeal, it is possible that all, or some portion of, the adjustments proposed by the IRS and
sustained by the Tax Court could ultimately be upheld. In that event, the Company would not receive a refund of the applicable portion or all of the $6.0 billion it paid in
response to the IRS invoices issued in September 2024 and the related accrued interest receivable of $457 million as of April 3, 2026. Additionally, the Company would likely
be subject to significant additional liabilities for subsequent years, which could have a material adverse impact on the Company’s financial position, results of operations and
cash flows. The Company estimates that the potential aggregate remaining incremental tax and interest liability for the tax years 2010 through 2025 could be approximately
$14 billion as of December 31, 2025. Additional income tax and interest on any unpaid potential liabilities for the 2010 through 2025 tax years would continue to accrue until
the time any such potential liability, or portion thereof, were to be paid. The Company estimates the impact of the continued application of the methodology asserted by the IRS
and affirmed in the Opinions for the three months ended April 3, 2026 would increase the potential aggregate incremental tax and interest liability by approximately
$450 million. Refer to Note 9 of Notes to Consolidated Financial Statements for additional information on the tax litigation.
While we believe it is more likely than not that we will prevail in the tax litigation discussed above, we are confident that, between our ability to generate cash flows from
operating activities and our ability to borrow funds at reasonable interest rates, we can manage the range of possible outcomes in the final resolution of the matter.
Based on all of the aforementioned factors, the Company believes its current liquidity position is strong and will continue to be sufficient to fund our operating activities and
cash commitments for investing and financing activities for the foreseeable future.
35

-- 38 of 156 --

Cash Flows from Operating Activities
Net cash provided by operating activities during the three months ended April 3, 2026 was $2,021 million, and net cash used in operating activities during the three months
ended March 28, 2025 was $5,202 million. The increase was primarily driven by strong cash operating results, a benefit of the trade accounts receivable factoring program in
the current year, a favorable impact due to foreign currency exchange rate fluctuations, lower net interest payments and lower annual incentive payments. These items were
partially offset by higher tax payments and unfavorable hedging activity.
Additionally, the activity in 2025 included $6,069 million of the $6,173 million final milestone payment for fairlife that was made during the three months ended March 28,
2025. Refer to Note 12 of Notes to Consolidated Financial Statements for additional information on our milestone payment for fairlife.
Cash Flows from Investing Activities
Net cash provided by investing activities during the three months ended April 3, 2026 was $1,746 million, and net cash used in investing activities during the three months
ended March 28, 2025 was $1,067 million.
Purchases of Investments and Proceeds from Disposals of Investments
During the three months ended April 3, 2026, purchases of investments were $1,459 million and proceeds from disposals of investments were $3,503 million, resulting in a net
cash inflow of $2,044 million. During the three months ended March 28, 2025, purchases of investments were $2,507 million and proceeds from disposals of investments were
$1,005 million, resulting in a net cash outflow of $1,502 million. This activity primarily represents the purchases of, and proceeds from the disposals of, investments in
marketable securities and short-term investments that were made as part of the Company’s overall cash management strategy. Also included in this activity are purchases of,
and proceeds from the disposals of, investments held by our captive insurance companies. Refer to Note 4 of Notes to Consolidated Financial Statements for additional
information on our investments.
Acquisitions of Businesses, Equity Method Investments and Nonmarketable Securities
During the three months ended April 3, 2026 and March 28, 2025, the Company’s acquisitions of businesses, equity method investments and nonmarketable securities totaled
$37 million and $42 million, respectively. The activity during the three months ended April 3, 2026 and March 28, 2025 included $32 million and $30 million, respectively, of
investments in alternative energy limited partnerships. Refer to Note 14 of Notes to Consolidated Financial Statements for additional information on these investments.
Proceeds from Disposals of Businesses, Equity Method Investments and Nonmarketable Securities
During the three months ended March 28, 2025, proceeds from disposals of businesses, equity method investments and nonmarketable securities were $748 million, which
primarily related to the sale of a portion of our ownership interest in CCEP. Refer to Note 2 of Notes to Consolidated Financial Statements.
Purchases of Property, Plant and Equipment
Purchases of property, plant and equipment during the three months ended April 3, 2026 and March 28, 2025 were $266 million and $309 million, respectively.
Cash Flows from Financing Activities
Net cash used in financing activities during the three months ended April 3, 2026 was $3,868 million, and net cash provided by financing activities during the three months
ended March 28, 2025 was $3,432 million.
Loans, Notes Payable and Long-Term Debt
The Company made payments of debt of $1,262 million during the three months ended April 3, 2026, which consisted of $746 million of payments related to commercial paper
and short-term debt with maturities of 90 days or less, $500 million of payments related to commercial paper and short-term debt with maturities greater than 90 days and
payments of long-term debt of $16 million.
During the three months ended March 28, 2025, the Company had issuances of debt of $5,436 million, which consisted of $3,917 million of net issuances of commercial paper
and short-term debt with maturities of 90 days or less, $1,033 million of issuances of commercial paper and short-term debt with maturities greater than 90 days and long-term
debt issuances of $486 million, net of related discounts and issuance costs.
The Company made payments of debt of $1,599 million during the three months ended March 28, 2025, which consisted of $1,047 million of payments related to commercial
paper and short-term debt with maturities greater than 90 days and payments of long-term debt of $552 million.
36

-- 39 of 156 --

Issuances of Stock
The issuances of stock during the three months ended April 3, 2026 and March 28, 2025 were related to the exercise of stock options by employees.
Purchases of Stock for Treasury
During the three months ended April 3, 2026, the total cash outflow for treasury stock purchases was $477 million. The Company repurchased 4.9 million shares of common
stock under the share repurchase plan authorized by our Board of Directors. These shares were repurchased at an average cost of $74.04 per share, for a total cost of $361
million. In addition to shares repurchased under the share repurchase plan, the Company’s treasury stock activity included shares surrendered to the Company to pay the
exercise price and/or to satisfy tax withholding obligations in connection with stock swap exercises of employee stock options and/or the vesting of restricted stock issued to
employees. The net impact of the Company’s issuances of stock and share repurchases during the three months ended April 3, 2026 resulted in a net cash outflow of
$322 million.
During the three months ended March 28, 2025, the total cash outflow for treasury stock purchases was $370 million. The Company repurchased 4.3 million shares of common
stock under the share repurchase plan authorized by our Board of Directors. These shares were repurchased at an average cost of $65.04 per share, for a total cost of $279
million. In addition to shares repurchased under the share repurchase plan, the Company’s treasury stock activity included shares surrendered to the Company to pay the
exercise price and/or to satisfy tax withholding obligations in connection with stock swap exercises of employee stock options and/or the vesting of restricted stock issued to
employees. The net impact of the Company’s issuances of stock and share repurchases during the three months ended March 28, 2025 resulted in a net cash outflow of $211
million.
Dividends
During the three months ended April 3, 2026 and March 28, 2025, the Company paid dividends of $2,281 million and $89 million, respectively. As a result of the timing of our
quarterly reporting periods as well as our dividend payment dates, the Company paid substantially all of the 2025 first quarterly dividend in the second quarter and paid all of
the 2026 first quarterly dividend in the first quarter.
Our Board of Directors approved the Company’s regular quarterly dividend of $0.53 per share at its April 2026 meeting. This dividend is payable on July 1, 2026 to
shareowners of record as of the close of business on June 15, 2026.
Other Financing Activities
During the three months ended April 3, 2026 and March 28, 2025, the total cash outflow for other financing activities was $3 million and $105 million, respectively. The cash
outflow during the three months ended March 28, 2025 included $104 million of the $6,173 million final milestone payment for fairlife.
Foreign Exchange
Our international operations are subject to certain opportunities and risks, including currency fluctuations and governmental actions. We closely monitor our operations in each
country and seek to adopt appropriate strategies that are responsive to changing economic and political environments as well as to fluctuations in currencies.
Due to the geographic diversity of our operations, weakness in some currencies may be offset by strength in other currencies over time. Our hedging activities are designed to
mitigate, over time, a portion of the impact of exchange rate fluctuations on our net income. Taking into account the effects of our hedging activities, the impact of fluctuations
in foreign currency exchange rates increased our operating income for the three months ended April 3, 2026 by 4%.
Based on current spot rates and our hedging coverage in place, we expect foreign currency exchange rate fluctuations will have a favorable impact on operating income and
cash flows from operating activities through the end of the year.
Item 3. Quantitative and Qualitative Disclosures About Market Risk
We have no material changes to the disclosures on this matter made in our Annual Report on Form 10-K for the year ended December 31, 2025.
37

-- 40 of 156 --

Item 4. Controls and Procedures
Evaluation of Disclosure Controls and Procedures
The Company, under the supervision and with the participation of its management, including the Chief Executive Officer and the Chief Financial Officer, evaluated the
effectiveness of the design and operation of the Company’s “disclosure controls and procedures” (as defined in Rule 13a-15(e) under the Securities Exchange Act of 1934, as
amended (“Exchange Act”)) as of the end of the period covered by this report. Based on that evaluation, the Chief Executive Officer and the Chief Financial Officer concluded
that the Company’s disclosure controls and procedures were effective as of April 3, 2026.
Changes in Internal Control Over Financial Reporting
There have been no changes in the Company’s internal control over financial reporting during the quarter ended April 3, 2026 that have materially affected, or are reasonably
likely to materially affect, the Company’s internal control over financial reporting.
Part II. Other Information
Item 1. Legal Proceedings
Information regarding reportable legal proceedings is contained in Part I, “Item 3. Legal Proceedings” in our Annual Report on Form 10-K for the year ended December 31,
2025. The following updates and restates the description of the previously reported U.S. Federal Income Tax Dispute matter. Management believes that, except as disclosed
in “U.S. Federal Income Tax Dispute” below, the total liabilities of the Company that may arise as a result of currently pending legal proceedings will not have a material
adverse effect on the Company taken as a whole.
U.S. Federal Income Tax Dispute
On September 17, 2015, the Company received a Notice from the IRS seeking approximately $3.3 billion of additional federal income tax for years 2007 through 2009. In
the Notice, the IRS stated its intent to reallocate over $9 billion of income to the U.S. parent company from certain of its foreign affiliates that the U.S. parent company
licensed to manufacture, distribute, sell, market and promote its products in certain non-U.S. markets.
The Notice concerned the Company’s transfer pricing between its U.S. parent company and certain of its foreign affiliates. IRS rules governing transfer pricing require arm’s-
length pricing of transactions between related parties such as the Company’s U.S. parent and its foreign affiliates.
To resolve the same transfer pricing issue for the tax years 1987 through 1995, the Company and the IRS had agreed in 1996 on an arm’s-length methodology for determining
the amount of U.S. taxable income that the U.S. parent company would report as compensation from its foreign licensees. The Company and the IRS memorialized this accord
in the Closing Agreement resolving that dispute. The Closing Agreement provided that, absent a change in material facts or circumstances or relevant federal tax law, in
calculating the Company’s income taxes going forward, the Company would not be assessed penalties by the IRS for using the agreed-upon tax calculation methodology that
the Company and the IRS agreed would be used for the 1987 through 1995 tax years.
The IRS audited and confirmed the Company’s compliance with the agreed-upon Closing Agreement methodology in five successive audit cycles for tax years 1996 through
2006.
The September 17, 2015 Notice from the IRS retroactively rejected the previously agreed-upon methodology for the 2007 through 2009 tax years in favor of an entirely
different methodology, without prior notice to the Company. Using the new tax calculation methodology, the IRS reallocated over $9 billion of income to the U.S. parent
company from its foreign licensees for tax years 2007 through 2009. Consistent with the Closing Agreement, the IRS did not assert penalties, and it has yet to do so.
The IRS designated the Company’s matter for litigation on October 15, 2015. Litigation designation is an IRS determination that forecloses to a company any and all alternative
means for resolution of a tax dispute. As a result of the IRS’ designation of the Company’s matter for litigation, the Company was forced to either accept the IRS’ newly
imposed tax assessment and pay the full amount of the asserted tax or litigate the matter in the federal courts. The matter remains subject to the IRS’ litigation designation,
preventing the Company from any attempt to settle or otherwise mutually resolve the matter with the IRS.
The Company consequently initiated litigation by filing a petition in the Tax Court in December 2015, challenging the tax adjustments enumerated in the Notice.
Prior to trial, the IRS increased its transfer pricing adjustment by $385 million, resulting in an additional tax adjustment of $135 million. The Company obtained a summary
judgment in its favor on a different matter related to Mexican foreign tax credits, which thereafter effectively reduced the IRS’ potential tax adjustment by $138 million.
38

-- 41 of 156 --

The trial was held in the Tax Court from March through May 2018, and final post-trial briefs were filed and exchanged in April 2019.
On November 18, 2020, the Tax Court issued the Opinion in which it predominantly sided with the IRS but agreed with the Company that dividends previously paid by the
foreign licensees to the U.S. parent company in reliance upon the Closing Agreement should continue to be allowed to offset royalties, including those that would become
payable to the Company in accordance with the Opinion. On November 8, 2023, the Tax Court issued a supplemental opinion, siding with the IRS in concluding both that
certain U.S. tax regulations (known as the blocked-income regulations) that address the effect of certain Brazilian legal restrictions on royalty payments by the Company’s
licensee in Brazil apply to the Company’s operations and that the Tax Court opinion in the 3M case controlled as to the validity of those regulations. On October 1, 2025, the
U.S. Court of Appeals for the Eighth Circuit issued an opinion reversing the judgment of the Tax Court in the 3M case. In its decision, the court concluded that the blocked-
income regulation was inconsistent with IRC Section 482 and that the IRS therefore could not reallocate income from 3M’s subsidiary in Brazil to 3M in contravention of
Brazilian restrictions on the payment of royalties. Further, the U.S. Court of Appeals for the Eighth Circuit specifically rejected the IRS’ argument that the ability of 3M’s
subsidiary in Brazil to pay dividends, rather than royalties, meant that royalty income should not be treated as blocked. Both of these conclusions are highly supportive of the
Company’s position in its case and reinforce its prior conclusions.
The Company believes that the IRS and the Tax Court misinterpreted and misapplied the applicable regulations in reallocating income earned by the Company’s foreign
licensees to increase the Company’s U.S. tax. Moreover, the Company believes that the retroactive imposition of such tax liability using a calculation methodology different
from that previously agreed upon by the IRS and the Company, and audited by the IRS for over a decade, is unconstitutional. The Company intends to assert its claims on
appeal and vigorously defend its positions. In addition, for its litigation with the IRS and for purposes of its appeal of the Tax Court decision, the Company continues to
evaluate the implications of several significant administrative law cases recently decided by the U.S. Supreme Court, most notably Loper Bright v. Raimondo, which overruled
the Chevron case. Since 1984, the Chevron case had required that courts defer to agency interpretations of statutes and agency action. In Ohio v. EPA and Garland v. Cargill,
two of the recent decisions, the U.S. Supreme Court demonstrated how courts are to rule on agency interpretations and actions without the deference previously required by the
Chevron case.
On August 2, 2024, the Tax Court entered a decision reflecting additional federal income tax of $2.7 billion for the 2007 through 2009 tax years. With applicable interest, the
total liability for the 2007 through 2009 tax years resulting from the Tax Court’s decision is $6.0 billion, for which the IRS issued the Company invoices on September 3, 2024.
The Company paid the IRS Tax Litigation Deposit on September 10, 2024, which stopped interest from accruing on the additional tax due for the 2007 through 2009 tax years.
That amount, plus interest earned, would be refunded in full or in part if the Company’s tax positions are ultimately sustained on appeal. For the three months ended April 3,
2026 and March 28, 2025, the Company recorded net interest income of $55 million and $53 million, respectively, related to this tax payment in the line item income taxes in
our consolidated statements of income, in accordance with our accounting policy. The payment of the IRS invoices and the related accrued interest were recorded in the line
item other noncurrent assets in our consolidated balance sheets as of April 3, 2026 and December 31, 2025. On October 22, 2024, the Company appealed the Tax Court’s
decision to the U.S. Court of Appeals for the Eleventh Circuit. The Company filed its principal appellate brief with the U.S. Court of Appeals for the Eleventh Circuit on March
12, 2025. The IRS filed its appellate brief on July 7, 2025. The Company filed its reply brief on August 27, 2025.
In determining the amount of tax reserve to be recorded as of December 31, 2020, the Company completed the required two-step evaluation process prescribed by Accounting
Standards Codification 740, Accounting for Income Taxes. In doing so, we consulted with outside advisors, and we reviewed and considered relevant laws, rules, and
regulations, including, but not limited to, the Opinions and relevant caselaw. We also considered our intention to vigorously defend our positions and assert our various well-
founded legal claims via every available avenue of appeal. We concluded, based on the technical and legal merits of the Company’s tax positions, that it is more likely than not
the Company’s tax positions will ultimately be sustained on appeal. In addition, we considered a number of alternative transfer pricing methodologies, including the Tax Court
Methodology, that could be applied by the courts upon final resolution of the litigation. Based on the required probability analysis, we determined the methodologies we believe
the federal courts could ultimately order to be used in calculating the Company’s tax. As a result of this analysis, we recorded a tax reserve of $438 million during the year
ended December 31, 2020 related to the application of the resulting methodologies as well as the different tax treatment applicable to dividends originally paid to the U.S.
parent company by its foreign licensees, in reliance upon the Closing Agreement, that would be recharacterized as royalties in accordance with the Opinions and the Company’s
analysis.
The Company’s conclusion that it is more likely than not the Company’s tax positions will ultimately be sustained on appeal is unchanged as of April 3, 2026. However, based
on the required probability analysis and the accrual of interest through the current reporting period, we updated our tax reserve as of April 3, 2026 to $520 million.
While the Company strongly disagrees with the IRS’ positions and the portions of the Opinions affirming such positions, it is possible that some portion or all of the
adjustments proposed by the IRS and sustained by the Tax Court could ultimately be upheld. In that event, the Company would not receive a refund of the applicable portion or
all of the $6.0 billion it paid in
39

-- 42 of 156 --

response to the IRS invoices issued in September 2024 and the related accrued interest receivable of $457 million as of April 3, 2026. Additionally, the Company would likely
be subject to significant additional liabilities for subsequent years, which could have a material adverse impact on the Company’s financial position, results of operations and
cash flows.
The Company calculated the potential impact of applying the Tax Court Methodology to reallocate income from foreign licensees potentially covered within the scope of the
Opinions for the 2010 through 2025 tax years, assuming such methodology were to be ultimately upheld by the courts, and the IRS were to decide to apply that methodology to
subsequent years, with consent of the federal courts. This impact would include taxes and interest accrued through December 31, 2025. The calculations incorporated the
estimated impact of correlative adjustments to the previously accrued transition tax payable under the 2017 Tax Cuts and Jobs Act. The Company estimates that the potential
aggregate remaining incremental tax and interest liability for the tax years 2010 through 2025 could be approximately $14 billion as of December 31, 2025. Additional income
tax and interest on any unpaid potential liabilities for the 2010 through 2025 tax years would continue to accrue until the time any such potential liability, or portion thereof,
were to be paid. The Company estimates the impact of the continued application of the Tax Court Methodology for the three months ended April 3, 2026 would increase the
potential aggregate incremental tax and interest liability by approximately $450 million. We currently project the continued application of the Tax Court Methodology in 2026,
assuming similar facts and circumstances as of December 31, 2025 and reflecting changes enacted under the One Big Beautiful Bill Act effective in 2026, would result in an
incremental annual tax liability that would increase the Company’s effective tax rate by approximately 3.8%.
Item 1A. Risk Factors
In addition to the other information set forth in this report, you should carefully consider the factors discussed in Part I, “Item 1A. Risk Factors” in our Annual Report on Form
10-K for the year ended December 31, 2025, which could materially affect our business, financial condition or future results. The risks described in this report and in our
Annual Report on Form 10-K are not the only risks facing our Company. Additional risks and uncertainties not currently known to us, or that we currently deem to be
immaterial, could also materially adversely affect our business, financial condition or future results.
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
The following table presents information with respect to purchases of common stock of the Company made during the three months ended April 3, 2026 by the Company or
any “affiliated purchaser” of the Company as defined in Rule 10b-18(a)(3) under the Exchange Act:
Period Total Number of Shares
Purchased
Average
Price Paid
Per Share
Total Number of
Shares Purchased as Part of the
Publicly
Announced Plan
Maximum Number
of Shares That May
Yet Be Purchased
Under the Publicly
Announced Plan
January 1, 2026 through January 30, 2026 	2,523,175 $ 	70.62 	2,520,600 	64,428,144
January 31, 2026 through February 27, 2026 	2,695,423 	79.56 	1,281,000 	63,147,144
February 28, 2026 through April 3, 2026 	1,082,612 	76.71 	1,080,304 	62,066,840
Total 	6,301,210 $ 	75.49 	4,881,904
The total number of shares purchased includes: (1) shares purchased, if any, pursuant to the plan described in footnote 2 below and (2) shares surrendered, if any, to the Company to pay the
exercise price and/or to satisfy tax withholding obligations in connection with stock swap exercises of employee stock options and/or the vesting of restricted stock issued to employees.
In February 2019, the Company publicly announced that our Board of Directors had authorized a plan (“2019 Plan”) for the Company to purchase up to 150 million shares of our common stock.
This column discloses the number of shares purchased, if any, pursuant to the 2019 Plan during the indicated time periods (including shares purchased pursuant to the terms of preset trading
plans meeting the requirements of Rule 10b5-1 under the Exchange Act).
Item 5. Other Information
During the fiscal quarter ended April 3, 2026, none of our Directors or officers (as defined in Rule 16a-1(f) under the Exchange Act) adopted or terminated a “Rule 10b5-1
trading arrangement” or a “non-Rule 10b5-1 trading arrangement,” as each term is defined in Item 408 of Regulation S-K, except as follows:
Jennifer K. Mann, Executive Vice President and President, North America operating unit, adopted a Rule 10b5-1 trading arrangement on March 6, 2026 for the potential sale of
up to 50,000 shares of common stock of the Company and the potential exercise of vested stock options and the associated sale of up to 273,984 shares of common stock of the
Company, subject to certain conditions. The arrangement’s expiration date is March 5, 2027, or such earlier date upon which all transactions are completed.
1 	2
1
2
40

-- 43 of 156 --

James Quincey, Chairman of the Board of Directors, adopted a Rule 10b5-1 trading arrangement on March 5, 2026 for the potential exercise of vested stock options and the
associated sale of up to 971,383 shares of common stock of the Company, subject to certain conditions. The arrangement’s expiration date is March 5, 2028, or such earlier date
upon which all transactions are completed.
These trading plans were adopted during an open trading window.
Item 6. Exhibits
In reviewing the agreements included as exhibits to this report, please remember they are included to provide you with information regarding their terms and are not intended to
provide any other factual or disclosure information about the Company or the other parties to the agreements. The agreements contain representations, warranties, covenants
and conditions by or of each of the parties to the applicable agreement. These representations, warranties, covenants and conditions have been made solely for the benefit of the
other parties to the applicable agreement and:
• should not in all instances be treated as categorical statements of fact, but rather as a way of allocating the risk to one of the parties if those statements prove to be
inaccurate;
• may have been qualified by disclosures that were made to the other party in connection with the negotiation of the applicable agreement, which disclosures are not
necessarily reflected in the agreement;
• may apply standards of materiality in a way that is different from what may be viewed as material to you or other investors; and
• were made only as of the date of the applicable agreement, or such other date or dates as may be specified in the agreement, and are subject to more recent developments.
Accordingly, these representations, warranties, covenants and conditions may not describe the actual state of affairs as of the date they were made or at any other time.
Additional information about the Company may be found elsewhere in this report and the Company’s other public filings, which are available without charge through the
Securities and Exchange Commission’s website at http://www.sec.gov.
EXHIBIT INDEX
Exhibit No.
(With regard to applicable cross-references in the list of exhibits below, the Company’s Current, Quarterly and Annual Reports are filed with the Securities and Exchange
Commission (“SEC”) under File No. 001-02217; and Coca-Cola Refreshments USA, LLC’s (formerly known as Coca-Cola Refreshments USA, Inc. and Coca-Cola
Enterprises Inc.) Current, Quarterly and Annual Reports are filed with the SEC under File No. 001-09300.)
3.1 	Certificate of Incorporation of the Company, including Amendment of Certificate of Incorporation, dated July 27, 2012 — incorporated herein by reference to
Exhibit 3.1 to the Company’s Quarterly Report on Form 10-Q for the quarter ended September 28, 2012.
3.2 	By-Laws of the Company, as amended and restated through October 19, 2023 — incorporated herein by reference to Exhibit 3.2 to the Company’s Current Report
on Form 8-K filed on October 20, 2023.
4.1 	As permitted by the rules of the SEC, the Company has not filed certain instruments defining the rights of holders of long-term debt of the Company or
consolidated subsidiaries under which the total amount of securities authorized does not exceed 10% of the total assets of the Company and its consolidated
subsidiaries. The Company agrees to furnish to the SEC, upon request, a copy of any omitted instrument.
4.2 	Amended and Restated Indenture, dated as of April 26, 1988, between the Company and Deutsche Bank Trust Company Americas, as successor to Bankers Trust
Company, as trustee — incorporated herein by reference to Exhibit 4.1 to the Company’s Current Report on Form 8-K filed on May 25, 2017.
4.3 	First Supplemental Indenture, dated as of February 24, 1992, to Amended and Restated Indenture, dated as of April 26, 1988, between the Company and Deutsche
Bank Trust Company Americas, as successor to Bankers Trust Company, as trustee — incorporated herein by reference to Exhibit 4.2 to the Company’s Current
Report on
Form 8-K filed on May 25, 2017.
4.4 	Second Supplemental Indenture, dated as of November 1, 2007, to Amended and Restated Indenture, dated as of April 26, 1988, as amended, between the
Company and Deutsche Bank Trust Company Americas, as successor to Bankers Trust Company, as trustee — incorporated herein by reference to Exhibit 4.3 to
the Company’s Current Report on Form 8-K filed on May 25, 2017.
4.5 	Form of Note for 1.875% Notes due 2026 — incorporated herein by reference to Exhibit 4.4 to the Company’s Registration Statement on Form 8-A filed on
September 19, 2014.
4.6 	Form of Note for 1.125% Notes due 2027 — incorporated herein by reference to Exhibit 4.7 to the Company’s Registration Statement on Form 8-A filed on March
6, 2015.
41

-- 44 of 156 --

4.7 	Form of Note for 1.625% Notes due 2035 — incorporated herein by reference to Exhibit 4.8 to the Company’s Registration Statement on Form 8-A filed on March
6, 2015.
4.8 	Form of Note for 1.100% Notes due 2036 — incorporated herein by reference to Exhibit 4.4 to the Company’s Registration Statement on Form 8-A filed on
September 2, 2016.
4.9 	Form of Note for 2.900% Notes due 2027 — incorporated herein by reference to Exhibit 4.5 to the Company’s Current Report on Form 8-K filed on May 25,
2017.
4.10 	Form of Note for 0.750% Notes due 2026 — incorporated herein by reference to Exhibit 4.6 to the Company’s Current Report on Form 8-K filed on March 8,
2019.
4.11 	Form of Note for 1.250% Notes due 2031 — incorporated herein by reference to Exhibit 4.7 to the Company’s Current Report on Form 8-K filed on March 8,
2019.
4.12 	Form of Note for 2.125% Notes due 2029 — incorporated herein by reference to Exhibit 4.5 to the Company’s Current Report on Form 8-K filed on September 9,
2019.
4.13 	Form of Note for 3.375% Notes due 2027 — incorporated herein by reference to Exhibit 4.5 to the Company’s Current Report on Form 8-K filed on March 25,
2020.
4.14 	Form of Note for 3.450% Notes due 2030 — incorporated herein by reference to Exhibit 4.6 to the Company’s Current Report on Form 8-K filed on March 25,
2020.
4.15 	Form of Note for 4.125% Notes due 2040 — incorporated herein by reference to Exhibit 4.7 to the Company’s Current Report on Form 8-K filed on March 25,
2020.
4.16 	Form of Note for 4.200% Notes due 2050 — incorporated herein by reference to Exhibit 4.8 to the Company’s Current Report on Form 8-K filed on March 25,
2020.
4.17 	Form of Note for 1.450% Notes due 2027 — incorporated herein by reference to Exhibit 4.4 to the Company’s Current Report on Form 8-K filed on May 4, 2020.
4.18 	Form of Note for 1.650% Notes due 2030 — incorporated herein by reference to Exhibit 4.5 to the Company’s Current Report on Form 8-K filed on May 4, 2020.
4.19 	Form of Note for 2.500% Notes due 2040 — incorporated herein by reference to Exhibit 4.6 to the Company’s Current Report on Form 8-K filed on May 4, 2020.
4.20 	Form of Note for 2.600% Notes due 2050 — incorporated herein by reference to Exhibit 4.7 to the Company’s Current Report on Form 8-K filed on May 4, 2020.
4.21 	Form of Note for 2.750% Notes due 2060 — incorporated herein by reference to Exhibit 4.8 to the Company’s Current Report on Form 8-K filed on May 4, 2020.
4.22 	Form of Note for 0.125% Notes due 2029 — incorporated herein by reference to Exhibit 4.4 to the Company’s Current Report on Form 8-K filed on September
18, 2020.
4.23 	Form of Note for 0.375% Notes due 2033 — incorporated herein by reference to Exhibit 4.5 to the Company’s Current Report on Form 8-K filed on September
18, 2020.
4.24 	Form of Note for 0.800% Notes due 2040 — incorporated herein by reference to Exhibit 4.6 to the Company’s Current Report on Form 8-K filed on September
18, 2020.
4.25 	Form of Note for 1.000% Notes due 2028 — incorporated herein by reference to Exhibit 4.7 to the Company’s Current Report on Form 8-K filed on September
18, 2020.
4.26 	Form of Note for 1.375% Notes due 2031 — incorporated herein by reference to Exhibit 4.8 to the Company’s Current Report on Form 8-K filed on September
18, 2020.
4.27 	Form of Note for 2.500% Notes due 2051 — incorporated herein by reference to Exhibit 4.9 to the Company’s Current Report on Form 8-K filed on September
18, 2020.
4.28 	Form of Note for 1.500% Notes due 2028 — incorporated herein by reference to Exhibit 4.4 to the Company’s Current Report on Form 8-K filed on March 5,
2021.
4.29 	Form of Note for 2.000% Notes due 2031 — incorporated herein by reference to Exhibit 4.5 to the Company’s Current Report on Form 8-K filed on March 5,
2021.
4.30 	Form of Note for 0.125% Notes due 2029 — incorporated herein by reference to Exhibit 4.4 to the Company’s Current Report on Form 8-K filed on March 9,
2021.
4.31 	Form of Note for 0.500% Notes due 2033 — incorporated herein by reference to Exhibit 4.5 to the Company’s Current Report on Form 8-K filed on March 9,
2021.
4.32 	Form of Note for 1.000% Notes due 2041 — incorporated herein by reference to Exhibit 4.6 to the Company’s Current Report on Form 8-K filed on March 9,
2021.
4.33 	Form of Note for 2.250% Notes due 2032 — incorporated herein by reference to Exhibit 4.4 to the Company’s Current Report on Form 8-K filed on May 5, 2021.
4.34 	Form of Note for 2.875% Notes due 2041 — incorporated herein by reference to Exhibit 4.5 to the Company’s Current Report on Form 8-K filed on May 5, 2021.
42

-- 45 of 156 --

4.35 	Form of Note for 3.000% Notes due 2051 — incorporated herein by reference to Exhibit 4.6 to the Company’s Current Report on Form 8-K filed on May 5, 2021.
4.36 	Form of Note for 0.950% Notes due 2036 — incorporated herein by reference to Exhibit 4.5 to the Company’s Current Report on Form 8-K filed on May 6, 2021.
4.37 	Form of Note for 0.400% Notes due 2030 — incorporated herein by reference to Exhibit 4.4 to the Company’s Current Report on Form 8-K filed on May 17,
2021.
4.38 	Form of Note for 5.000% Notes due 2034 — incorporated herein by reference to Exhibit 4.4 to the Company’s Current Report on Form 8-K filed on May 13,
2024.
4.39 	Form of Note for 5.300% Notes due 2054 — incorporated herein by reference to Exhibit 4.5 to the Company’s Current Report on Form 8-K filed on May 13,
2024.
4.40 	Form of Note for 5.400% Notes due 2064 — incorporated herein by reference to Exhibit 4.6 to the Company’s Current Report on Form 8-K filed on May 13,
2024.
4.41 	Form of Note for 3.125% Notes due 2032 — incorporated herein by reference to Exhibit 4.4 to the Company’s Current Report on Form 8-K filed on May 14,
2024.
4.42 	Form of Note for 3.500% Notes due 2044 — incorporated herein by reference to Exhibit 4.5 to the Company’s Current Report on Form 8-K filed on May 14,
2024.
4.43 	Form of Note for 4.650% Notes due 2034 — incorporated herein by reference to Exhibit 4.4 to the Company’s Current Report on Form 8-K filed on August 14,
2024.
4.44 	Form of Note for 5.200% Notes due 2055 — incorporated herein by reference to Exhibit 4.5 to the Company’s Current Report on Form 8-K filed on August 14,
2024.
4.45 	Form of Note for 3.375% Notes due 2037 — incorporated herein by reference to Exhibit 4.4 to the Company’s Current Report on Form 8-K filed on August 15,
2024.
4.46 	Form of Note for 3.750% Notes due 2053 — incorporated herein by reference to Exhibit 4.5 to the Company’s Current Report on Form 8-K filed on August 15,
2024.
4.47 	Indenture, dated as of July 30, 1991, between Coca-Cola Refreshments USA, Inc. and Deutsche Bank Trust Company Americas, as trustee — incorporated herein
by reference to Exhibit 4.1 to Coca-Cola Refreshments USA, Inc.’s Current Report on Form 8-K dated July 30, 1991.
4.48 	First Supplemental Indenture, dated as of January 29, 1992, to the Indenture, dated as of July 30, 1991, between Coca-Cola Refreshments USA, Inc. and Deutsche
Bank Trust Company Americas, as trustee — incorporated herein by reference to Exhibit 4.01 to Coca-Cola Refreshments USA, Inc.’s Current Report on Form 8-
K dated January 29, 1992.
4.49 	Second Supplemental Indenture, dated as of June 22, 2017, to the Indenture, dated as of July 30, 1991, as amended, among Coca-Cola Refreshments USA, Inc.,
the Company and Deutsche Bank Trust Company Americas, as trustee — incorporated herein by reference to Exhibit 4.3 to the Company’s Current Report on
Form 8-K filed on June 23, 2017.
4.50 	Third Supplemental Indenture, dated as of July 5, 2017, to the Indenture, dated as of July 30, 1991, as amended, among Coca-Cola Refreshments USA, Inc., the
Company and Deutsche Bank Trust Company Americas, as trustee — incorporated herein by reference to Exhibit 4.3 to the Company’s Current Report on Form 8-
K filed on July 6, 2017.
10.1 	Letter, dated January 13, 2026, from the Company to Sedef Salingan Sahin.
10.2 	Letter, dated January 13, 2026, from the Company to Claudia Lorenzo.
10.3 	Letter, dated January 13, 2026, from the Company to Sanket Ray.
10.4 	Letter, dated February 19, 2026, from the Company to Henrique Braun, incorporated herein by reference to Exhibit 10.1 to the Company’s Current Report on
Form 8-K filed on February 20, 2026.
10.5 	Letter, dated February 19, 2026, from the Company to James Quincey, incorporated herein by reference to Exhibit 10.2 to the Company’s Current Report on Form
8-K filed on February 20, 2026.
10.6 	Form of Performance Share Agreement for grants under The Coca-Cola Company 2024 Equity Plan (the “2024 Equity Plan”), as adopted February 18, 2026.
10.7 	Form of Restricted Stock Unit Agreement for grants under the 2024 Equity Plan, as adopted February 18, 2026.
10.8 	Form of Stock Option Agreement for grants under the 2024 Equity Plan, as adopted February 18, 2026.
31.1 	Rule 13a-14(a)/15d-14(a) Certification, executed by Henrique Braun, Chief Executive Officer of The Coca-Cola Company.
31.2 	Rule 13a-14(a)/15d-14(a) Certification, executed by John Murphy, President and Chief Financial Officer of The Coca-Cola Company.
32.1 	Certifications required by Rule 13a-14(b) or Rule 15d-14(b) and Section 1350 of Chapter 63 of Title 18 of the United States Code (18 U.S.C. Section 1350),
executed by Henrique Braun, Chief Executive Officer of The Coca-Cola Company, and by John Murphy, President and Chief Financial Officer of The Coca-Cola
Company.
43

-- 46 of 156 --

101 	The following financial information from The Coca-Cola Company’s Quarterly Report on Form 10-Q for the quarter ended April 3, 2026, formatted in iXBRL
(Inline Extensible Business Reporting Language): (i) Consolidated Statements of Income for the three months ended April 3, 2026 and March 28, 2025; (ii)
Consolidated Statements of Comprehensive Income for the three months ended April 3, 2026 and March 28, 2025; (iii) Consolidated Balance Sheets as of April 3,
2026 and December 31, 2025; (iv) Consolidated Statements of Cash Flows for the three months ended April 3, 2026 and March 28, 2025; and (v) Notes to
Consolidated Financial Statements.
104 	Cover Page Interactive Data File (the cover page XBRL tags are embedded within the iXBRL document and included in Exhibit 101).
44

-- 47 of 156 --

SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly
authorized.
THE COCA-COLA COMPANY
(Registrant)
/s/ ERIN L. MAY
Date: 	April 30, 2026 	Erin L. May
Senior Vice President, Controller and Chief Accounting Officer
(Principal Accounting Officer)
45

-- 48 of 156 --

Exhibit 10.1
January 13, 2026
Sedef Salingan Sahin
Dear Sedef,
I am delighted to confirm your promotion to Chief Digital Officer. The role will be effective March 31, 2026, subject to the obtainment of the appropriate work
permits. You will report to me. The information contained in this letter provides the terms and compensation details of this position, all of which are pending
approval of the Talent and Compensation Committee of the Board. All payments set forth below are subject to tax and withholding.
• 	Your annual base pay for your new position will be USD 600,000. Your next base salary review will be in April 2027.
• 	Your principal place of assignment will be Atlanta, GA. You will be employed by The Coca-Cola Company, upon receipt of required work permits.
• 	You will continue to participate in the Global Mobility Tier 1 HQ Program and be provided the standard benefits of that program. The duration and type of
assignment are contingent upon the business needs of the Company provided suitable performance standards are maintained. The Code of Business
Conduct, Confidentiality Agreements, or any other document related to knowledge you acquire of Company business or conducting business remain in
effect during international assignments.
• 	You will continue to be eligible to participate in the Annual Incentive Plan. Your target annual incentive for your new position is 100% of your annual base
pay. Any payment will depend on both the business performance and your personal contributions. Awards are made at the discretion of the Talent and
Compensation Committee of the Board of Directors based upon recommendations by Senior Management. As a discretionary program, the performance
factors, eligibility criteria, payment frequency, award opportunity levels and other provisions are variable. The plan may be modified from time to time.
• 	You will continue to be eligible to participate in The Coca-Cola Company’s Long-Term Incentive (LTI) program. Awards are made at the discretion of the
Talent and Compensation Committee of the Board of Directors based upon recommendations by Senior Management. You will be eligible to receive LTI
awards within guidelines for the level assigned to your position and based upon your leadership potential to impact the company’s future growth. As a
discretionary program, eligibility criteria, award opportunity levels, the award timing, frequency, size and mix of award vehicles are variable.
• 	You will be expected to acquire and maintain share ownership at a level equal to two times your base salary. As part of the Company’s ownership
expectations, you will have five years, or until December 31, 2031, to achieve this level of ownership. You will be asked to provide information in December
each year on your progress toward your ownership goal, and that information will be reviewed with the Talent and Compensation Committee of the Board of
Directors the following February.

-- 49 of 156 --

Sedef Salingan Sahin
January 13, 2026
Page 2
• 	You are required to enter into the Agreement on Confidentiality, Non-Competition, and Non-Solicitation, as well as the Agreement Covering Inventions,
Discoveries, Copyrightable Material, Trade Secrets, and Confidential Information that will be provided to you soon.
• 	This letter is provided as information and does not constitute an employment contract.
Sedef, I feel certain that you will continue to find challenge, satisfaction, and opportunity in this role and as we continue our journey during this important time.
Sincerely,
/s/ Henrique Braun
Henrique Braun
EVP and Chief Operating Officer
cc: Margie Lewis
Executive Compensation
Advanced Care
I, Sedef Salingan Sahin, accept this offer
Signature: /s/ Sedef Salingan Sahin
Date: January 16, 2026

-- 50 of 156 --

Exhibit 10.2
January 13, 2026
Claudia Lorenzo
Dear Claudia,
I am delighted to confirm your promotion to President, EME and Emerging Multi-Markets Lead. The role will be effective March 31, 2026, subject to the
obtainment of the appropriate work permits. You will report to me. The information contained in this letter provides the terms and compensation details of this
position, all of which are pending approval of the Talent and Compensation Committee of the Board. All payments set forth below are subject to tax and
withholding.
• 	Your annual base pay for your new position will be USD 575,000. Your next base salary review will be in April 2027.
• 	Your principal place of assignment will be Dubai, United Arab Emirates. You will be employed by The Coca-Cola Export Corporation - Dubai Branch, upon
receipt of required work permits.
• 	You will continue to participate in the Global Mobility Tier 1 HQ Program and be provided the standard benefits of that program. The duration and type of
assignment are contingent upon the business needs of the Company provided suitable performance standards are maintained. The Code of Business
Conduct, Confidentiality Agreements, or any other document related to knowledge you acquire of Company business or conducting business remain in
effect during international assignments.
• 	You will continue to be eligible to participate in the Annual Incentive Plan. Your target annual incentive for your new position is 100% of your annual base
pay. Any payment will depend on both the business performance and your personal contributions. Awards are made at the discretion of the Talent and
Compensation Committee of the Board of Directors based upon recommendations by Senior Management. As a discretionary program, the performance
factors, eligibility criteria, payment frequency, award opportunity levels and other provisions are variable. The plan may be modified from time to time.
• 	You will continue to be eligible to participate in The Coca-Cola Company’s Long-Term Incentive (LTI) program. Awards are made at the discretion of the
Talent and Compensation Committee of the Board of Directors based upon recommendations by Senior Management. You will be eligible to receive LTI
awards within guidelines for the level assigned to your position and based upon your leadership potential to impact the company’s future growth. As a
discretionary program, eligibility criteria, award opportunity levels, the award timing, frequency, size and mix of award vehicles are variable.
• 	You will be expected to acquire and maintain share ownership at a level equal to two times your base salary. As part of the Company’s ownership
expectations, you will have five years, or until December 31, 2031, to achieve this level of ownership. You will be asked to provide information in December
each year on your progress toward your ownership goal, and that information will be reviewed with the Talent and Compensation Committee of the Board of
Directors the following February.

-- 51 of 156 --

Claudia Lorenzo
January 13, 2026
Page 2
• 	You are required to enter into the Agreement on Confidentiality, Non-Competition, and Non-Solicitation, as well as the Agreement Covering Inventions,
Discoveries, Copyrightable Material, Trade Secrets, and Confidential Information that will be provided to you soon.
• 	This letter is provided as information and does not constitute an employment contract.
Claudia, I feel certain that you will continue to find challenge, satisfaction, and opportunity in this role and as we continue our journey during this important time.
Sincerely,
/s/ Henrique Braun
Henrique Braun
EVP and Chief Operating Officer
cc: Margie Lewis
Executive Compensation
Advanced Care
I, Claudia Lorenzo, accept this offer.
Signature: /s/ Claudia Loreno
Date: January 14, 2026

-- 52 of 156 --

Exhibit 10.3
January 13, 2026
Sanket Ray
Dear Sanket,
I am delighted to confirm your promotion to President, INSWA and Emerging Large Markets Lead, with an effective date of March 31, 2026. You will report to
me. The information contained in this letter provides the terms and compensation details of this position, all of which are pending approval of the Talent and
Compensation Committee of the Board. All payments set forth below are subject to tax and withholding.
• 	Your annual Fixed Cost to the Company for your new position will be INR 55,000,000. You will be eligible to receive the standard allowances and benefits
that are typical in India. Your next base salary review will be in April 2027.
• 	Your principal place of assignment will continue to be Gurugram, India. Your employer in India
will be Coca-Cola India Private Limited.
• 	You will continue to be eligible to participate in the Annual Incentive Plan. Your target annual incentive for your new position is 100% of your annual base
pay. Any payment will depend on both the business performance and your personal contributions. Awards are made at the discretion of the Talent and
Compensation Committee of the Board of Directors based upon recommendations by Senior Management. As a discretionary program, the performance
factors, eligibility criteria, payment frequency, award opportunity levels and other provisions are variable. The plan may be modified from time to time.
• 	You will continue to be eligible to participate in The Coca-Cola Company’s Long-Term Incentive (LTI) program. Awards are made at the discretion of the
Talent and Compensation Committee of the Board of Directors based upon recommendations by Senior Management. You will be eligible to receive LTI
awards within guidelines for the level assigned to your position and based upon your leadership potential to impact the company’s future growth. As a
discretionary program, eligibility criteria, award opportunity levels, the award timing, frequency, size and mix of award vehicles are variable.
• 	You will be expected to acquire and maintain share ownership at a level equal to two times your base salary. As part of the Company’s ownership
expectations, you will have five years, or until December 31, 2031, to achieve this level of ownership. You will be asked to provide information in December
each year on your progress toward your ownership goal, and that information will be reviewed with the Talent and Compensation Committee of the Board of
Directors the following February.
• 	You are required to enter into the Agreement on Confidentiality, Non-Competition, and Non-Solicitation, as well as the Agreement Covering Inventions,
Discoveries, Copyrightable Material, Trade Secrets, and Confidential Information that will be provided to you soon.
• 	This letter is provided as information and does not constitute an employment contract.

-- 53 of 156 --

Sanket Ray
January 13, 2026
Page 2
Sanket, I feel certain that you will continue to find challenge, satisfaction, and opportunity in this role and as we continue our journey during this important time.
Sincerely,
/s/ Henrique Braun
Henrique Braun
EVP and Chief Operating Officer
cc: Margie Lewis
Executive Compensation
Advanced Care
I, Sanket Ray, accept this offer.
Signature: /s/ Sanket Ray
Date: January 15, 2026

-- 54 of 156 --

Exhibit 10.6
Award Notification – Performance Share
Congratulations [INSERT FULL NAME]! On [INSERT GRANT DATE], The Coca-Cola Company (the Company) granted you an award (your Award) under The
Coca-Cola Company 2024 Equity Plan, as amended from time to time (the Plan). Your Award is a great opportunity to share in the long-term success of the
Company and contribute to its future growth.
This document provides details of the key terms of your Award. Your Award is subject to the formal rules of the Plan, plus the additional terms and conditions
(including country specific terms) as set out in a document called the “Additional Terms”. The Additional Terms is available to review as part of the Award
acceptance process. The Plan is available in the Documents section of the Morgan Stanley at Work® website. This Award Notification (including the
appendices), the Plan and the Additional Terms together form your Award Agreement. You are being asked to confirm that you understand and agree to be
bound by these documents as part of the Award acceptance process, so we recommend you read them carefully.
Details of Award
Type of Award 	Performance Award (sometimes called Performance Share Units) -This is a conditional right to receive $0.25 par value
common stock of the Company (Stock) in the future. You will not receive the Stock (or have any shareholder rights) unless
your Award vests.
Target number of
shares of Stock subject
to your Award
[INSERT]
Continuing employment Your Award is subject to your continuing employment, as set out in the Employment Events Appendix to this document and
the Plan.
Performance conditions Performance conditions apply to your Award, which are set out in the Performance Criteria Appendix to this document. The
performance conditions must be met in order for your Award to vest.
Performance period 	[INSERT]
The performance conditions are measured during this period. See the Performance Criteria Appendix for more details.

-- 55 of 156 --

Details of Award
Date your Award
normally vests
[INSERT DATE], or if later when the performance conditions are certified.
When your Award vests, you become entitled to the Stock subject to your Award. You do not need to purchase that Stock - it
is delivered automatically to you.
The number of shares of Stock that vest will be calculated based upon the target number of shares of Stock set forth above
and the provisions of the Performance Criteria Appendix.
The number of shares of Stock that vest will normally be delivered to you as soon as administratively possible following
vesting, unless a different timing for delivering the Stock applies under the Employment Events Appendix.
Your Award will generally be settled in Shares, except where the appendices to this Award Notification apply and specify
otherwise.
You are liable for any tax, fees and costs due on vesting, which may be withheld.
Remember: your Award will only vest if and to the extent that all of the terms and conditions of your Award are satisfied. To
the extent that your Award does not vest, it will be forfeited.
Prohibited Activities 	If you engage in certain activities (called Prohibited Activities), your Award will be forfeited and you will be required to pay
back any gain from your Award. Refer to the Prohibited Activities Appendix to this document.
Malus and clawback 	Your Award is subject to additional malus and clawback provisions which means your Award will be subject to reduction,
cancellation, repayment or forfeiture in the circumstances set out in the Additional Terms.
Finally, certain data privacy provisions apply to you in connection with your Award, as set out in the Data Privacy Appendix to this document.
In the event of any conflict between this Award Notification (including the appendices), the Additional Terms and the Plan, the Plan takes precedence.
Action required!
If you wish to accept your Award, you must accept it using the Morgan Stanley at Work ® website by [INSERT DATE/TIME]. If you fail to do so by this
deadline, then the Company may declare your Award grant null and void at any time. If this happens, your Award will be forfeited, and you will have no right to
the underlying Stock. Acceptance of this award will constitute acknowledgement of and consent to the updated Annual Incentive and Long-Term Incentive
design and mix of awards.
Interpretation
The appendices below form part of your Award Notification. The singular includes the plural and defined terms have the meaning given in the Plan, unless otherwise specified. For the purposes of the
Prohibited Activities Appendix, references to your employer include your former employer, and for the purposes of the Data Privacy Appendix, references to your employer include your current local
employing entity or former local employing entity and the Company (where applicable). References to the Committee mean The Talent and Compensation Committee of the Board of Directors of the
Company, unless otherwise specified.

-- 56 of 156 --

Employment Events Appendix – Performance Share
The table below sets out the impact to your Award (if any) upon certain employment events. The terms of the table below apply to vested and unvested portions
of an Award equally, unless otherwise stated. Except as otherwise specified herein, all other terms and conditions of your Award continue to apply.
Event 	Impact to your Award
Disability 	Whether your employment with the Company or a Subsidiary terminates because of Disability or whether you remain
employed, there is no impact to your Award.
Death 	Any Award that has not been accepted terminates immediately upon your death and may not be transferred to your heirs.
If you die while employed with the Company or a Subsidiary, your Award immediately vests, and your estate will be paid, within
90 days after your death, a cash amount equal to the value of (1) the target number of shares of Stock subject to the Award, if
you die before the end of the performance period, or (2) the shares of Stock earned, if you die after the end of the performance
period. The value shall be determined based on the closing price of the Stock on the date of death (or in the case of a non-
trading day, the next trading day).
Leave of absences 	If you are on (1) US military leave, (2) a Company-paid leave of absence (meaning paid under Company payroll), or (3) an
unpaid leave of absence (approved pursuant to a published Company policy available to all employees covered under the
policy) of 12 months or less, there is no impact to your Award.
For all other leaves of absence not specified in the paragraph above, including all approved unpaid leaves that extend beyond
12 months:
• 	any portion of your Award that is unvested is immediately forfeited ; or
• 	if the Committee identifies a valid business interest in doing otherwise, it may specify what provisions it deems
appropriate at its sole discretion (provided that the Committee shall have no obligation to consider any such matters).
Transfer 	If you transfer (1) between the Company and any Subsidiary or, (2) at the Committee’s discretion, to an Affiliate that is not a
Subsidiary, there is no impact to your Award.
If an approved unpaid leave of absence extends beyond 12 months, the portion of your Award that is unvested as of the end of the 12 month is forfeited.
1
1
1 	th

-- 57 of 156 --

Event 	Impact to your Award
Termination 	A. If your employment with the Company or a Subsidiary terminates after attaining age 60:
• 	Awards held less than 12 months are immediately forfeited, and
• 	there is no impact on Awards held at least 12 months.
B. If your employment with the Company or a Subsidiary terminates involuntarily for any reason other than for cause within one
year after a Change in Control, your Award will be treated as described in the Plan.
C. If your employment with the Company or a Subsidiary terminates prior to attaining age 60 (or after attaining age 60 and your
award would be forfeited under paragraph A) because of (1) an involuntarily termination due to a reduction in workforce,
internal reorganization, or job elimination and you sign a release of all claims and, if requested, an agreement on
confidentiality and competition, or (2) you participate in a Company or Subsidiary-sponsored voluntary separation program:
• 	if any portion of your Award normally vests within 10 months after your termination date, there is no impact to that
portion of your Award, and
• 	all other Awards, or portions thereof, are immediately forfeited.
D. If your employment (1) with the Company or a Subsidiary terminates for any other reason, or (2) with an Affiliate (that is not
a Subsidiary) terminates for any reason , your Award is immediately forfeited.
Notwithstanding anything herein, if your employment with an Affiliate terminates and you immediately become employed by
the Company or a Subsidiary, there is no impact on your Award.
For the purposes of your Award, you are deemed to have terminated employment on the date you are no longer actively providing services to the relevant entity
or entities, regardless of the reasons for termination and whether or not later found to be invalid or in breach of your employment agreement, if any, or
employment laws in the jurisdiction where you are employed. The Committee has exclusive discretion to decide when you are considered to be no longer
actively providing services for the purposes of your Award. However, you will not be considered to be actively providing services during any contractual notice
period or any period of “garden leave” or similar period mandated under employment laws in the jurisdiction where you are employed or in your employment
agreement, if any, unless the Committee decides otherwise.
This would apply in the case where the Committee determined that your transfer to the Affiliate would not impact your Award. If your employer no longer meets the definition of “Affiliate”, you are
deemed to have terminated employment for the purposes of the Plan.
2
2

-- 58 of 156 --

Prohibited Activities Appendix
1. 	Engaging in Prohibited Activity
1.1 Timing
Section 1.2 (Implications) applies if you engage in a Prohibited Activity (as defined in section 5 (Types of Prohibited Activity) below) at any time during
the term of your Award or within one year after the later of:
1.1.1 the termination of your employment with the Company, your employer or any Affiliate; and
1.1.2 the last date of vesting or exercise of all or any portion of your Award.
1.2 Implications
If this section 1.2 applies:
1.2.1 your Award will immediately terminate, be forfeited and (if relevant) cease to be exercisable; and
1.2.2 within 10 days after receiving written notice from the Company that this section applies, you must pay in cash to the Company:
(i) any and all gains associated with any previous vesting or exercise of all or any portion of your Award; and
(ii) interest calculated from the time of the notice until the date of repayment to the Company.
2. 	Implications for settled Awards
2.1 Calculation of gain
For the purposes of section 1.2.2, each gain associated with the vesting or exercise of all or any portion of your Award will be calculated as:
2.1.1 where your Award is in the form of an Option, the closing price per share of Stock on the date of exercise as reported on the New York Stock
Exchange Composite Transactions listing minus the exercise price per share of Stock, multiplied by the number of shares of Stock over which
the Award was exercised;
2.1.2 where your Award is in the form of Restricted Stock Units or Performance Share Units, the closing price per share of Stock on the date of
vesting as reported on the New York Stock Exchange Composite Transactions listing, multiplied by the number of shares of Stock that vested;
and
2.1.3 where your Award is in the form of Performance Cash, the gross amount of the cash payment that vested.

-- 59 of 156 --

3. 	Alternative payment
3.1 Return of Stock
If all or any part of this Prohibited Activities Appendix is held to be invalid, illegal or unenforceable for any reason by any court with jurisdiction:
3.1.1 you will transfer to the Company all of the shares of Stock that you acquired on vesting or exercise of your Award that you still hold (and if your
Award is an Option, the Company will pay to you the exercise price you paid for that Stock in exchange); and
3.1.2 where you have already sold, transferred or disposed of any shares of Stock you acquired on vesting or exercise of your Award, you must pay
to the Company:
(i) any and all gains associated with each sale, transfer or disposal; and
(ii) interest calculated from the date of each sale, transfer or disposal until the date of repayment to the Company.
3.2 Calculation of gain
For the purposes of section 3.1.2, the gain associated with the sale, transfer or disposal will in each case be calculated as the closing price per share of
Stock on the date of the sale, transfer or disposal as reported on the New York Stock Exchange Composite Transactions listing (minus, where your
Award is an Option, the exercise price per share of Stock), multiplied by the number of shares of Stock sold, transferred or disposed of.
4. Interest
Any interest payable under this Prohibited Activities Appendix will be calculated using the weighted prime rate at SunTrust Bank, Atlanta.
5. Types of Prohibited Activity
The term Prohibited Activity includes any and all of the following:
5.2 Disparagement
Making any statement, written or verbal, in any forum or media, or taking any action in disparagement of the Company, your employer and/or any
Affiliate, including but not limited to negative references to the Company or its products, services, corporate policies, or current or former officers or
employees, customers, suppliers, or business partners or associates.
5.2 Publicity
Publishing any opinion, fact, or material, delivering any lecture or address, participating in the making of any film, radio broadcast or television
transmission, or communicating with any representative of the media relating to confidential matters regarding the business or affairs of the Company,
your employer and/or any Affiliate which you were involved with during your employment.

-- 60 of 156 --

5.3 Disclosure of a Trade Secret
Failure to hold in confidence any and all Trade Secrets of the Company that came into your knowledge during your employment with the Company,
your employer and/or any Affiliate, or disclosing, publishing, or making use of, at any time, such Trade Secrets.
For these purposes, Trade Secret means any technical or non-technical data, formula, pattern, compilation, program, device, method, technique,
drawing, process, financial data, financial plan, product plan, list of actual or potential customers or suppliers or other information similar to any of the
foregoing, which:
5.3.1 derives economic value, actual or potential, from not being generally known to and not being readily ascertainable by proper means by other
persons who can derive economic value from its disclosure or use; and
5.3.2 is the subject of efforts that are reasonable under the circumstances to maintain its secrecy.
5.4 Disclosure of Confidential Information
Failure to hold in confidence all Confidential Information of the Company, your employer and/or any Affiliate that came into your knowledge during your
employment with the Company, your employer or any Affiliate, or disclosing, publishing, or making use of such Confidential Information.
For these purposes, Confidential Information means any data or information, other than Trade Secrets (as defined in section 5.3 (Disclosure of a
Trade Secret)), that is valuable to the Company and not generally known to the public or to competitors of the Company.
5.5 Failing to return materials
Your failure, in the event of your termination of employment for any reason, promptly to deliver to the Company all memoranda, notes, records, manuals
or other documents, including all copies of such materials and all documentation prepared or produced in connection therewith, containing Trade
Secrets (as defined in section 5.3 (Disclosure of a Trade Secret)) or Confidential Information (as defined in section 5.4 (Disclosure of Confidential
Information)) regarding the Company’s business, whether made or compiled by you or furnished to you by virtue of your employment with the
Company, your employer or any Affiliate, or failure promptly to deliver to the Company all vehicles, computers, credit cards, telephones, handheld
electronic devices, office equipment, and other property furnished to you by virtue of your employment with the Company, your employer or any Affiliate.
5.6 Competing
Rendering services for any organization which, or engaging directly or indirectly in any business which, in the sole judgment of the Committee or the
Chief Executive Officer of the Company or any senior officer designated by the Committee, is or becomes competitive with the Company.
Notwithstanding the preceding sentence, this Section 5.6 will not be applicable for any employee living or working in California.

-- 61 of 156 --

5.7 Solicitation
Soliciting or attempting to solicit for employment, for or on behalf of any corporation, partnership, or other business entity, any employee of the
Company, your employer or an Affiliate with whom you had professional interaction during the last twelve months of your employment with the
Company, your employer or the Affiliate.
5.8 Violation of Company policies
Violating any written policies of the Company or your employer applicable to you, including, without limitation, The Coca-Cola Company Global Insider
Trading Compliance Policy.
6. Release
You may be released from the effects of this Prohibited Activities Appendix if the Committee determines in its sole discretion that such action is in the
best interest of the Company and its stockholders.
7. Other rights apply
Nothing in this Prohibited Activities Appendix is intended to or will be interpreted as diminishing or otherwise limiting the Company’s right under
applicable state or local law or any prior agreement you have signed or made with the Company regarding trade secrets, confidential information, or
intellectual property.

-- 62 of 156 --

Data Privacy Appendix
1. 	General
1.1 Introduction
This Data Privacy Appendix sets out certain data privacy provisions that apply to you in connection with your Award.
1.2 Meaning of Data
For the purposes of this Data Privacy Appendix, Data means personal information that directly or indirectly identifies you, including: your name, home
address and telephone number, your date of birth, your government identification number, your salary information, nationality, job title and employment
location, any shares or directorships you hold or held in the Company or any Affiliate, details of your Award and any equity or cash awards or any other
entitlements to stock or cash granted (regardless of whether or not exercised, vested or settled, and including any cancelled or forfeited awards), any
information necessary to process your Award or any other award (e.g. your mailing address for a check payment or bank account wire transfer
information), any other information necessary to process mandatory tax withholding and reporting and/or, where applicable, your employment or service
termination date and the reason for the termination.
2. For Award recipients not located in the EEA or UK
This section applies if you reside anywhere in the world except the European Economic Area (EEA) or the United Kingdom (UK). By accepting your
Award, you confirm the following:
2.1 Consent
You voluntarily consent to the collection, use and transfer, in electronic or other form, of your Data by and between the Company, your employer or any
Affiliate for the purpose of implementing, administering, and managing your participation in the Plan.
2.2 Data collected
You understand that the Company and its Affiliates may hold Data for the exclusive purpose of implementing, administering, and managing the Plan.
2.3 Purposes of collection
You understand that Data will be transferred to one or more stock or incentive plan service providers selected by the Company, which may assist the
Company with the implementation, administration, and/or management of the Plan.
2.4 Recipients of Data
You understand that the recipients of Data may be located in the United States or elsewhere. The Company also uses third party service providers who
may assist with the implementation, administration or management of the Plan. These service providers are bound by contract to handle Data in a way
that aligns with this Data Privacy Appendix and applicable law. If you have

-- 63 of 156 --

any questions about the local entities or services providers who may access or handle your Data, please contact your local human resources
representative.
By consenting at section 2.1 (Consent) above, you authorize the Company and any other possible recipients that do or may assist the Company with
implementing, administering or managing the Plan to receive, possess, use, retain and transfer the Data, in electronic or other form, for the sole
purpose of implementing, administering and/or managing your participation in the Plan.
2.5 Data retention
You understand that Data will be held only as long as is necessary to implement, administer and manage your participation in the Plan. In some cases,
your information will be retained for the Company or your employer to comply with a legal or tax obligation.
2.6 Your rights
You understand that if you reside in certain jurisdictions, to the extent required by applicable laws, you may, at any time and without cost:
2.6.1 request access to Data;
2.6.2 request additional information about the storage and processing of Data;
2.6.3 require any necessary amendments to Data; or
2.6.4 refuse or withdraw the consents you give by accepting the Award,
by contacting your local human resources representative in writing.
2.7 Implications of not consenting or withdrawing consent
You understand that you provide these consents on a purely voluntary basis. If you do not consent, or if you later withdraw your consent, your
employment or service contract with the Company or an Affiliate will not be adversely affected. Refusing or withdrawing your consent will mean that the
Company will not be able to grant new awards or administer or maintain any existing awards (including this Award) under the Plan. You understand that
refusing or withdrawing your consent may affect your ability to participate in the Plan (including the right to retain an award, such as this Award). You
understand that you may contact a local human resources representative for more information on the consequences of refusal to consent or withdrawal
of consent.
3. For Award recipients located in the EEA and/or UK
This section applies if you reside inside the United Kingdom (UK) and/or the European Economic Area (EEA). By accepting your Award, you confirm
the following:
3.1 Data collected
You understand that the your employer (acting as controller) and the Company may collect, to the extent permissible under applicable law, Data for the
exclusive purpose of implementing, administering, and managing the Plan. The Data is collected from you, the employer, and the

-- 64 of 156 --

Company for the exclusive purpose of implementing, administering, and managing the Plan in accordance with the terms of your Award.
3.2 Purposes of collection/processing
You acknowledge the legal basis for Data processing is performance of the contract comprising your Award. The Data must be provided in order for you
to participate in the Plan and for the parties to your Award to perform their respective obligations as set out in your Award documents. If you do not
provide Data, you will not be able to participate in the Plan or continue to hold your Award.
3.3 Transfers and retention of Data
You understand that your employer will transfer Data to the Company for Plan administration purposes. The Company and your employer may also
transfer your Data to other service providers (such as accounting firms, payroll processing firms or tax firms), as may be selected by the Company now
or in the future, to assist the Company and your employer with the implementation, administration and/or management of your Award. You understand
that recipients of the Data may be located in a country that does not benefit from an adequacy decision issued by the European Commission. When
your information is transferred outside the EEA or the UK (as applicable), it is done in accordance with data protection laws and regulations requiring
adequate transfer mechanisms. For further information as to the transfer of your Data, please contact privacy@coca-cola.com. Your Data will be held
only as long as is necessary to implement, administer and manage your rights and obligations under the terms of your Award documents, as well as in
compliance with other laws requiring a longer retention period.
3.4 Accuracy
You understand the Company and your employer will take steps in accordance with applicable legislation to keep Data accurate, complete and up to
date.
3.5 Your rights
You understand you are entitled to:
3.5.1 have any inadequate, incomplete or incorrect Data corrected;
3.5.2 request access to your Data and additional information about the processing of that Data;
3.5.3 object to the processing of Data or have your Data erased, under certain circumstances; and
3.5.4 subject to applicable law:
(i) restrict the processing of your Data so that it is stored but not actively processed (e.g. while the Company assesses whether you are
entitled to have Data erased); and
(ii) receive a copy of the Data provided in connection with your Award or generated by you, in a common machine-readable format,
and you may exercise these rights by contacting a local human resources representative.

-- 65 of 156 --

3.6 Other contacts
You understand you have the right to contact, and may lodge a complaint with, the relevant data protection supervisory authority.
You may also contact the EU Data Protection Officer:
Coca-Cola Italia s.r.l.
Viale Edison 110
Building B
20099 Sesto San Giovanni (Milan)
Italy
DPO-Europe@coca-cola.com
4. Country specific provisions
The provisions below supplement section 2 (For Award recipients not located in the EEA or UK) of this Data Privacy Appendix. By accepting your
Award, you confirm the following:
4.1 If you are subject to the laws of Canada
You authorize the Company, your employer, and your employer’s representatives to discuss with and obtain all relevant information from all personnel
(professional or not) involved in the administration and operation of the Plan. You authorize your employer, the Company, any Affiliates and any stock or
incentive plan service provider that may be selected by the Company to assist with the Plan to disclose and discuss the Plan with their respective
advisors. You further authorize your employer, the Company and any Affiliates to record this information and to keep it in your employee file.
4.2 If you are subject to the laws of Russia
You acknowledge that you have read, understood and agree to the terms regarding the collection, processing and transfer of data described in section
2 (For Award recipients not located in the EEA or UK) of this Data Privacy Appendix. Upon request of the Company or your employer, you agree to
provide an executed data privacy consent form or any similar agreements or consents that the Company or your employer may deem necessary to
obtain under the data privacy laws in Russia, either now or in the future. You understand that you will not be able to participate in the Plan if you fail to
execute any such consent or agreement that may be requested.

-- 66 of 156 --

Awards made under
The Coca-Cola Company 2024 Equity Plan
Additional Terms
By accepting your Award you:
1. 	Plan Documents
Agree that you have been given all relevant information and materials regarding the terms and conditions of your Award, which are set out in the rules
of The Coca-Cola Company 2024 Equity Plan, as amended from time to time (the Plan), your Award Notification (including any appendices attached to
it) and these Additional Terms (including the Global Appendix set out below) (collectively, the Plan Documents).
2. 	Employment
2.1 Acknowledge that the grant of your Award does not form part of and does not affect or change your employment contract or your employment relationship
with your employer (which is entirely separate from the Plan). The grant of your Award and your participation in the Plan does not create a right to
employment or continued service and will not be interpreted as forming an employment or service contract with The Coca-Cola Company (the
Company), your employer or any Affiliate (as defined in the Plan). The Award does not impact the ability of the Company, your employer or any
Affiliate to terminate that employment or service relationship. All benefits granted by your Award will constitute an occasional extraordinary payment and
may not, in any way or for any purpose, be considered part of your normal remuneration or constitute consideration for any services you provide to the
Company, your employer or any Affiliate, including when calculating any other benefits.
2.2 	Acknowledge that the Company’s decision to grant your Award is voluntary and discretionary, and that you have no right to participate in the Plan.
Acceptance of your Award and participation in the Plan does not create any right to, or expectation of, future employment or service, future participation
in the Plan or the grant of future awards (on the same basis, or at all). The Company may at any time decide to cease offering awards under the Plan,
or amend, modify, suspend, cancel or terminate the Plan and any benefits under it.
2.3 	Acknowledge that you are not entitled to the exercise of any discretion under the Plan in your favor, that decisions with respect to your Award and any
future awards are at the sole discretion of the Company and are final, binding and conclusive, and that you do not have any claim or right of action in
respect of any decision, omission, or discretion, which may in each case operate to your disadvantage.
2.4 Agree, in consideration for and as a condition of your Award, to waive all rights which might arise in connection with the Plan, including:
2.4.1 the right to institute any claim against the Company, your employer or any Affiliate; and
2.4.2 the right to pursue any claim that is allowed by a court,
other than the right to acquire, as relevant, $0.25 par value shares of common stock of the Company (Stock) or cash (subject to and in accordance
with the Plan).

-- 67 of 156 --

2.5 Acknowledge that you do not have any right to compensation or damages for any loss (actual or potential) in relation to the Plan or your Award, including
where it is forfeited on termination of employment or cessation of services for any reason, whether or not lawful or in breach of employment laws or the
terms of your employment or service agreement, if any.
3. 	No transfer
Accept that you must not pledge, encumber, assign, transfer, charge or otherwise dispose of your Award or any rights in respect of it, whether
voluntarily or involuntarily (other than to your personal representatives on death).
4. 	Modifications and additional requirements
4.1 Agree that the Company may modify any of the terms of your Award to be consistent with any applicable law or applicable government agency regulation
where, in the opinion of the Company, that term might otherwise conflict or be inconsistent.
4.2 Agree that the Company may impose additional conditions, requirements and restrictions on your Award, your participation in the Plan and any Stock or
cash you acquire on vesting or exercise of your Award, and that you will comply with them, including signing any additional agreements or
undertakings.
4.3 	Agree to any amendment made to the Plan or any term of your Award (including an amendment with retroactive effect) where the amendment is
necessary or advisable to ensure the Plan or your Award complies with any future law relating to plans of this nature or their administration (including
Section 409A of the U.S. Internal Revenue Code of 1986, as amended).
4.4 	Agree to any amendment made to any of the terms of your Award (including rescinding your Award entirely) to correct any error that occurred in
connection with the grant or documentation of your Award.
4.5 	Acknowledge that your Award may be adjusted to reflect a change in capital structure, in accordance with the terms of the Plan, and agree that, where
your Award is over Stock and an adjustment results in a fractional share, the fractional share may be disregarded at the Company’s discretion.
5. 	Tax
5.1 Acknowledge that participating in the Plan will probably have tax consequences for you and that all payments made with respect to your Award (including
payments in Stock or cash) may be subject to tax, social security and any similar charges in any country where you are employed, reside, or are
otherwise subject to tax (Tax).
5.2 	Agree that you (or your personal representative) are ultimately responsible for and will bear any liability for any Tax in respect of your Award and your
participation in the Plan, and understand that this liability may exceed any amounts withheld and paid on your behalf.
5.3 	Acknowledge that the Company, your employer, an Affiliate, any trustee of any employee benefit trust and any third party service provider (each, a
Withholding Person) is entitled to do any, all or a combination of the following methods (where relevant) to enable a Withholding Person to raise an
amount it considers necessary or desirable to recover the Liabilities:

-- 68 of 156 --

5.3.1 sell or procure the sale on your behalf of a sufficient number of the Stock you acquire on vesting or exercise of your Award;
5.3.2 reduce the number of Stock you acquire on vesting or exercise of your Award accordingly and settle the balance in cash; and
5.3.3 withhold amounts from:
(i) proceeds of sale under section 5.3.1;
(ii) the balance settled in cash under section 5.3.2; and
(iii) any other cash payments of any kind owed to you.
For these purposes, Liabilities means any obligation on the Withholding Person to pay or account for Tax, any unpaid exercise price, any associated
costs (including under section 7 (Costs)) and any amount you owe to the Company, your employer or any Affiliate due to any obligation of any nature
whatsoever (including under a loan, the Company’s tax equalization program or any travel or expenses policy) to the extent that the Company, the
employer or any Affiliate in its reasonable judgement determines you owe them that amount.
5.4 Agree that, for tax purposes, and where allowed by applicable law, you are deemed to have received the full number of Stock where the number of Stock
you acquire is reduced under section 5.3.2.
5.5 Agree that, where permitted by the Company, you may elect to satisfy Tax and/or pay any exercise price by delivering (including by attestation) Stock to
the Company.
5.6 Agree that if a Withholding Person’s obligation to pay or account for Tax cannot or has not been fully satisfied by the above methods, you must pay to the
Withholding Person an amount sufficient to enable them to discharge that obligation.
5.7 Agree to enter any tax elections for particular tax and/or social security treatment, execute any documents, give any directions and take any action as may
be requested by the Company, your employer or any Affiliate in relation to any Liabilities.
5.8 	Acknowledge that the Company, your employer and any Affiliate do not guarantee or warrant any particular Tax treatment in relation to your Award, the
cash or Stock you acquire in connection with your Award (including any dividends on Stock), or your participation in the Plan and that they are not
under any obligation to structure the Award in a Tax favorable way or avoid adverse Tax treatment in any jurisdiction.
5.9 	Acknowledge that neither the Company, your employer nor any Affiliate will be liable for any Tax, interest, penalties or other amounts owed by any
taxpayer as a consequence of the Plan or an Award and that any Tax information provided is for guidance purposes only.
5.10 Accept that the cash or Stock subject to your Award may only vest or be exercised (as applicable) if satisfactory arrangements are in place to enable all
Withholding Persons to obtain the funds needed to satisfy any Liabilities.
5.11 	Acknowledge that the vested (and, if applicable, exercised) Stock or cash subject to your Award may not be delivered or paid to you unless you have
complied with your obligation to pay the Liabilities.

-- 69 of 156 --

6. 	Internationally mobile employees
6.1 Acknowledge that if you are a mobile employee, meaning that you are based in different jurisdictions during the course of your employment or service that
you are or may be subject to Tax in more than one country, you are strongly encouraged to inform the Company and your employer, and to speak with
your personal tax adviser regarding the tax treatment of your participation in the Plan.
6.2 Accept that, if you are a mobile employee, the Company or your employer may be required to withhold for Tax in more than one jurisdiction.
6.3 	Accept that if you are a “Global Mobility Associate” as defined in the Company’s Global Mobility Policy (or the equivalent under any applicable
international service policy from time to time), you remain responsible for all Tax except where expressly stated otherwise in that policy and/or the
Company’s tax equalization program. A copy of the Company’s Global Mobility Policy is available on the Company’s intranet.
7. 	Costs
Agree that you are responsible for the payment of any fees, dealing, commission or currency conversion costs or any other costs associated with your
Award, including costs associated with the payment of any cash and the sale of any Stock.
8. 	Notices
8.1 Agree that any notice or other communication required in relation to your Award will be given in writing, which may include electronic means.
8.2 Agree that any notice or other communication to be given to you in connection with your Award may be delivered by electronic means (including by email,
or through the Company or your employer’s intranet or a share plan portal), personally delivered, or sent by ordinary post to the principal address on file
for you from time to time with the Company, your employer, an Affiliate or the Company’s agents.
8.3 	Agree that any notice or other communication to be given to the Company or its agents in connection with your Award may be delivered or sent to its
registered office or to such other place and by such means as communicated to you by or on behalf of the Company from time to time.
8.4 Accept that notices or other communications:
8.4.1 	sent electronically will be deemed to have been received immediately (if sent during usual business hours) or at the opening of
business on the next business day (if sent outside usual business hours);
8.4.2 	that are personally delivered will be deemed to have been received when left at the relevant address (if left during usual business
hours) or at the opening of business on the next business day (if left outside usual business hours); and
8.4.3 	sent by post will be deemed to have been received 24 hours after posting to a U.S. address or 3 days after posting to an address
outside the U.S.,
unless there is evidence to the contrary.

-- 70 of 156 --

8.5 Agree that all notices or communications to be given to you are given and sent at your risk and that neither the Company, your employer nor any Affiliate
has any liability in respect of any notice or communication given or sent, nor need they be concerned to see that you actually receive it.
9. 	Insider trading and market abuse
9.1 	Acknowledge that rules on insider trading, dealing notification requirements, and market abuse laws may apply in relation to any actions or decisions
taken relating to your Award, including in relation to the acceptance, vesting, exercise or settlement of your Award, the delivery or payment of any Stock
or cash, and the sale of any Stock. These rules, requirements and laws:
9.1.1 	are separate from and in addition to the requirements that apply to you under The Coca-Cola Company Global Insider Trading Compliance
Policy; and
9.1.2 may prohibit or delay your actions or decisions.
9.2 Agree that it is your responsibility to comply with the rules, requirements and laws referred to in section 9.1. You should consult with your personal legal
adviser on these matters.
10. 	Currency risk
10.1 Acknowledge that if any Stock relating to your Award is traded in a currency that is not the currency in your jurisdiction, the value of the Stock may also
be affected by movements in the exchange rate.
10.2 Agree that neither the Company, your employer nor any Affiliate is liable for any loss due to movements in the exchange rate nor any charges imposed in
relation to the conversion or transfer of money.
11. 	No advice
11.1 	Confirm you are accepting your Award and participating in the Plan voluntarily and understand that the Company is not making any recommendations
regarding your Award or any Stock or cash relating to your Award.
11.2 Agree that neither the Company, your employer, any Affiliate nor any person or entity acting on their behalf has provided you with any legal, investment,
tax (including reporting) or financial advice with respect to your participation in the Plan, your Award or any Stock or cash acquired upon vesting or
exercise of your Award. You should consult with your own suitably qualified advisers before taking any action under the Plan.
11.3 	Acknowledge that the information and materials provided do not take into account your objectives, financial situation or needs and that if you do not
understand the contents of the Plan Documents, or you are in any doubt, you should consult an independent authorized financial adviser.
11.4 Agree you will have no remedies for any statement, representation, assurance or warranty that is not set out in your Plan Documents.
12. 	No guarantee
12.1 Acknowledge that neither the Company, your employer nor any Affiliate guarantees a specified level of return in respect of your Award or any Stock.

-- 71 of 156 --

12.2 Acknowledge that there is a risk that any Stock relating to your Award may fall as well as rise in value, that the future value of Stock cannot be predicted
with certainty and that market forces will impact the price of any Stock relating to your Award and, in the worst case, the market value of the Stock may
become zero. More information in relation to the Company, including its share price, can be found at https://www.coca-colacompany.com/.
13. No public offer
13.1 Acknowledge that your Award is being offered to you in your capacity as an employee of the Company’s group and that the offer is not intended for the
general public and may not be used for any public offer.
13.2 Acknowledge that the Company is not required to deliver any Stock or cash on settlement of your Award before it completes, on terms to its satisfaction,
any registration, listing, exemption or qualification or other legal requirements or obtains any clearance or approval that the Company considers is
necessary or desirable, and you agree to provide any information, make any agreements and give any representations that the Company requests as
part of this process.
13.3 	Agree that the Company may (whether under Section 17.7(b) of the Plan or otherwise) refuse to deliver any Stock or cash where the Company
considers the delivery of Stock or cash may conflict or be inconsistent with applicable law or applicable government agency regulation.
13.4 	Acknowledge that neither the Company, your employer nor any Affiliate is under any obligation to register, exempt or qualify, or seek clearance or
approval for, your Award or any Stock or cash that you may acquire in connection with your Award.
13.5 Acknowledge that your Award may not have been authorized or approved by any applicable securities authorities and may have been offered pursuant
to an exemption from registration in your local jurisdiction.
13.6 Acknowledge that the regulatory bodies in your jurisdiction accept no responsibility for the accuracy and completeness of the statements and information
contained in the Plan Documents and take no liability whatsoever for any loss arising from reliance upon the whole or any part of the contents of those
documents.
13.7 	Acknowledge that a prospectus or similar offering or registration document may not have been prepared, authorized or approved by any applicable
authority in any jurisdiction outside the United States.
14. Exchange controls and any reporting requirements
14.1 	Accept that exchange control regulations and/or foreign asset reporting requirements may apply to you in respect of your Award and/or any Stock or
cash acquired in connection with your Award, and that you are solely responsible for complying with those regulations and requirements.
14.2 Agree that neither the Company, your employer nor any Affiliate are responsible for obtaining exchange control approval or making any reports on your
behalf, nor for monitoring compliance with those regulations and requirements and that if you fail to obtain any required exchange control approval or
make the necessary reports, neither the Company, your employer nor any Affiliate will be liable in any way for any resulting fines or penalties. You
should seek independent professional advice if you are unsure about the obligations that apply to you as a result of your participation in the Plan.

-- 72 of 156 --

14.3 Accept that you are solely responsible for complying with any filing, notification or reporting requirements in respect of:
14.3.1 your participation in the Plan and/or
14.3.2 benefits received under the Plan,
as required by the local law in any jurisdiction. The Company accepts no responsibility for your failure or delay in complying with such requirements. If
you are in any doubt as to what actions you should take, you should consult a duly authorized independent adviser.
15. General
15.1 Consent to the use of electronic communications in connection with the Plan.
15.2 Confirm that references to “employer” throughout these Additional Terms include your former employer, where applicable.
15.3 	Agree that all determinations and decisions on questions of interpretation in respect of your Award and the Plan Documents will be made by the
Company (or any committee on its behalf) in its sole and absolute discretion. Those determinations and decisions will be final, binding and conclusive.
Any references to determinations or decisions made, or actions taken, by the “Company” as referred to in these Additional Terms include any
committee acting on its behalf.
15.4 Agree that if any provision of your Plan Documents is held to be invalid, illegal or unenforceable for any reason by any court in any jurisdiction then, for
the purposes of that jurisdiction only:
15.4.1 such provision will be deleted; and
15.4.1 the remaining provisions will continue in full force and effect.
15.5 Agree that if the Company waives a breach of one or more provisions in the Plan Documents, this does not constitute a waiver of any other provision of
the Plan Documents, or a waiver of any subsequent breach of the Plan Documents (by you or anyone else).
15.6 Accept that:
15.6.1 	the federal laws of the United States of America and the state laws of the State of Delaware, United States of America, govern your Plan
Documents and your Award without regard to the conflict of law provisions; and
15.6.2 	the courts of the United States District Court for the District of Delaware or the Delaware Superior Court, New Castle County have exclusive
jurisdiction in respect of disputes arising under or in connection with the Plan or your Award,
and you waive any current or future objection you may have to this choice of law and jurisdiction.
16. English language (this applies if you have received an English language version only of any Plan Document)
16.1 Accept that you fully understand the contents of the English language version of the Plan Documents.

-- 73 of 156 --

16.2 Acknowledge that you do not need a translation of the Plan Documents and that you are fluent and regularly conduct business in the English language
as part of your duties and responsibilities to your employer.
17. Translations (this applies if you have received a Plan Document in a language other than English)
17.1 	Agree that if there is any conflict between the terms of the English language version of the Plan Documents and a version in any other language, the
English language version will prevail.
18. Options (this applies if your Award Notification specifies that your Award is an Option)
18.1 Understand that, in order to exercise your Award, you will need to pay the exercise price.
18.2 Acknowledge that you will be informed of the acceptable forms and methods of paying the exercise price when you come to exercise your Award.
19. Restricted resale (this applies if your Award is over Stock)
Acknowledge that any Stock you may acquire upon settlement of your Award may be subject to restrictions on transfer and resale in your local
jurisdiction and you agree that you will comply with those restrictions, including that you will not offer, sell, advertise or otherwise market the Stock (or
cause any of these to occur) in circumstances which constitute any type of public offering of securities, unless an exemption applies.
20. Performance conditions (this applies if your Award Notification specifies that your Award is subject to performance conditions)
20.1 	Accept that the vesting of your Award is conditional on the satisfaction of one or more performance conditions as set out in the Performance Criteria
Appendix to your Award Notification (the Performance Criteria) and, to the extent the Performance Criteria are not satisfied, your Award may be
forfeited.
20.2 Accept that the Performance Criteria may be altered in the circumstances specified in Section 10.2 of the Plan.
21. Malus and clawback (this applies if your Award Notification specifies that your Award is subject to “Malus and clawback”)
21.1 Agree that any benefits you may receive with respect to your Award will be subject to reduction, cancellation, repayment, forfeiture or recoupment if there
is a determination that the vesting of, or amount realized from, your Award was based on:
21.1.1 materially inaccurate financial statements; or
21.1.2 any other materially inaccurate performance metric criteria,
and you acknowledge that this applies regardless of whether you caused or contributed to the material inaccuracy.
21.2 	Agree that the Company may also seek to recover your Award where required by the provisions of the Dodd-Frank Wall Street Reform and Consumer
Protection Act or any other “clawback”

-- 74 of 156 --

provision required by applicable law, regulation or listing standards, including the listing standards of the New York Stock Exchange, and you authorize
such recovery.
22. Stock ownership guidelines (this only applies if you are subject to the Company’s stock ownership guidelines)
22.1 Accept that if you have not met the Company’s stock ownership guidelines before the applicable compliance deadline but you are a “Section 16 officer”
under the U.S. Securities Exchange Act of 1934, you are prohibited from selling 50% of any Stock you obtain upon vesting or exercise of your Award
until you meet the relevant guidelines, except for any Stock that is sold or cash settled to cover Tax and any exercise price.
22.2 Accept that if you have not met the guidelines by the applicable compliance deadline, you are prohibited at all times after that compliance deadline from
selling any Stock you obtain on vesting or exercise of your Award, except for any Stock that is sold or cash settled to cover Tax, commissions and fees
and any exercise price. Once you meet the guidelines, you can sell Stock in excess of the guidelines.

-- 75 of 156 --

Global Appendix – Equity Awards
1. 	If you are subject to the laws of the European Union
This offer is being made to selected employees as part of an employee incentive program in order to provide an additional incentive and to encourage
employee share ownership and to increase your interest in the success of the Company. The company offering these rights is The Coca-Cola Company.
The Stock which is the subject of these rights is new or existing par value common stock in the Company. More information in relation to the Company
including the stock price can be found at the following web address: https://investors.coca-colacompany.com/.
The obligation to publish a prospectus does not apply because of Article 1(4)(i) of the EU Prospectus Regulation. The total maximum number of Stock
which is the subject of this offer is 240,000,000.
2. 	If you are subject to the laws of Argentina
Neither the Award nor the underlying Stock are publicly offered or listed on any stock exchange in Argentina.
This provision applies if your Award Notification specifies that your Award is an Option:
Depending upon the method of exercise chosen for the Option, you may be subject to restrictions with respect to the purchase and/or remittance of
U.S. dollars pursuant to Argentine currency exchange regulations. The Company reserves the right to restrict the methods of exercise if required or
advisable to comply with Argentine laws.
3. 	If you are subject to the laws of Australia
The grant of Awards under the Plan is intended to comply with the provisions of the Corporations Act 2001, ASIC Regulatory Guide 49 and ASIC Class
Order CO 14/1000. Additional details are set forth in the Australia Offer Document, which is available on the Morgan Stanley at Work® website.
The offer is intended to receive tax deferred treatment under Subdivision 83A-C of the Income Tax Assessment Act 1997(Cth). The conditions to receive
such treatment are contained in the Award Agreement.
4. 	If you are subject to the laws of Belgium
If your Award Notification specifies that your Award is an Option, you confirm you have read and understood the information regarding the Belgian
taxation of Options which has been separately made available to you by email and/or on the Morgan Stanley at Work® website. You should review this
information thoroughly before accepting your Option grant.
__________________________
3. If your are subject to the laws of any of the following countries, there are no country-specific provisions for your country in this appendix: Bangladesh, Costa Rica, Dominican Republic, Ecuador,
Egypt, Japan, Kenya, Korea, Malaysia, Nigeria, Puerto Rico, Serbia, Sri Lanka, Swaziland, Taiwan, Thailand and Ukraine.
3

-- 76 of 156 --

5. 	If you are subject to the laws of Brazil
By accepting the Award, you agree that you are (i) making an investment decision, and (ii) the value of the underlying Stock is not fixed and may increase
or decrease in value over the vesting or exercise period without compensation to you.
6. 	If you are subject to the laws of Canada
For purposes of your Award, your employment will be considered terminated and your right (if any) to vest in any Award or exercise any Option after such
termination (regardless of the reason for such termination and whether or not later found to be invalid, unlawful or in breach of the employment laws in
the jurisdiction where you are employed or the terms of your employment agreement, if any) will be measured as of the earlier of: (a) the date your
employment with the Company or one of its Subsidiaries (as defined in the Plan) or Affiliates is terminated, (b) the date you receive written notice of
termination from the Company or a Subsidiary or Affiliate, regardless of any notice period or period of pay in lieu of such notice mandated under the
employment laws in the jurisdiction where you are employed or the terms of your employment agreement, if any, or (c) the date you are no longer
employed by the Company or any of its Subsidiaries or Affiliates. You will not be entitled to a pro-rata portion of the Award for any time before the date on
which your right to vest terminates, nor will you be entitled to any compensation for lost vesting. In the event the date on which you are no longer actively
providing services cannot be reasonably determined under the terms of your Award, the Company, in its sole discretion, shall determine when you are no
longer employed for purposes of the Award (including whether you may still be considered employed or actively providing services while on a leave of
absence).
Notwithstanding the foregoing, if applicable employment standards legislation explicitly requires continued entitlement to vesting during a statutory notice
period, your right to vest in the Award under the Plan, if any, will terminate effective as of the last day of your minimum statutory notice period, but you will
not earn or be entitled to pro-rated vesting if the vesting date falls after the end of your statutory notice period, nor will you be entitled to any
compensation for lost vesting.
In addition to any restrictions on resale and transfer noted in the Plan Documents, Stock acquired pursuant to the Plan will be subject to certain
restrictions on resale imposed by Canadian provincial securities laws (in general, you may not resell your Stock to Canadian purchasers). Accordingly,
you are encouraged to seek legal advice prior to any resale of the Stock.
Furthermore, notwithstanding anything to the contrary in the Plan or the Award Agreement, Awards granted to Canadian residents shall only be settled in
Stock and shall not be settled in cash.
The following terms and conditions apply if you are resident in Quebec:
You agree that you wish the Plan Documents to be drawn up in English.
Vous confirmez que vous souhaitiez que les Documents du Plan soient rédigés en anglais
7. 	If you are subject to the laws of Chile
Neither the Company, the Plan nor the Stock have been registered in the Registro de Valores (Securities Registry) or in the Registro de Valores
Extranjeros (Foreign Securities Registry) of the

-- 77 of 156 --

Comisión para el Mercado Financiero de Chile (Chilean Commission for the Financial market or CMF) and they are not subject to the control of the CMF.
The Plan is governed by General Regulation 336. As the Stock is not registered, the Company has no obligation under Chilean law to deliver public
information regarding the Stock in Chile. Shares of Stock cannot be publicly offered in Chile unless they are registered with the CMF.
Ni The Coca-Cola Company, ni el Plan ni las Acciones han sido registradas en el Registro de Valores o en el Registro de Valores Extranjeros que
lleva la Comisión para el Mercado Financiero de Chile (CMF) y ninguno de ellos está sujeto a la fiscalización de la CMF. Esta oferta de Acciones se
acoge a la Norma de Carácter General 336. Por tratarse de valores no inscritos, el emisor de las Acciones no tiene obligación bajo la ley chilena de
entregar en Chile información pública acerca de las Acciones. Las Acciones no pueden ser ofrecidas públicamente en Chile en tanto éstas no se
inscriban en el Registro de Valores correspondiente.
8. 	If you are subject to exchange control restrictions imposed by the China State Administration of Foreign Exchange (SAFE), as
determined by the Company in its sole discretion, or you are subject to mandatory retirement in China
Notwithstanding any other provision in the Plan Documents, the following provisions apply in the event of the termination of your employment (as
interpreted in accordance with the Employment Events Appendix) with the Company or a Subsidiary (as defined in the Plan) (1) because of your
Disability, or (2) after attaining age 55:
Awards that are Options and Awards held at least 12 months will immediately vest and will be settled in cash. The cash amount will be determined
based on the closing price of the Stock on the date of your termination of employment (or, if a non-trading day, the next trading day) or the exercise of
your Option (if applicable) within the post-termination exercise period stated below. Awards that are not Options and that are held less than 12
months from the date of grant are forfeited.
Where Performance Criteria apply, the Performance Criteria will be measured over a shortened performance period, ending at the end of the year
prior to your termination of employment.
If your Award is an Option, the period over which you may exercise your Option expires upon earlier of (1) six months from your termination of
employment or (2) the Option expiration date provided in the Plan Documents.
The Company has the discretion to arrange for the sale of any Stock issued upon settlement of your Award, either immediately upon settlement or at any
time thereafter. In any event, if you terminate employment, you will be required to sell all Stock acquired upon settlement of the Award within such time
period as required by the Company in accordance with SAFE requirements. Any Stock remaining in your brokerage account at the end of this period shall
be sold by the broker (on your behalf pursuant to this authorization and without further consent). In addition, any Award that has not vested by the end of
this period will then immediately be forfeited. The Company shall have the exclusive discretion to determine when your employment has been terminated
for the purposes of the Award.

-- 78 of 156 --

You agree to sign any additional agreements, forms and/or consents that reasonably may be requested by the Company (or the Company’s designated
broker) to effectuate the sale of the Stock (including, without limitation, as to the transfer of the sale proceeds and other exchange control matters noted
below) and shall otherwise cooperate with the Company with respect to such matters. You acknowledge that neither the Company nor the designated
broker is under any obligation to arrange for the sale of Stock at any particular price (it being understood that the sale will occur in the market) and that
broker’s fees and similar expenses may be incurred in any such sale. In any event, when the Stock is sold, the sale proceeds, less any withholding for
applicable taxes, any broker’s fees or commissions, and any similar expenses of the sale will be remitted to you in accordance with applicable exchange
control laws and regulations.
By accepting the Award, you acknowledge that you understand and agree that you are not permitted to transfer any Stock acquired under the Plan out of
your account established with the Company’s designated broker until the Stock is sold. The limitation applies to all Stock issued to you under the Plan,
whether or not you remained employed with the Company or a Subsidiary.
You understand and agree that you will be required to immediately repatriate to China the proceeds from the sale of any Stock acquired under the Plan
and any such dividends paid on such shares. You further understand that such repatriation proceeds may need to be effected through a special bank
account established by the Company (or a Subsidiary or Affiliate in China), and you hereby consent and agree that any sale proceeds and cash
dividends may be transferred to such special account by the Company (or a Subsidiary or Affiliate in China) on your behalf prior to being delivered to you
and that no interest shall be paid with respect to funds held in such account.
The proceeds may be paid to you in U.S. dollars or local currency at the Company’s discretion. If the proceeds are paid to you in U.S. dollars, you
understand that a U.S. dollar bank account in China must be established and maintained so that the proceeds may be deposited into such account. If
the proceeds are paid to you in local currency, you acknowledge that the Company (and its Subsidiaries and Affiliates) are under no obligation to secure
any particular exchange conversion rate and that the Company (and its Subsidiaries and Affiliates) may face delays in converting the proceeds to local
currency due to exchange control restrictions. You agree to bear any currency fluctuation risk between the time the Stock is sold and the net proceeds
are converted into local currency and distributed to you. You further agree to comply with any other requirements that may be imposed by the Company
in the future in order to facilitate compliance with exchange control requirements in China.
In addition to the vesting schedule for your Award, settlement of the Award is also conditioned on the continued effectiveness of the Company’s
registration of the Plan with SAFE (the SAFE Registration Requirement). If or to the extent the Company is unable to maintain the registration, no
Stock for which a registration cannot be maintained shall be issued. In this case, the Company retains the discretion to settle any Award for which the
vesting schedule, but not the SAFE Registration Requirement, has been met in cash paid through local payroll in an amount equal to the market value of
the Stock subject to the Award less any withholding for applicable taxes.
The Company (and its Subsidiaries and Affiliates) shall not be liable for any costs, fees, lost interest or dividends or other losses that you may incur or
suffer resulting from the enforcement of the foregoing terms or otherwise from the Company’s operation and enforcement of the Plan, the

-- 79 of 156 --

Award Agreement, and the Award in accordance with any applicable laws, rules, regulations and requirements.
9. If you are subject to the laws of Colombia
You acknowledge that pursuant to Article 128 of the Colombian Labor Code, the Plan and related benefits do not constitute a component of “salary” for
any legal purpose.
10. If you are subject to the laws of France
By accepting the Award, you confirm that you have read and understood the Plan Documents, which were provided in English. You accept the terms of
those Plan Documents and confirm that you have a good knowledge of the English language.
En acceptant ce paiement, vous confirmez avoir lu et compris les documents relatifs à ce plan d’incitation à long terme (qui vous ont été fournis en
anglais) et que vous acceptez les termes de ce plan.
11. If you are subject to the laws of Hong Kong
WARNING:
The contents of the Plan Documents have not been reviewed by any regulatory authority in Hong Kong. You are advised to exercise caution in relation
to the offer. If you are in any doubt about any of the contents of the Plan Documents, you should obtain independent professional advice.
This offer to receive an Award under the Plan (the Offer) is strictly private and only available to eligible employees of Coca-Cola China Limited. The
Offer has also not been approved by the Securities and Futures Commission in Hong Kong and it should not be made in whole or in part to the public or
any third-party.
No Awards granted under the Plan may be transferred or assigned, except as expressly permitted by the Company in writing.
Sale of Stock. Any Stock received at vesting is accepted as a personal investment. In the event that any portion of this Award vests within six months of
the grant date, you agree that you will not offer to the public or otherwise dispose of the Stock acquired prior to the six-month anniversary of the grant
date.
12. If you are subject to the laws of India
You must repatriate to India all funds resulting from the sale of Stock acquired in relation to your Award within 90 days, and all proceeds from the receipt
of any dividends within 180 days. You should receive a foreign inward remittance certificate (FIRC) from your bank where you deposit the foreign
currency. You should maintain the FIRC as evidence of the repatriation of funds in the event that the Reserve Bank of India or your employer requests
proof of repatriation.

-- 80 of 156 --

13. If you are subject to the laws of Indonesia
A translation of the documents relating to this grant into Bahasa Indonesia can be provided to you upon request to your local human resources
representative. By accepting the grant of the Award, you (i) confirm having read and understood the documents relating to this grant which were provided
in the English language, (ii) accept the terms of those documents accordingly, and (iii) agree not to challenge the validity of this document based on Law
No. 24 of 2009 on National Flag, Language, Coat of Arms and National Anthem or the implementing Presidential Regulation (when issued).
Terjemahan dari dokumen-dokumen terkait dengan pemberian ini ke Bahasa Indonesia dapat disediakan bagi anda berdasarkan permintaan kepada
perwakilan sumber daya manusia lokal anda. Dengan menerima pemberian Award, anda (i) mengkonfirmasi bahwa dirinya telah membaca dan
mengerti dokumen-dokumen yang terkait dengan pemberian ini yang disediakan dalam Bahasa Inggris, (ii) menerima syarat-syarat dari dokumen-
dokumen tersebut, dan (iii) setuju untuk tidak mengajukan keberatan atas keberlakuan dokumen ini berdasarkan Undang-Undang No. 24 Tahun
2009 tentang Bendera, Bahasa, dan Lambang Negara, Serta Lagu Kebangsaan atau Peraturan Presiden pelaksananya (ketika diterbitkan).
14. If you are subject to the laws of Italy
By accepting the grant of the Award, you acknowledge that you have received a copy of the Plan Documents, you have reviewed the Plan Documents in
their entirety and you fully understand and accept all provisions of the Plan Documents. You further acknowledge that you have read and expressly
approve the following sections of the Additional Terms: section 2 (Employment); section 4 (Modifications and additional requirements); section 5 (Tax);
and section 15 (General).
15. If you are subject to the laws of Mexico
By participating in the Plan, you acknowledge that you have received a copy of the Plan, reviewed the Plan in its entirety and fully understand and accept
all provisions of the Plan. You further acknowledge that you have read and expressly approve the terms and conditions set forth in section 2
(Employment) of the Additional Terms, in which the following is clearly described and established: (i) your participation in the Plan does not constitute an
acquired right; (ii) the Plan and your participation in the Plan are offered by the Company on a wholly discretionary basis; (iii) your participation in the Plan
is voluntary; and (iv) the Company and its Subsidiaries (as defined in the Plan) are not responsible for any decrease in the value of the underlying Stock.
By participating in the Plan, you expressly recognize that The Coca Cola Company, with registered offices at One Coca-Cola Plaza, Atlanta, Georgia
30313, USA, is solely responsible for the administration of the Plan and that your participation in the Plan and acquisition of Stock does not constitute an
employment relationship between you and the Company since you are participating in the Plan on a wholly commercial basis. Based on the foregoing,
you expressly recognize that the Plan and the benefits that you may derive from participation in the Plan do not establish any rights between you and the
Company and do not form part of the employment conditions and/or benefits provided by the Company and any modification of the Plan or its termination
shall not constitute a change or impairment of the terms and conditions of your employment.

-- 81 of 156 --

You further understand that your participation in the Plan is as a result of a unilateral and discretionary decision of the Company; therefore, the Company
reserves the absolute right to amend and/or discontinue your participation at any time without any liability to you.
Finally, you hereby declare that you do not reserve any action or right to bring any claim against the Company for any compensation or damages
regarding any provision of the Plan or the benefits derived under the Plan, and you therefore grant a full and broad release to the Company, its
Subsidiaries, branches, representation offices, its shareholders, officers, agents or legal representatives with respect to any claim that may arise.
Al participar en el Plan, usted reconoce que ha recibido una copia del Plan, que ha revisado el Plan en su totalidad, y que entiende y acepta en su
totalidad, todas y cada una de las disposiciones del Plan. Asimismo reconoce que ha leído y aprueba expresamente los términos y condiciones
señalados en el párrafo titulado Naturaleza de la Oferta en el Convenio, en lo que claramente se describe y establece lo siguiente: (i) su
participación en el Plan no constituye un derecho adquirido; (ii) el Plan y su participación en el Plan son ofrecidos por la Compañía sobre una base
completamente discrecional; (iii) su participación en el Plan es voluntaria; y (iv) la Compañía y sus Afiliadas no son responsables de ninguna por la
disminución en el valor de las Acciones subyacentes.
Al participar en el Plan, usted reconoce expresamente que The Coca-Cola Company, con oficinas registradas en One Coca-Cola Plaza, Atlanta,
Georgia 30313, Estados Unidos de América, es la única responsable por la administración del Plan, y que su participación en el Plan, así como la
adquisición de las Acciones, no constituye una relación laboral entre usted y la Compañía, debido a que usted participa en el plan sobre una base
completamente mercantil. Con base en lo anterior, usted reconoce expresamente que el Plan y los beneficios que pudiera obtener por su
participación en el Plan, no establecen derecho alguno entre usted y la Compañía, y no forman parte de las condiciones y/o prestaciones laborales
que la Compañía ofrece, y que las modificaciones al Plan o su terminación, no constituirán un cambio ni afectarán los términos y condiciones de su
relación laboral.
Asimismo usted entiende que su participación en el Plan es el resultado de una decisión unilateral y discrecional de la Compañía; por lo tanto, la
Compañía se reserva el derecho absoluto de modificar y/o suspender su participación en cualquier momento, sin que usted incurra en
responsabilidad alguna.
Finalmente, usted declara que no se reserva acción o derecho alguno para interponer reclamación alguna en contra de la Compañía, por concepto
de compensación o daños relacionados con cualquier disposición del Plan o de los beneficios derivados del Plan, y por lo tanto, usted libera total y
ampliamente de toda responsabilidad a la Compañía, a sus Afiliadas, sucursales, oficinas de representación, sus accionistas, funcionarios, agentes
o representantes legales, con respecto a cualquier reclamación que pudiera surgir.
The Stock underlying your Award has not been registered with the National Register of Securities maintained by the Mexican Banking and Securities
Commission and may not be offered or sold publicly in Mexico. The Plan Documents may not be publicly distributed in Mexico. These materials are
addressed to you only because of your existing relationship with the Company and its Subsidiaries and may not be reproduced or copied in any form.
The offer contained in these

-- 82 of 156 --

materials is addressed solely to the present employees of the Company and its Subsidiaries in Mexico and any rights under the Plan may not be
assigned or transferred. The Stock underlying your Award will be offered pursuant to a private placement exception under the Mexican Securities Law.
16. If you are subject to the laws of New Zealand
You are being offered an Award which, if vested, will entitle you to acquire Stock in accordance with the terms of the Plan Documents. The Stock, if
issued, will give you a stake in the ownership of the Company. You may receive a return if dividends are paid.
If the Company runs into financial difficulties and is wound up, you will be paid only after all creditors and holders of preference shares (if any) have been
paid. You may lose some or all of your investment, if any.
New Zealand law normally requires people who offer financial products to give information to investors before they invest. This information is designed to
help investors to make an informed decision. The usual rules do not apply to this offer because it is made under an employee share scheme. As a result,
you may not be given all the information usually required. You will also have fewer other legal protections for this investment. You are advised to ask
questions, read all documents carefully, and seek independent financial advice before committing.
The Stock is quoted on the New York Stock Exchange. This means that if you acquire Stock under the Plan, you may be able to sell the Stock on the
New York Stock Exchange if there are interested buyers. You may get less than you invested. The price will depend on the demand for the Stock.
For information on risk factors impacting the Company’s business that may affect the value of the Stock, you should refer to the risk factors discussion on
the Company’s Annual Report on Form 10-K and Quarterly Reports on Form 10-Q, which are filed with the U.S. Securities and Exchange Commission
and are available online at www.sec.gov, as well as on the Company’s “Investor Relations” website at https://investors.coca-colacompany.com/.
17. If you are subject to the laws of Peru
The grant of the Award is considered a private offering in Peru; therefore, it is not subject to registration in Peru. For more information concerning the
offer, please refer to the Plan Documents and any other materials or documentation made available by the Company. For more information regarding the
Company, please refer to the Company’s Annual Report on Form 10-K and Quarterly Reports on Form 10-Q, which are filed with the U.S. Securities and
Exchange Commission and are available at www.sec.gov, as well as the Company’s “Investor Relations” website at https://investors.coca-
colacompany.com/.
By accepting the Award, you acknowledge that the Award is being granted ex gratia with the purpose of rewarding you.
18. If you are subject to the laws of Philippines
The following wording is hereby made a part of the Plan Documents:

-- 83 of 156 --

The securities being offered or sold under the Plan have not been registered with the Philippine Securities and Exchange Commission under the
Philippine Securities Regulation Code. Any future offer or sale of the securities in the Philippines is subject to registration requirements under the
Securities Regulation Code unless such offer or sale qualifies as an exempt transaction.
This applies if your Award Notification specifies that your Award is an Option:
Notwithstanding any terms or conditions of the Plan Documents, you acknowledge and agree that you will be restricted to the cashless sell-all
method of exercise. To complete a cashless sell-all exercise, you must to instruct the broker to (i) sell all of the Stock issued upon exercise of the
Option; (ii) use the proceeds to pay the exercise price, any applicable Liabilities and brokerage fees or commissions; and (iii) remit the balance in
cash to you. You will not be permitted to hold the Stock after exercise. Depending on the development of local laws, the Company reserves the right
to modify the methods of exercising the Option and, in its sole discretion, to permit cash exercise, cashless sell-to cover exercise or any other method
of exercise and payment of Liabilities permitted under the Plan.
19. If you are subject to the laws of Russia
Information contained in the Plan Documents does not constitute an advertisement of any securities in Russia and must not be passed on to third parties
or otherwise be made publicly available in Russia. The Awards and the Stock to be granted under the Plan have not been and will not be registered in
Russia and are not intended for 'placement' or 'circulation' in Russia.
20. If you are subject to the laws of Singapore
You acknowledge that the Plan Documents have not been registered as a prospectus with the Monetary Authority of Singapore. Accordingly, the Plan
Documents and any other document or material in connection with the offer or sale, or invitation for subscription or purchase of the Stock may not be
circulated or distributed, nor may the Stock be offered or sold, or be made the subject of an invitation for subscription or purchase, whether directly or
indirectly, to persons in Singapore other than pursuant to, and in accordance with the conditions of, an exemption under any provision (other than Section
280) of Subdivision (4) of Division 1 of Part XIII of the Securities and Futures Act, Chapter 289 of Singapore.
The Awards under the Plan are prescribed capital markets products (as defined in the Securities and Futures (Capital Markets Products) Regulations
2018) and Excluded Investment Products (as defined in MAS Notices SFA 04-N12 and FAA-N16).
21. If you are subject to the laws of South Africa
By accepting the Award, you agree to immediately notify your employer of the amount of any income realized upon exercise or vesting of the Award. If
you fail to advise your employer of the income realized upon exercise or vesting of the Award, then you may be liable for a fine. You personally will be
responsible for paying the difference between the actual tax liability and the amount withheld by the Company or your employer.

-- 84 of 156 --

The documents listed below are available for your review on the Company’s website at https://investors.coca-colacompany.com/ and the Company’s
intranet:
1. The Company’s most recent annual financial statements; and
2. The Company’s most recent Plan prospectus.
A copy of the above-listed documents will be sent to you free of charge on written request to Global Equity, The Coca-Cola Company, at One Coca-Cola
Plaza, Atlanta, Georgia 30313, USA. You should read these materials carefully before making a decision whether to participate in the Plan.
22. If you are subject to the laws of Spain
By accepting the Award, you acknowledge that you consent to participation in the Plan and have received a copy of the Plan Documents. Except as
otherwise provided in the Plan Documents, termination of your employment for any reason (including for the reasons listed below) will automatically result
in the forfeiture of any unvested Awards; in particular, you understand and agree that such Awards will be forfeited without entitlement to the underlying
Stock or to any amount as indemnification in the event of a termination of your employment prior to vesting by reason of, including, but not limited to,
resignation, disciplinary dismissal with or without cause, individual or collective layoff with or without cause, material modification of employment under
Article 41 of the Worker’s Statute, relocation under Article 40 of the Worker’s Statute, Article 50 of the Worker’s Statute, Article 10.3 of Royal Decree
1382/1985 and unilateral withdrawal by your employer.
Furthermore, you understand that the Company has unilaterally, gratuitously, and in its sole discretion decided to grant Awards under the Plan to
individuals who may be employees of the Company's group throughout the world. The decision is a limited decision that is entered into upon the express
assumption and condition that any grant will not bind the Company or any Subsidiary (as defined in the Plan) or Affiliate, other than to the extent set forth
in the Plan Documents. Consequently, you understand that the Awards are offered on the assumption and condition that the Awards and any Stock
acquired under the Plan are not part of any employment contract (either with the Company or any Subsidiary or Affiliate), and shall not be considered a
mandatory benefit, salary for any purposes (including severance compensation), or any other right whatsoever. In addition, you understand that this offer
would not be made but for the assumptions and conditions referred to above; thus, you acknowledge and freely accept that, should any or all of the
assumptions be mistaken or should any of the conditions not be met for any reason, then any grant of or right to the Award shall be null and void.
23. If you are subject to the laws of Sweden
The following provision supplements section 5 (Tax) of the Additional Terms:
Without limiting the authority of any Withholding Person to satisfy their withholding obligations for Tax as set forth in section 5 (Tax) of the Additional
Terms, by accepting the grant of the Award, you authorize any Withholding Person to withhold or to sell Stock otherwise deliverable to you to satisfy
Tax, regardless of whether the Withholding Person has an obligation to withhold such Tax.

-- 85 of 156 --

24. If you are subject to the laws of Switzerland
The offering of the Plan in Switzerland is exempt from the requirement to prepare and publish a prospectus under the Swiss Financial Services Act
(FinSA) because such offering by the Company is made exclusively to current or former members of the board of directors, members of the
management board or employees of the Company, the employer and its Affiliates. The Plan Documents do not constitute a prospectus pursuant to
FinSA, and no such prospectus has been or will be prepared for or in connection with the offering of the Plan.
25. If you are subject to the laws of Turkey
Under Turkish law, you are not permitted to sell any Stock acquired under the Plan in Turkey. The shares are currently traded on the New York Stock
Exchange, which is located outside of Turkey, under the ticker symbol “KO” and the Stock may be sold through this exchange.
You acknowledge that any activity related to investments in foreign securities (e.g. the sale of Stock) should be conducted through a bank or financial
intermediary institution licensed by the Turkey Capital Markets Board and should be reported to the Turkish Capital Markets Board. You are solely
responsible for complying with this requirement and should consult with a personal legal advisor for further information regarding any obligations in this
respect.
26. If you are subject to the laws of the United Arab Emirates
The Awards are granted under the Plan only to select employees of the Company's group and are in the nature of providing employee equity incentives
in the United Arab Emirates. The Plan Documents are intended for distribution only to such employees and must not be delivered to, or relied on by, any
other person. Prospective purchasers of the securities offered should conduct their own due diligence on the securities. If you do not understand the
contents of the Plan Documents, you should consult an authorized financial adviser. The Emirates Securities and Commodities Authority has no
responsibility for reviewing or verifying any documents in connection with the Plan. Neither the Ministry of Economy nor the Dubai Department of
Economic Development has approved the Plan Documents nor taken steps to verify the information set out herein, and has no responsibility for such
documents.
27. If you are subject to the laws of the United Kingdom
This offer is being made to selected employees as part of an employee incentive program in order to provide an additional incentive and to encourage
employee share ownership and to increase your interest in the success of the Company. The company offering these rights is The Coca-Cola Company.
The Stock which is the subject of these rights is new or existing par value common stock in the Company. More information in relation to the Company
including the stock price can be found at the following web address: https://investors.coca-colacompany.com/.
The obligation to publish a prospectus does not apply because of Section 86(aa) of the Financial Services and Markets Act 2000 (as amended,
supplemented or substituted by any UK legislation enacted in connection with the UK’s exit from the European Union). The total maximum number of
Stock which is the subject of this offer is 240,000,000.

-- 86 of 156 --

28. If you are subject to the laws of Cambodia, Morocco, Myanmar, Nepal, Pakistan, or Vietnam
The Company reserves the right to restrict you from acquiring Stock at exercise or vesting of your Award. Instead, the Company reserves the right to
make a payment to you in cash upon exercise or vesting of your Award. Any references to the issuance of shares or Stock in any documents related to
the Award shall not be applicable in these circumstances.

-- 87 of 156 --

Exhibit 10.7
Award Notification – Restricted Stock Unit
Congratulations [INSERT FULL NAME]! On [INSERT GRANT DATE], The Coca-Cola Company (the Company) granted you an award (your Award) under The
Coca-Cola Company 2024 Equity Plan, as amended from time to time (the Plan). Your Award is a great opportunity to share in the long-term success of the
Company and contribute to its future growth.
This document provides details of the key terms of your Award. Your Award is subject to the formal rules of the Plan, plus the additional terms and conditions
(including country specific terms) as set out in a document called the “Additional Terms”. The Additional Terms is available to review as part of the Award
acceptance process. The Plan is available in the Documents section of the Morgan Stanley at Work® website. This Award Notification (including the
appendices), the Plan and the Additional Terms together form your Award Agreement. You are being asked to confirm that you understand and agree to be
bound by these documents as part of the Award acceptance process, so we recommend you read them carefully.
Details of Award
Type of Award 	Restricted Stock Units - This is a conditional right to receive $0.25 par value common stock of the Company (Stock) in the
future. You will not receive the Stock (or have any shareholder rights) unless your Award vests.
Number of shares of
Stock subject to your
Award
[INSERT]
Continuing employment Your Award is subject to your continuing employment, as set out in the Employment Events Appendix to this document and
the Plan.
Date your Award
normally vests [INSERT DATE]
When your Award vests, you become entitled to the Stock subject to your Award. You do not need to purchase that Stock - it
is delivered automatically to you.
The number of shares of Stock that vest will normally be delivered to you as soon as administratively possible following
vesting, unless a different timing for delivering the Stock applies under the Employment Events Appendix.
Your Award will generally be settled in Shares, except where the appendices to this Award Notification apply and specify
otherwise.
You are liable for any tax, fees and costs due on vesting, which may be withheld.
Remember: your Award will only vest if and to the extent that all of the terms and conditions of your Award are satisfied. To
the extent that your Award does not vest, it will be forfeited.
Prohibited Activities 	If you engage in certain activities (called Prohibited Activities), your Award will be forfeited and you will be required to pay
back any gain from your Award. Refer to the Prohibited Activities Appendix to this document.
Finally, certain data privacy provisions apply to you in connection with your Award, as set out in the Data Privacy Appendix to this document.
In the event of any conflict between this Award Notification (including the appendices), the Additional Terms and the Plan, the Plan takes precedence.

-- 88 of 156 --

Action required!
If you wish to accept your Award, you must accept it using the Morgan Stanley at Work ® website by [INSERT DATE/TIME]. If you fail to do so by this
deadline, then the Company may declare your Award grant null and void at any time. If this happens, your Award will be forfeited, and you will have no right to
the underlying Stock. Acceptance of this award will constitute acknowledgement of and consent to the updated Annual Incentive and Long-Term Incentive
design and mix of awards.
Interpretation
The appendices below form part of your Award Notification. The singular includes the plural and defined terms have the meaning given in the Plan, unless otherwise specified. For the purposes of the
Prohibited Activities Appendix, references to your employer include your former employer, and for the purposes of the Data Privacy Appendix, references to your employer include your current local
employing entity or former local employing entity and the Company (where applicable). References to the Committee mean The Talent and Compensation Committee of the Board of Directors of the
Company, unless otherwise specified.

-- 89 of 156 --

Employment Events Appendix – Restricted Stock Unit
The table below sets out the impact to your Award (if any) upon certain employment events. The terms of the table below apply to vested and unvested portions
of an Award equally, unless otherwise stated. Except as otherwise specified herein, all other terms and conditions of your Award continue to apply.
Event 	Impact to your Award
Disability 	If your employment with the Company or a Subsidiary terminates because of Disability, your Award immediately vests, and
shares of Stock will be released within 90 days after your termination date. Otherwise, if you remain employed, there is no
impact to your Award.
Death 	Any Award that has not been accepted terminates immediately upon your death and may not be transferred to your heirs.
If you die while employed with the Company or a Subsidiary, your Award immediately vests, and your estate will be paid, within
90 days after your death, a cash amount equal to the value of the shares of Stock subject to the Award. The value shall be
determined based on the closing price of the Stock on the date of death (or in the case of a non-trading day, the next trading
day).
Leave of absences 	If you are on (1) US military leave, (2) a Company-paid leave of absence (meaning paid under Company payroll), or (3) an
unpaid leave of absence (approved pursuant to a published Company policy available to all employees covered under the
policy) of 12 months or less, there is no impact to your Award.
For all other leaves of absence not specified in the paragraph above, including all approved unpaid leaves that extend beyond
12 months:
• 	any portion of your Award that is unvested is immediately forfeited ; or
• 	if the Committee identifies a valid business interest in doing otherwise, it may specify what provisions it deems
appropriate at its sole discretion (provided that the Committee shall have no obligation to consider any such matters).
Transfer 	If you transfer (1) between the Company and any Subsidiary or, (2) at the Committee’s discretion, to an Affiliate that is not a
Subsidiary, there is no impact to your Award.
If an approved unpaid leave of absence extends beyond 12 months, the portion of your Award that is unvested as of the end of the 12 month is forfeited.
1
1
1 	th

-- 90 of 156 --

Event 	Impact to your Award
Termination 	A. If your employment with the Company or a Subsidiary terminates after attaining age 60:
• 	Awards held less than 12 months are immediately forfeited, and
• 	Awards held at least 12 months immediately vest and shares of Stock will be released within 90 days after your
termination date.
B. If your employment with the Company or a Subsidiary terminates involuntarily for any reason other than for cause within one
year after a Change in Control, your Award will be treated as described in the Plan.
C. If your employment with the Company or a Subsidiary terminates prior to attaining age 60 (or after attaining age 60 and your
award is not immediately vested under paragraph A) because of (1) an involuntarily termination due to a reduction in
workforce, internal reorganization, or job elimination and you sign a release of all claims and, if requested, an agreement
on confidentiality and competition, or (2) you participate in a Company or Subsidiary-sponsored voluntary separation
program:
• 	if any portion of your Award normally vests within 10 months after your termination date, there is no impact to that
portion of your Award, and
• 	All other Awards, or portions thereof, are immediately forfeited.
D. If your employment (1) with the Company or a Subsidiary terminates for any other reason, or (2) with an Affiliate (that is not
a Subsidiary) terminates for any reason , your Award is immediately forfeited.
Notwithstanding anything herein, if your employment with an Affiliate terminates and you immediately become employed by
the Company or a Subsidiary, there is no impact on your Award.
For the purposes of your Award, you are deemed to have terminated employment on the date you are no longer actively providing services to the relevant entity
or entities, regardless of the reasons for termination and whether or not later found to be invalid or in breach of your employment agreement, if any, or
employment laws in the jurisdiction where you are employed. The Committee has exclusive discretion to decide when you are considered to be no longer
actively providing services for the purposes of your Award. However, you will not be considered to be actively providing services during any contractual notice
period or any period of “garden leave” or similar period mandated under employment laws in the jurisdiction where you are employed or in your employment
agreement, if any, unless the Committee decides otherwise.
If required by Section 409A of the Code, the payment may not be made (if applicable) until at least six months following the termination date.
This also would apply in the case where the Committee determined that your transfer to the Affiliate would not impact your Award. If your employer no longer meets the definition of “Affiliate”, you are
deemed to have terminated employment for the purposes of the Plan.
2
3
2
3

-- 91 of 156 --

Prohibited Activities Appendix
1. 	Engaging in Prohibited Activity
1.1 Timing
Section 1.2 (Implications) applies if you engage in a Prohibited Activity (as defined in section 5 (Types of Prohibited Activity) below) at any time during
the term of your Award or within one year after the later of:
1.1.1 the termination of your employment with the Company, your employer or any Affiliate; and
1.1.2 the last date of vesting or exercise of all or any portion of your Award.
1.2 Implications
If this section 1.2 applies:
1.2.1 your Award will immediately terminate, be forfeited and (if relevant) cease to be exercisable; and
1.2.2 within 10 days after receiving written notice from the Company that this section applies, you must pay in cash to the Company:
(i) any and all gains associated with any previous vesting or exercise of all or any portion of your Award; and
(ii) interest calculated from the time of the notice until the date of repayment to the Company.
2. 	Implications for settled Awards
2.1 Calculation of gain
For the purposes of section 1.2.2, each gain associated with the vesting or exercise of all or any portion of your Award will be calculated as:
2.1.1 where your Award is in the form of an Option, the closing price per share of Stock on the date of exercise as reported on the New York Stock
Exchange Composite Transactions listing minus the exercise price per share of Stock, multiplied by the number of shares of Stock over which
the Award was exercised;
2.1.2 where your Award is in the form of Restricted Stock Units or Performance Share Units, the closing price per share of Stock on the date of
vesting as reported on the New York Stock Exchange Composite Transactions listing, multiplied by the number of shares of Stock that vested;
and
2.1.3 where your Award is in the form of Performance Cash, the gross amount of the cash payment that vested.

-- 92 of 156 --

3. 	Alternative payment
3.1 Return of Stock
If all or any part of this Prohibited Activities Appendix is held to be invalid, illegal or unenforceable for any reason by any court with jurisdiction:
3.1.1 you will transfer to the Company all of the shares of Stock that you acquired on vesting or exercise of your Award that you still hold (and if your
Award is an Option, the Company will pay to you the exercise price you paid for that Stock in exchange); and
3.1.2 where you have already sold, transferred or disposed of any shares of Stock you acquired on vesting or exercise of your Award, you must pay
to the Company:
(i) any and all gains associated with each sale, transfer or disposal; and
(ii) interest calculated from the date of each sale, transfer or disposal until the date of repayment to the Company.
3.2 Calculation of gain
For the purposes of section 3.1.2, the gain associated with the sale, transfer or disposal will in each case be calculated as the closing price per share of
Stock on the date of the sale, transfer or disposal as reported on the New York Stock Exchange Composite Transactions listing (minus, where your
Award is an Option, the exercise price per share of Stock), multiplied by the number of shares of Stock sold, transferred or disposed of.
4. Interest
Any interest payable under this Prohibited Activities Appendix will be calculated using the weighted prime rate at SunTrust Bank, Atlanta.
5. Types of Prohibited Activity
The term Prohibited Activity includes any and all of the following:
5.2 Disparagement
Making any statement, written or verbal, in any forum or media, or taking any action in disparagement of the Company, your employer and/or any
Affiliate, including but not limited to negative references to the Company or its products, services, corporate policies, or current or former officers or
employees, customers, suppliers, or business partners or associates.
5.2 Publicity
Publishing any opinion, fact, or material, delivering any lecture or address, participating in the making of any film, radio broadcast or television
transmission, or communicating with any representative of the media relating to confidential matters regarding the business or affairs of the Company,
your employer and/or any Affiliate which you were involved with during your employment.

-- 93 of 156 --

5.3 Disclosure of a Trade Secret
Failure to hold in confidence any and all Trade Secrets of the Company that came into your knowledge during your employment with the Company,
your employer and/or any Affiliate, or disclosing, publishing, or making use of, at any time, such Trade Secrets.
For these purposes, Trade Secret means any technical or non-technical data, formula, pattern, compilation, program, device, method, technique,
drawing, process, financial data, financial plan, product plan, list of actual or potential customers or suppliers or other information similar to any of the
foregoing, which:
5.3.1 derives economic value, actual or potential, from not being generally known to and not being readily ascertainable by proper means by other
persons who can derive economic value from its disclosure or use; and
5.3.2 is the subject of efforts that are reasonable under the circumstances to maintain its secrecy.
5.4 Disclosure of Confidential Information
Failure to hold in confidence all Confidential Information of the Company, your employer and/or any Affiliate that came into your knowledge during your
employment with the Company, your employer or any Affiliate, or disclosing, publishing, or making use of such Confidential Information.
For these purposes, Confidential Information means any data or information, other than Trade Secrets (as defined in section 5.3 (Disclosure of a
Trade Secret)), that is valuable to the Company and not generally known to the public or to competitors of the Company.
5.5 Failing to return materials
Your failure, in the event of your termination of employment for any reason, promptly to deliver to the Company all memoranda, notes, records, manuals
or other documents, including all copies of such materials and all documentation prepared or produced in connection therewith, containing Trade
Secrets (as defined in section 5.3 (Disclosure of a Trade Secret)) or Confidential Information (as defined in section 5.4 (Disclosure of Confidential
Information)) regarding the Company’s business, whether made or compiled by you or furnished to you by virtue of your employment with the
Company, your employer or any Affiliate, or failure promptly to deliver to the Company all vehicles, computers, credit cards, telephones, handheld
electronic devices, office equipment, and other property furnished to you by virtue of your employment with the Company, your employer or any Affiliate.
5.6 Competing
Rendering services for any organization which, or engaging directly or indirectly in any business which, in the sole judgment of the Committee or the
Chief Executive Officer of the Company or any senior officer designated by the Committee, is or becomes competitive with the Company.
Notwithstanding the preceding sentence, this Section 5.6 will not be applicable for any employee living or working in California.

-- 94 of 156 --

5.7 Solicitation
Soliciting or attempting to solicit for employment, for or on behalf of any corporation, partnership, or other business entity, any employee of the
Company, your employer or an Affiliate with whom you had professional interaction during the last twelve months of your employment with the
Company, your employer or the Affiliate.
5.8 Violation of Company policies
Violating any written policies of the Company or your employer applicable to you, including, without limitation, The Coca-Cola Company Global Insider
Trading Compliance Policy.
6. Release
You may be released from the effects of this Prohibited Activities Appendix if the Committee determines in its sole discretion that such action is in the
best interest of the Company and its stockholders.
7. Other rights apply
Nothing in this Prohibited Activities Appendix is intended to or will be interpreted as diminishing or otherwise limiting the Company’s right under
applicable state or local law or any prior agreement you have signed or made with the Company regarding trade secrets, confidential information, or
intellectual property.

-- 95 of 156 --

Data Privacy Appendix
1. 	General
1.1 Introduction
This Data Privacy Appendix sets out certain data privacy provisions that apply to you in connection with your Award.
1.2 Meaning of Data
For the purposes of this Data Privacy Appendix, Data means personal information that directly or indirectly identifies you, including: your name, home
address and telephone number, your date of birth, your government identification number, your salary information, nationality, job title and employment
location, any shares or directorships you hold or held in the Company or any Affiliate, details of your Award and any equity or cash awards or any other
entitlements to stock or cash granted (regardless of whether or not exercised, vested or settled, and including any cancelled or forfeited awards), any
information necessary to process your Award or any other award (e.g. your mailing address for a check payment or bank account wire transfer
information), any other information necessary to process mandatory tax withholding and reporting and/or, where applicable, your employment or service
termination date and the reason for the termination.
2. For Award recipients not located in the EEA or UK
This section applies if you reside anywhere in the world except the European Economic Area (EEA) or the United Kingdom (UK). By accepting your
Award, you confirm the following:
2.1 Consent
You voluntarily consent to the collection, use and transfer, in electronic or other form, of your Data by and between the Company, your employer or any
Affiliate for the purpose of implementing, administering, and managing your participation in the Plan.
2.2 Data collected
You understand that the Company and its Affiliates may hold Data for the exclusive purpose of implementing, administering, and managing the Plan.
2.3 Purposes of collection
You understand that Data will be transferred to one or more stock or incentive plan service providers selected by the Company, which may assist the
Company with the implementation, administration, and/or management of the Plan.
2.4 Recipients of Data
You understand that the recipients of Data may be located in the United States or elsewhere. The Company also uses third party service providers who
may assist with the implementation, administration or management of the Plan. These service providers are bound by contract to handle Data in a way
that aligns with this Data Privacy Appendix and applicable law. If you have

-- 96 of 156 --

any questions about the local entities or services providers who may access or handle your Data, please contact your local human resources
representative.
By consenting at section 2.1 (Consent) above, you authorize the Company and any other possible recipients that do or may assist the Company with
implementing, administering or managing the Plan to receive, possess, use, retain and transfer the Data, in electronic or other form, for the sole
purpose of implementing, administering and/or managing your participation in the Plan.
2.5 Data retention
You understand that Data will be held only as long as is necessary to implement, administer and manage your participation in the Plan. In some cases,
your information will be retained for the Company or your employer to comply with a legal or tax obligation.
2.6 Your rights
You understand that if you reside in certain jurisdictions, to the extent required by applicable laws, you may, at any time and without cost:
2.6.1 request access to Data;
2.6.2 request additional information about the storage and processing of Data;
2.6.3 require any necessary amendments to Data; or
2.6.4 refuse or withdraw the consents you give by accepting the Award,
by contacting your local human resources representative in writing.
2.7 Implications of not consenting or withdrawing consent
You understand that you provide these consents on a purely voluntary basis. If you do not consent, or if you later withdraw your consent, your
employment or service contract with the Company or an Affiliate will not be adversely affected. Refusing or withdrawing your consent will mean that the
Company will not be able to grant new awards or administer or maintain any existing awards (including this Award) under the Plan. You understand that
refusing or withdrawing your consent may affect your ability to participate in the Plan (including the right to retain an award, such as this Award). You
understand that you may contact a local human resources representative for more information on the consequences of refusal to consent or withdrawal
of consent.
3. For Award recipients located in the EEA and/or UK
This section applies if you reside inside the United Kingdom (UK) and/or the European Economic Area (EEA). By accepting your Award, you confirm
the following:
3.1 Data collected
You understand that the your employer (acting as controller) and the Company may collect, to the extent permissible under applicable law, Data for the
exclusive purpose of implementing, administering, and managing the Plan. The Data is collected from you, the employer, and the

-- 97 of 156 --

Company for the exclusive purpose of implementing, administering, and managing the Plan in accordance with the terms of your Award.
3.2 Purposes of collection/processing
You acknowledge the legal basis for Data processing is performance of the contract comprising your Award. The Data must be provided in order for you
to participate in the Plan and for the parties to your Award to perform their respective obligations as set out in your Award documents. If you do not
provide Data, you will not be able to participate in the Plan or continue to hold your Award.
3.3 Transfers and retention of Data
You understand that your employer will transfer Data to the Company for Plan administration purposes. The Company and your employer may also
transfer your Data to other service providers (such as accounting firms, payroll processing firms or tax firms), as may be selected by the Company now
or in the future, to assist the Company and your employer with the implementation, administration and/or management of your Award. You understand
that recipients of the Data may be located in a country that does not benefit from an adequacy decision issued by the European Commission. When
your information is transferred outside the EEA or the UK (as applicable), it is done in accordance with data protection laws and regulations requiring
adequate transfer mechanisms. For further information as to the transfer of your Data, please contact privacy@coca-cola.com. Your Data will be held
only as long as is necessary to implement, administer and manage your rights and obligations under the terms of your Award documents, as well as in
compliance with other laws requiring a longer retention period.
3.4 Accuracy
You understand the Company and your employer will take steps in accordance with applicable legislation to keep Data accurate, complete and up to
date.
3.5 Your rights
You understand you are entitled to:
3.5.1 have any inadequate, incomplete or incorrect Data corrected;
3.5.2 request access to your Data and additional information about the processing of that Data;
3.5.3 object to the processing of Data or have your Data erased, under certain circumstances; and
3.5.4 subject to applicable law:
(i) restrict the processing of your Data so that it is stored but not actively processed (e.g. while the Company assesses whether you are
entitled to have Data erased); and
(ii) receive a copy of the Data provided in connection with your Award or generated by you, in a common machine-readable format,
and you may exercise these rights by contacting a local human resources representative.

-- 98 of 156 --

3.6 Other contacts
You understand you have the right to contact, and may lodge a complaint with, the relevant data protection supervisory authority.
You may also contact the EU Data Protection Officer:
Coca-Cola Italia s.r.l.
Viale Edison 110
Building B
20099 Sesto San Giovanni (Milan)
Italy
DPO-Europe@coca-cola.com
4. Country specific provisions
The provisions below supplement section 2 (For Award recipients not located in the EEA or UK) of this Data Privacy Appendix. By accepting your
Award, you confirm the following:
4.1 If you are subject to the laws of Canada
You authorize the Company, your employer, and your employer’s representatives to discuss with and obtain all relevant information from all personnel
(professional or not) involved in the administration and operation of the Plan. You authorize your employer, the Company, any Affiliates and any stock or
incentive plan service provider that may be selected by the Company to assist with the Plan to disclose and discuss the Plan with their respective
advisors. You further authorize your employer, the Company and any Affiliates to record this information and to keep it in your employee file.
4.2 If you are subject to the laws of Russia
You acknowledge that you have read, understood and agree to the terms regarding the collection, processing and transfer of data described in section
2 (For Award recipients not located in the EEA or UK) of this Data Privacy Appendix. Upon request of the Company or your employer, you agree to
provide an executed data privacy consent form or any similar agreements or consents that the Company or your employer may deem necessary to
obtain under the data privacy laws in Russia, either now or in the future. You understand that you will not be able to participate in the Plan if you fail to
execute any such consent or agreement that may be requested.

-- 99 of 156 --

Awards made under
The Coca-Cola Company 2024 Equity Plan
Additional Terms
By accepting your Award you:
1. 	Plan Documents
Agree that you have been given all relevant information and materials regarding the terms and conditions of your Award, which are set out in the rules
of The Coca-Cola Company 2024 Equity Plan, as amended from time to time (the Plan), your Award Notification (including any appendices attached to
it) and these Additional Terms (including the Global Appendix set out below) (collectively, the Plan Documents).
2. 	Employment
2.1 Acknowledge that the grant of your Award does not form part of and does not affect or change your employment contract or your employment relationship
with your employer (which is entirely separate from the Plan). The grant of your Award and your participation in the Plan does not create a right to
employment or continued service and will not be interpreted as forming an employment or service contract with The Coca-Cola Company (the
Company), your employer or any Affiliate (as defined in the Plan). The Award does not impact the ability of the Company, your employer or any
Affiliate to terminate that employment or service relationship. All benefits granted by your Award will constitute an occasional extraordinary payment and
may not, in any way or for any purpose, be considered part of your normal remuneration or constitute consideration for any services you provide to the
Company, your employer or any Affiliate, including when calculating any other benefits.
2.2 	Acknowledge that the Company’s decision to grant your Award is voluntary and discretionary, and that you have no right to participate in the Plan.
Acceptance of your Award and participation in the Plan does not create any right to, or expectation of, future employment or service, future participation
in the Plan or the grant of future awards (on the same basis, or at all). The Company may at any time decide to cease offering awards under the Plan,
or amend, modify, suspend, cancel or terminate the Plan and any benefits under it.
2.3 	Acknowledge that you are not entitled to the exercise of any discretion under the Plan in your favor, that decisions with respect to your Award and any
future awards are at the sole discretion of the Company and are final, binding and conclusive, and that you do not have any claim or right of action in
respect of any decision, omission, or discretion, which may in each case operate to your disadvantage.
2.4 Agree, in consideration for and as a condition of your Award, to waive all rights which might arise in connection with the Plan, including:
2.4.1 the right to institute any claim against the Company, your employer or any Affiliate; and
2.4.2 the right to pursue any claim that is allowed by a court,
other than the right to acquire, as relevant, $0.25 par value shares of common stock of the Company (Stock) or cash (subject to and in accordance
with the Plan).

-- 100 of 156 --

2.5 Acknowledge that you do not have any right to compensation or damages for any loss (actual or potential) in relation to the Plan or your Award, including
where it is forfeited on termination of employment or cessation of services for any reason, whether or not lawful or in breach of employment laws or the
terms of your employment or service agreement, if any.
3. 	No transfer
Accept that you must not pledge, encumber, assign, transfer, charge or otherwise dispose of your Award or any rights in respect of it, whether
voluntarily or involuntarily (other than to your personal representatives on death).
4. 	Modifications and additional requirements
4.1 Agree that the Company may modify any of the terms of your Award to be consistent with any applicable law or applicable government agency regulation
where, in the opinion of the Company, that term might otherwise conflict or be inconsistent.
4.2 Agree that the Company may impose additional conditions, requirements and restrictions on your Award, your participation in the Plan and any Stock or
cash you acquire on vesting or exercise of your Award, and that you will comply with them, including signing any additional agreements or
undertakings.
4.3 	Agree to any amendment made to the Plan or any term of your Award (including an amendment with retroactive effect) where the amendment is
necessary or advisable to ensure the Plan or your Award complies with any future law relating to plans of this nature or their administration (including
Section 409A of the U.S. Internal Revenue Code of 1986, as amended).
4.4 	Agree to any amendment made to any of the terms of your Award (including rescinding your Award entirely) to correct any error that occurred in
connection with the grant or documentation of your Award.
4.5 	Acknowledge that your Award may be adjusted to reflect a change in capital structure, in accordance with the terms of the Plan, and agree that, where
your Award is over Stock and an adjustment results in a fractional share, the fractional share may be disregarded at the Company’s discretion.
5. 	Tax
5.1 Acknowledge that participating in the Plan will probably have tax consequences for you and that all payments made with respect to your Award (including
payments in Stock or cash) may be subject to tax, social security and any similar charges in any country where you are employed, reside, or are
otherwise subject to tax (Tax).
5.2 	Agree that you (or your personal representative) are ultimately responsible for and will bear any liability for any Tax in respect of your Award and your
participation in the Plan, and understand that this liability may exceed any amounts withheld and paid on your behalf.
5.3 	Acknowledge that the Company, your employer, an Affiliate, any trustee of any employee benefit trust and any third party service provider (each, a
Withholding Person) is entitled to do any, all or a combination of the following methods (where relevant) to enable a Withholding Person to raise an
amount it considers necessary or desirable to recover the Liabilities:

-- 101 of 156 --

5.3.1 sell or procure the sale on your behalf of a sufficient number of the Stock you acquire on vesting or exercise of your Award;
5.3.2 reduce the number of Stock you acquire on vesting or exercise of your Award accordingly and settle the balance in cash; and
5.3.3 withhold amounts from:
(i) proceeds of sale under section 5.3.1;
(ii) the balance settled in cash under section 5.3.2; and
(iii) any other cash payments of any kind owed to you.
For these purposes, Liabilities means any obligation on the Withholding Person to pay or account for Tax, any unpaid exercise price, any associated
costs (including under section 7 (Costs)) and any amount you owe to the Company, your employer or any Affiliate due to any obligation of any nature
whatsoever (including under a loan, the Company’s tax equalization program or any travel or expenses policy) to the extent that the Company, the
employer or any Affiliate in its reasonable judgement determines you owe them that amount.
5.4 Agree that, for tax purposes, and where allowed by applicable law, you are deemed to have received the full number of Stock where the number of Stock
you acquire is reduced under section 5.3.2.
5.5 Agree that, where permitted by the Company, you may elect to satisfy Tax and/or pay any exercise price by delivering (including by attestation) Stock to
the Company.
5.6 Agree that if a Withholding Person’s obligation to pay or account for Tax cannot or has not been fully satisfied by the above methods, you must pay to the
Withholding Person an amount sufficient to enable them to discharge that obligation.
5.7 Agree to enter any tax elections for particular tax and/or social security treatment, execute any documents, give any directions and take any action as may
be requested by the Company, your employer or any Affiliate in relation to any Liabilities.
5.8 	Acknowledge that the Company, your employer and any Affiliate do not guarantee or warrant any particular Tax treatment in relation to your Award, the
cash or Stock you acquire in connection with your Award (including any dividends on Stock), or your participation in the Plan and that they are not
under any obligation to structure the Award in a Tax favorable way or avoid adverse Tax treatment in any jurisdiction.
5.9 	Acknowledge that neither the Company, your employer nor any Affiliate will be liable for any Tax, interest, penalties or other amounts owed by any
taxpayer as a consequence of the Plan or an Award and that any Tax information provided is for guidance purposes only.
5.10 Accept that the cash or Stock subject to your Award may only vest or be exercised (as applicable) if satisfactory arrangements are in place to enable all
Withholding Persons to obtain the funds needed to satisfy any Liabilities.
5.11 	Acknowledge that the vested (and, if applicable, exercised) Stock or cash subject to your Award may not be delivered or paid to you unless you have
complied with your obligation to pay the Liabilities.

-- 102 of 156 --

6. 	Internationally mobile employees
6.1 Acknowledge that if you are a mobile employee, meaning that you are based in different jurisdictions during the course of your employment or service that
you are or may be subject to Tax in more than one country, you are strongly encouraged to inform the Company and your employer, and to speak with
your personal tax adviser regarding the tax treatment of your participation in the Plan.
6.2 Accept that, if you are a mobile employee, the Company or your employer may be required to withhold for Tax in more than one jurisdiction.
6.3 	Accept that if you are a “Global Mobility Associate” as defined in the Company’s Global Mobility Policy (or the equivalent under any applicable
international service policy from time to time), you remain responsible for all Tax except where expressly stated otherwise in that policy and/or the
Company’s tax equalization program. A copy of the Company’s Global Mobility Policy is available on the Company’s intranet.
7. 	Costs
Agree that you are responsible for the payment of any fees, dealing, commission or currency conversion costs or any other costs associated with your
Award, including costs associated with the payment of any cash and the sale of any Stock.
8. 	Notices
8.1 Agree that any notice or other communication required in relation to your Award will be given in writing, which may include electronic means.
8.2 Agree that any notice or other communication to be given to you in connection with your Award may be delivered by electronic means (including by email,
or through the Company or your employer’s intranet or a share plan portal), personally delivered, or sent by ordinary post to the principal address on file
for you from time to time with the Company, your employer, an Affiliate or the Company’s agents.
8.3 	Agree that any notice or other communication to be given to the Company or its agents in connection with your Award may be delivered or sent to its
registered office or to such other place and by such means as communicated to you by or on behalf of the Company from time to time.
8.4 Accept that notices or other communications:
8.4.1 	sent electronically will be deemed to have been received immediately (if sent during usual business hours) or at the opening of
business on the next business day (if sent outside usual business hours);
8.4.2 	that are personally delivered will be deemed to have been received when left at the relevant address (if left during usual business
hours) or at the opening of business on the next business day (if left outside usual business hours); and
8.4.3 	sent by post will be deemed to have been received 24 hours after posting to a U.S. address or 3 days after posting to an address
outside the U.S.,
unless there is evidence to the contrary.

-- 103 of 156 --

8.5 Agree that all notices or communications to be given to you are given and sent at your risk and that neither the Company, your employer nor any Affiliate
has any liability in respect of any notice or communication given or sent, nor need they be concerned to see that you actually receive it.
9. 	Insider trading and market abuse
9.1 	Acknowledge that rules on insider trading, dealing notification requirements, and market abuse laws may apply in relation to any actions or decisions
taken relating to your Award, including in relation to the acceptance, vesting, exercise or settlement of your Award, the delivery or payment of any Stock
or cash, and the sale of any Stock. These rules, requirements and laws:
9.1.1 	are separate from and in addition to the requirements that apply to you under The Coca-Cola Company Global Insider Trading Compliance
Policy; and
9.1.2 may prohibit or delay your actions or decisions.
9.2 Agree that it is your responsibility to comply with the rules, requirements and laws referred to in section 9.1. You should consult with your personal legal
adviser on these matters.
10. 	Currency risk
10.1 Acknowledge that if any Stock relating to your Award is traded in a currency that is not the currency in your jurisdiction, the value of the Stock may also
be affected by movements in the exchange rate.
10.2 Agree that neither the Company, your employer nor any Affiliate is liable for any loss due to movements in the exchange rate nor any charges imposed in
relation to the conversion or transfer of money.
11. 	No advice
11.1 	Confirm you are accepting your Award and participating in the Plan voluntarily and understand that the Company is not making any recommendations
regarding your Award or any Stock or cash relating to your Award.
11.2 Agree that neither the Company, your employer, any Affiliate nor any person or entity acting on their behalf has provided you with any legal, investment,
tax (including reporting) or financial advice with respect to your participation in the Plan, your Award or any Stock or cash acquired upon vesting or
exercise of your Award. You should consult with your own suitably qualified advisers before taking any action under the Plan.
11.3 	Acknowledge that the information and materials provided do not take into account your objectives, financial situation or needs and that if you do not
understand the contents of the Plan Documents, or you are in any doubt, you should consult an independent authorized financial adviser.
11.4 Agree you will have no remedies for any statement, representation, assurance or warranty that is not set out in your Plan Documents.
12. 	No guarantee
12.1 Acknowledge that neither the Company, your employer nor any Affiliate guarantees a specified level of return in respect of your Award or any Stock.

-- 104 of 156 --

12.2 Acknowledge that there is a risk that any Stock relating to your Award may fall as well as rise in value, that the future value of Stock cannot be predicted
with certainty and that market forces will impact the price of any Stock relating to your Award and, in the worst case, the market value of the Stock may
become zero. More information in relation to the Company, including its share price, can be found at https://www.coca-colacompany.com/.
13. No public offer
13.1 Acknowledge that your Award is being offered to you in your capacity as an employee of the Company’s group and that the offer is not intended for the
general public and may not be used for any public offer.
13.2 Acknowledge that the Company is not required to deliver any Stock or cash on settlement of your Award before it completes, on terms to its satisfaction,
any registration, listing, exemption or qualification or other legal requirements or obtains any clearance or approval that the Company considers is
necessary or desirable, and you agree to provide any information, make any agreements and give any representations that the Company requests as
part of this process.
13.3 	Agree that the Company may (whether under Section 17.7(b) of the Plan or otherwise) refuse to deliver any Stock or cash where the Company
considers the delivery of Stock or cash may conflict or be inconsistent with applicable law or applicable government agency regulation.
13.4 	Acknowledge that neither the Company, your employer nor any Affiliate is under any obligation to register, exempt or qualify, or seek clearance or
approval for, your Award or any Stock or cash that you may acquire in connection with your Award.
13.5 Acknowledge that your Award may not have been authorized or approved by any applicable securities authorities and may have been offered pursuant
to an exemption from registration in your local jurisdiction.
13.6 Acknowledge that the regulatory bodies in your jurisdiction accept no responsibility for the accuracy and completeness of the statements and information
contained in the Plan Documents and take no liability whatsoever for any loss arising from reliance upon the whole or any part of the contents of those
documents.
13.7 	Acknowledge that a prospectus or similar offering or registration document may not have been prepared, authorized or approved by any applicable
authority in any jurisdiction outside the United States.
14. Exchange controls and any reporting requirements
14.1 	Accept that exchange control regulations and/or foreign asset reporting requirements may apply to you in respect of your Award and/or any Stock or
cash acquired in connection with your Award, and that you are solely responsible for complying with those regulations and requirements.
14.2 Agree that neither the Company, your employer nor any Affiliate are responsible for obtaining exchange control approval or making any reports on your
behalf, nor for monitoring compliance with those regulations and requirements and that if you fail to obtain any required exchange control approval or
make the necessary reports, neither the Company, your employer nor any Affiliate will be liable in any way for any resulting fines or penalties. You
should seek independent professional advice if you are unsure about the obligations that apply to you as a result of your participation in the Plan.

-- 105 of 156 --

14.3 Accept that you are solely responsible for complying with any filing, notification or reporting requirements in respect of:
14.3.1 your participation in the Plan and/or
14.3.2 benefits received under the Plan,
as required by the local law in any jurisdiction. The Company accepts no responsibility for your failure or delay in complying with such requirements. If
you are in any doubt as to what actions you should take, you should consult a duly authorized independent adviser.
15. General
15.1 Consent to the use of electronic communications in connection with the Plan.
15.2 Confirm that references to “employer” throughout these Additional Terms include your former employer, where applicable.
15.3 	Agree that all determinations and decisions on questions of interpretation in respect of your Award and the Plan Documents will be made by the
Company (or any committee on its behalf) in its sole and absolute discretion. Those determinations and decisions will be final, binding and conclusive.
Any references to determinations or decisions made, or actions taken, by the “Company” as referred to in these Additional Terms include any
committee acting on its behalf.
15.4 Agree that if any provision of your Plan Documents is held to be invalid, illegal or unenforceable for any reason by any court in any jurisdiction then, for
the purposes of that jurisdiction only:
15.4.1 such provision will be deleted; and
15.4.1 the remaining provisions will continue in full force and effect.
15.5 Agree that if the Company waives a breach of one or more provisions in the Plan Documents, this does not constitute a waiver of any other provision of
the Plan Documents, or a waiver of any subsequent breach of the Plan Documents (by you or anyone else).
15.6 Accept that:
15.6.1 	the federal laws of the United States of America and the state laws of the State of Delaware, United States of America, govern your Plan
Documents and your Award without regard to the conflict of law provisions; and
15.6.2 	the courts of the United States District Court for the District of Delaware or the Delaware Superior Court, New Castle County have exclusive
jurisdiction in respect of disputes arising under or in connection with the Plan or your Award,
and you waive any current or future objection you may have to this choice of law and jurisdiction.
16. English language (this applies if you have received an English language version only of any Plan Document)
16.1 Accept that you fully understand the contents of the English language version of the Plan Documents.

-- 106 of 156 --

16.2 Acknowledge that you do not need a translation of the Plan Documents and that you are fluent and regularly conduct business in the English language
as part of your duties and responsibilities to your employer.
17. Translations (this applies if you have received a Plan Document in a language other than English)
17.1 	Agree that if there is any conflict between the terms of the English language version of the Plan Documents and a version in any other language, the
English language version will prevail.
18. Options (this applies if your Award Notification specifies that your Award is an Option)
18.1 Understand that, in order to exercise your Award, you will need to pay the exercise price.
18.2 Acknowledge that you will be informed of the acceptable forms and methods of paying the exercise price when you come to exercise your Award.
19. Restricted resale (this applies if your Award is over Stock)
Acknowledge that any Stock you may acquire upon settlement of your Award may be subject to restrictions on transfer and resale in your local
jurisdiction and you agree that you will comply with those restrictions, including that you will not offer, sell, advertise or otherwise market the Stock (or
cause any of these to occur) in circumstances which constitute any type of public offering of securities, unless an exemption applies.
20. Performance conditions (this applies if your Award Notification specifies that your Award is subject to performance conditions)
20.1 	Accept that the vesting of your Award is conditional on the satisfaction of one or more performance conditions as set out in the Performance Criteria
Appendix to your Award Notification (the Performance Criteria) and, to the extent the Performance Criteria are not satisfied, your Award may be
forfeited.
20.2 Accept that the Performance Criteria may be altered in the circumstances specified in Section 10.2 of the Plan.
21. Malus and clawback (this applies if your Award Notification specifies that your Award is subject to “Malus and clawback”)
21.1 Agree that any benefits you may receive with respect to your Award will be subject to reduction, cancellation, repayment, forfeiture or recoupment if there
is a determination that the vesting of, or amount realized from, your Award was based on:
21.1.1 materially inaccurate financial statements; or
21.1.2 any other materially inaccurate performance metric criteria,
and you acknowledge that this applies regardless of whether you caused or contributed to the material inaccuracy.
21.2 	Agree that the Company may also seek to recover your Award where required by the provisions of the Dodd-Frank Wall Street Reform and Consumer
Protection Act or any other “clawback”

-- 107 of 156 --

provision required by applicable law, regulation or listing standards, including the listing standards of the New York Stock Exchange, and you authorize
such recovery.
22. Stock ownership guidelines (this only applies if you are subject to the Company’s stock ownership guidelines)
22.1 Accept that if you have not met the Company’s stock ownership guidelines before the applicable compliance deadline but you are a “Section 16 officer”
under the U.S. Securities Exchange Act of 1934, you are prohibited from selling 50% of any Stock you obtain upon vesting or exercise of your Award
until you meet the relevant guidelines, except for any Stock that is sold or cash settled to cover Tax and any exercise price.
22.2 Accept that if you have not met the guidelines by the applicable compliance deadline, you are prohibited at all times after that compliance deadline from
selling any Stock you obtain on vesting or exercise of your Award, except for any Stock that is sold or cash settled to cover Tax, commissions and fees
and any exercise price. Once you meet the guidelines, you can sell Stock in excess of the guidelines.

-- 108 of 156 --

Global Appendix – Equity Awards
1. 	If you are subject to the laws of the European Union
This offer is being made to selected employees as part of an employee incentive program in order to provide an additional incentive and to encourage
employee share ownership and to increase your interest in the success of the Company. The company offering these rights is The Coca-Cola Company.
The Stock which is the subject of these rights is new or existing par value common stock in the Company. More information in relation to the Company
including the stock price can be found at the following web address: https://investors.coca-colacompany.com/.
The obligation to publish a prospectus does not apply because of Article 1(4)(i) of the EU Prospectus Regulation. The total maximum number of Stock
which is the subject of this offer is 240,000,000.
2. 	If you are subject to the laws of Argentina
Neither the Award nor the underlying Stock are publicly offered or listed on any stock exchange in Argentina.
This provision applies if your Award Notification specifies that your Award is an Option:
Depending upon the method of exercise chosen for the Option, you may be subject to restrictions with respect to the purchase and/or remittance of
U.S. dollars pursuant to Argentine currency exchange regulations. The Company reserves the right to restrict the methods of exercise if required or
advisable to comply with Argentine laws.
3. 	If you are subject to the laws of Australia
The grant of Awards under the Plan is intended to comply with the provisions of the Corporations Act 2001, ASIC Regulatory Guide 49 and ASIC Class
Order CO 14/1000. Additional details are set forth in the Australia Offer Document, which is available on the Morgan Stanley at Work® website.
The offer is intended to receive tax deferred treatment under Subdivision 83A-C of the Income Tax Assessment Act 1997(Cth). The conditions to receive
such treatment are contained in the Award Agreement.
4. 	If you are subject to the laws of Belgium
If your Award Notification specifies that your Award is an Option, you confirm you have read and understood the information regarding the Belgian
taxation of Options which has been separately made available to you by email and/or on the Morgan Stanley at Work® website. You should review this
information thoroughly before accepting your Option grant.
__________________________
If your are subject to the laws of any of the following countries, there are no country-specific provisions for your country in this appendix: Bangladesh, Costa Rica, Dominican Republic, Ecuador,
Egypt, Japan, Kenya, Korea, Malaysia, Nigeria, Puerto Rico, Serbia, Sri Lanka, Swaziland, Taiwan, Thailand and Ukraine.
4
4

-- 109 of 156 --

5. 	If you are subject to the laws of Brazil
By accepting the Award, you agree that you are (i) making an investment decision, and (ii) the value of the underlying Stock is not fixed and may increase
or decrease in value over the vesting or exercise period without compensation to you.
6. 	If you are subject to the laws of Canada
For purposes of your Award, your employment will be considered terminated and your right (if any) to vest in any Award or exercise any Option after such
termination (regardless of the reason for such termination and whether or not later found to be invalid, unlawful or in breach of the employment laws in
the jurisdiction where you are employed or the terms of your employment agreement, if any) will be measured as of the earlier of: (a) the date your
employment with the Company or one of its Subsidiaries (as defined in the Plan) or Affiliates is terminated, (b) the date you receive written notice of
termination from the Company or a Subsidiary or Affiliate, regardless of any notice period or period of pay in lieu of such notice mandated under the
employment laws in the jurisdiction where you are employed or the terms of your employment agreement, if any, or (c) the date you are no longer
employed by the Company or any of its Subsidiaries or Affiliates. You will not be entitled to a pro-rata portion of the Award for any time before the date on
which your right to vest terminates, nor will you be entitled to any compensation for lost vesting. In the event the date on which you are no longer actively
providing services cannot be reasonably determined under the terms of your Award, the Company, in its sole discretion, shall determine when you are no
longer employed for purposes of the Award (including whether you may still be considered employed or actively providing services while on a leave of
absence).
Notwithstanding the foregoing, if applicable employment standards legislation explicitly requires continued entitlement to vesting during a statutory notice
period, your right to vest in the Award under the Plan, if any, will terminate effective as of the last day of your minimum statutory notice period, but you will
not earn or be entitled to pro-rated vesting if the vesting date falls after the end of your statutory notice period, nor will you be entitled to any
compensation for lost vesting.
In addition to any restrictions on resale and transfer noted in the Plan Documents, Stock acquired pursuant to the Plan will be subject to certain
restrictions on resale imposed by Canadian provincial securities laws (in general, you may not resell your Stock to Canadian purchasers). Accordingly,
you are encouraged to seek legal advice prior to any resale of the Stock.
Furthermore, notwithstanding anything to the contrary in the Plan or the Award Agreement, Awards granted to Canadian residents shall only be settled in
Stock and shall not be settled in cash.
The following terms and conditions apply if you are resident in Quebec:
You agree that you wish the Plan Documents to be drawn up in English.
Vous confirmez que vous souhaitiez que les Documents du Plan soient rédigés en anglais
7. 	If you are subject to the laws of Chile
Neither the Company, the Plan nor the Stock have been registered in the Registro de Valores (Securities Registry) or in the Registro de Valores
Extranjeros (Foreign Securities Registry) of the

-- 110 of 156 --

Comisión para el Mercado Financiero de Chile (Chilean Commission for the Financial market or CMF) and they are not subject to the control of the CMF.
The Plan is governed by General Regulation 336. As the Stock is not registered, the Company has no obligation under Chilean law to deliver public
information regarding the Stock in Chile. Shares of Stock cannot be publicly offered in Chile unless they are registered with the CMF.
Ni The Coca-Cola Company, ni el Plan ni las Acciones han sido registradas en el Registro de Valores o en el Registro de Valores Extranjeros que
lleva la Comisión para el Mercado Financiero de Chile (CMF) y ninguno de ellos está sujeto a la fiscalización de la CMF. Esta oferta de Acciones se
acoge a la Norma de Carácter General 336. Por tratarse de valores no inscritos, el emisor de las Acciones no tiene obligación bajo la ley chilena de
entregar en Chile información pública acerca de las Acciones. Las Acciones no pueden ser ofrecidas públicamente en Chile en tanto éstas no se
inscriban en el Registro de Valores correspondiente.
8. 	If you are subject to exchange control restrictions imposed by the China State Administration of Foreign Exchange (SAFE), as
determined by the Company in its sole discretion, or you are subject to mandatory retirement in China
Notwithstanding any other provision in the Plan Documents, the following provisions apply in the event of the termination of your employment (as
interpreted in accordance with the Employment Events Appendix) with the Company or a Subsidiary (as defined in the Plan) (1) because of your
Disability, or (2) after attaining age 55:
Awards that are Options and Awards held at least 12 months will immediately vest and will be settled in cash. The cash amount will be determined
based on the closing price of the Stock on the date of your termination of employment (or, if a non-trading day, the next trading day) or the exercise of
your Option (if applicable) within the post-termination exercise period stated below. Awards that are not Options and that are held less than 12
months from the date of grant are forfeited.
Where Performance Criteria apply, the Performance Criteria will be measured over a shortened performance period, ending at the end of the year
prior to your termination of employment.
If your Award is an Option, the period over which you may exercise your Option expires upon earlier of (1) six months from your termination of
employment or (2) the Option expiration date provided in the Plan Documents.
The Company has the discretion to arrange for the sale of any Stock issued upon settlement of your Award, either immediately upon settlement or at any
time thereafter. In any event, if you terminate employment, you will be required to sell all Stock acquired upon settlement of the Award within such time
period as required by the Company in accordance with SAFE requirements. Any Stock remaining in your brokerage account at the end of this period shall
be sold by the broker (on your behalf pursuant to this authorization and without further consent). In addition, any Award that has not vested by the end of
this period will then immediately be forfeited. The Company shall have the exclusive discretion to determine when your employment has been terminated
for the purposes of the Award.

-- 111 of 156 --

You agree to sign any additional agreements, forms and/or consents that reasonably may be requested by the Company (or the Company’s designated
broker) to effectuate the sale of the Stock (including, without limitation, as to the transfer of the sale proceeds and other exchange control matters noted
below) and shall otherwise cooperate with the Company with respect to such matters. You acknowledge that neither the Company nor the designated
broker is under any obligation to arrange for the sale of Stock at any particular price (it being understood that the sale will occur in the market) and that
broker’s fees and similar expenses may be incurred in any such sale. In any event, when the Stock is sold, the sale proceeds, less any withholding for
applicable taxes, any broker’s fees or commissions, and any similar expenses of the sale will be remitted to you in accordance with applicable exchange
control laws and regulations.
By accepting the Award, you acknowledge that you understand and agree that you are not permitted to transfer any Stock acquired under the Plan out of
your account established with the Company’s designated broker until the Stock is sold. The limitation applies to all Stock issued to you under the Plan,
whether or not you remained employed with the Company or a Subsidiary.
You understand and agree that you will be required to immediately repatriate to China the proceeds from the sale of any Stock acquired under the Plan
and any such dividends paid on such shares. You further understand that such repatriation proceeds may need to be effected through a special bank
account established by the Company (or a Subsidiary or Affiliate in China), and you hereby consent and agree that any sale proceeds and cash
dividends may be transferred to such special account by the Company (or a Subsidiary or Affiliate in China) on your behalf prior to being delivered to you
and that no interest shall be paid with respect to funds held in such account.
The proceeds may be paid to you in U.S. dollars or local currency at the Company’s discretion. If the proceeds are paid to you in U.S. dollars, you
understand that a U.S. dollar bank account in China must be established and maintained so that the proceeds may be deposited into such account. If
the proceeds are paid to you in local currency, you acknowledge that the Company (and its Subsidiaries and Affiliates) are under no obligation to secure
any particular exchange conversion rate and that the Company (and its Subsidiaries and Affiliates) may face delays in converting the proceeds to local
currency due to exchange control restrictions. You agree to bear any currency fluctuation risk between the time the Stock is sold and the net proceeds
are converted into local currency and distributed to you. You further agree to comply with any other requirements that may be imposed by the Company
in the future in order to facilitate compliance with exchange control requirements in China.
In addition to the vesting schedule for your Award, settlement of the Award is also conditioned on the continued effectiveness of the Company’s
registration of the Plan with SAFE (the SAFE Registration Requirement). If or to the extent the Company is unable to maintain the registration, no
Stock for which a registration cannot be maintained shall be issued. In this case, the Company retains the discretion to settle any Award for which the
vesting schedule, but not the SAFE Registration Requirement, has been met in cash paid through local payroll in an amount equal to the market value of
the Stock subject to the Award less any withholding for applicable taxes.
The Company (and its Subsidiaries and Affiliates) shall not be liable for any costs, fees, lost interest or dividends or other losses that you may incur or
suffer resulting from the enforcement of the foregoing terms or otherwise from the Company’s operation and enforcement of the Plan, the

-- 112 of 156 --

Award Agreement, and the Award in accordance with any applicable laws, rules, regulations and requirements.
9. If you are subject to the laws of Colombia
You acknowledge that pursuant to Article 128 of the Colombian Labor Code, the Plan and related benefits do not constitute a component of “salary” for
any legal purpose.
10. If you are subject to the laws of France
By accepting the Award, you confirm that you have read and understood the Plan Documents, which were provided in English. You accept the terms of
those Plan Documents and confirm that you have a good knowledge of the English language.
En acceptant ce paiement, vous confirmez avoir lu et compris les documents relatifs à ce plan d’incitation à long terme (qui vous ont été fournis en
anglais) et que vous acceptez les termes de ce plan.
11. If you are subject to the laws of Hong Kong
WARNING:
The contents of the Plan Documents have not been reviewed by any regulatory authority in Hong Kong. You are advised to exercise caution in relation to
the offer. If you are in any doubt about any of the contents of the Plan Documents, you should obtain independent professional advice.
This offer to receive an Award under the Plan (the Offer) is strictly private and only available to eligible employees of Coca-Cola China Limited. The Offer
has also not been approved by the Securities and Futures Commission in Hong Kong and it should not be made in whole or in part to the public or any
third-party.
No Awards granted under the Plan may be transferred or assigned, except as expressly permitted by the Company in writing.
Sale of Stock. Any Stock received at vesting is accepted as a personal investment. In the event that any portion of this Award vests within six months of
the grant date, you agree that you will not offer to the public or otherwise dispose of the Stock acquired prior to the six-month anniversary of the grant
date.
12. If you are subject to the laws of India
You must repatriate to India all funds resulting from the sale of Stock acquired in relation to your Award within 90 days, and all proceeds from the receipt
of any dividends within 180 days. You should receive a foreign inward remittance certificate (FIRC) from your bank where you deposit the foreign
currency. You should maintain the FIRC as evidence of the repatriation of funds in the event that the Reserve Bank of India or your employer requests
proof of repatriation.

-- 113 of 156 --

13. If you are subject to the laws of Indonesia
A translation of the documents relating to this grant into Bahasa Indonesia can be provided to you upon request to your local human resources
representative. By accepting the grant of the Award, you (i) confirm having read and understood the documents relating to this grant which were provided
in the English language, (ii) accept the terms of those documents accordingly, and (iii) agree not to challenge the validity of this document based on Law
No. 24 of 2009 on National Flag, Language, Coat of Arms and National Anthem or the implementing Presidential Regulation (when issued).
Terjemahan dari dokumen-dokumen terkait dengan pemberian ini ke Bahasa Indonesia dapat disediakan bagi anda berdasarkan permintaan kepada
perwakilan sumber daya manusia lokal anda. Dengan menerima pemberian Award, anda (i) mengkonfirmasi bahwa dirinya telah membaca dan
mengerti dokumen-dokumen yang terkait dengan pemberian ini yang disediakan dalam Bahasa Inggris, (ii) menerima syarat-syarat dari dokumen-
dokumen tersebut, dan (iii) setuju untuk tidak mengajukan keberatan atas keberlakuan dokumen ini berdasarkan Undang-Undang No. 24 Tahun
2009 tentang Bendera, Bahasa, dan Lambang Negara, Serta Lagu Kebangsaan atau Peraturan Presiden pelaksananya (ketika diterbitkan).
14. If you are subject to the laws of Italy
By accepting the grant of the Award, you acknowledge that you have received a copy of the Plan Documents, you have reviewed the Plan Documents in
their entirety and you fully understand and accept all provisions of the Plan Documents. You further acknowledge that you have read and expressly
approve the following sections of the Additional Terms: section 2 (Employment); section 4 (Modifications and additional requirements); section 5 (Tax);
and section 15 (General).
15. If you are subject to the laws of Mexico
By participating in the Plan, you acknowledge that you have received a copy of the Plan, reviewed the Plan in its entirety and fully understand and accept
all provisions of the Plan. You further acknowledge that you have read and expressly approve the terms and conditions set forth in section 2
(Employment) of the Additional Terms, in which the following is clearly described and established: (i) your participation in the Plan does not constitute an
acquired right; (ii) the Plan and your participation in the Plan are offered by the Company on a wholly discretionary basis; (iii) your participation in the Plan
is voluntary; and (iv) the Company and its Subsidiaries (as defined in the Plan) are not responsible for any decrease in the value of the underlying Stock.
By participating in the Plan, you expressly recognize that The Coca Cola Company, with registered offices at One Coca-Cola Plaza, Atlanta, Georgia
30313, USA, is solely responsible for the administration of the Plan and that your participation in the Plan and acquisition of Stock does not constitute an
employment relationship between you and the Company since you are participating in the Plan on a wholly commercial basis. Based on the foregoing,
you expressly recognize that the Plan and the benefits that you may derive from participation in the Plan do not establish any rights between you and the
Company and do not form part of the employment conditions and/or benefits provided by the Company and any modification of the Plan or its termination
shall not constitute a change or impairment of the terms and conditions of your employment.

-- 114 of 156 --

You further understand that your participation in the Plan is as a result of a unilateral and discretionary decision of the Company; therefore, the Company
reserves the absolute right to amend and/or discontinue your participation at any time without any liability to you.
Finally, you hereby declare that you do not reserve any action or right to bring any claim against the Company for any compensation or damages
regarding any provision of the Plan or the benefits derived under the Plan, and you therefore grant a full and broad release to the Company, its
Subsidiaries, branches, representation offices, its shareholders, officers, agents or legal representatives with respect to any claim that may arise.
Al participar en el Plan, usted reconoce que ha recibido una copia del Plan, que ha revisado el Plan en su totalidad, y que entiende y acepta en su
totalidad, todas y cada una de las disposiciones del Plan. Asimismo reconoce que ha leído y aprueba expresamente los términos y condiciones
señalados en el párrafo titulado Naturaleza de la Oferta en el Convenio, en lo que claramente se describe y establece lo siguiente: (i) su
participación en el Plan no constituye un derecho adquirido; (ii) el Plan y su participación en el Plan son ofrecidos por la Compañía sobre una base
completamente discrecional; (iii) su participación en el Plan es voluntaria; y (iv) la Compañía y sus Afiliadas no son responsables de ninguna por la
disminución en el valor de las Acciones subyacentes.
Al participar en el Plan, usted reconoce expresamente que The Coca-Cola Company, con oficinas registradas en One Coca-Cola Plaza, Atlanta,
Georgia 30313, Estados Unidos de América, es la única responsable por la administración del Plan, y que su participación en el Plan, así como la
adquisición de las Acciones, no constituye una relación laboral entre usted y la Compañía, debido a que usted participa en el plan sobre una base
completamente mercantil. Con base en lo anterior, usted reconoce expresamente que el Plan y los beneficios que pudiera obtener por su
participación en el Plan, no establecen derecho alguno entre usted y la Compañía, y no forman parte de las condiciones y/o prestaciones laborales
que la Compañía ofrece, y que las modificaciones al Plan o su terminación, no constituirán un cambio ni afectarán los términos y condiciones de su
relación laboral.
Asimismo usted entiende que su participación en el Plan es el resultado de una decisión unilateral y discrecional de la Compañía; por lo tanto, la
Compañía se reserva el derecho absoluto de modificar y/o suspender su participación en cualquier momento, sin que usted incurra en
responsabilidad alguna.
Finalmente, usted declara que no se reserva acción o derecho alguno para interponer reclamación alguna en contra de la Compañía, por concepto
de compensación o daños relacionados con cualquier disposición del Plan o de los beneficios derivados del Plan, y por lo tanto, usted libera total y
ampliamente de toda responsabilidad a la Compañía, a sus Afiliadas, sucursales, oficinas de representación, sus accionistas, funcionarios, agentes
o representantes legales, con respecto a cualquier reclamación que pudiera surgir.
The Stock underlying your Award has not been registered with the National Register of Securities maintained by the Mexican Banking and Securities
Commission and may not be offered or sold publicly in Mexico. The Plan Documents may not be publicly distributed in Mexico. These materials are
addressed to you only because of your existing relationship with the Company and its Subsidiaries and may not be reproduced or copied in any form.
The offer contained in these

-- 115 of 156 --

materials is addressed solely to the present employees of the Company and its Subsidiaries in Mexico and any rights under the Plan may not be
assigned or transferred. The Stock underlying your Award will be offered pursuant to a private placement exception under the Mexican Securities Law.
16. If you are subject to the laws of New Zealand
You are being offered an Award which, if vested, will entitle you to acquire Stock in accordance with the terms of the Plan Documents. The Stock, if
issued, will give you a stake in the ownership of the Company. You may receive a return if dividends are paid.
If the Company runs into financial difficulties and is wound up, you will be paid only after all creditors and holders of preference shares (if any) have been
paid. You may lose some or all of your investment, if any.
New Zealand law normally requires people who offer financial products to give information to investors before they invest. This information is designed to
help investors to make an informed decision. The usual rules do not apply to this offer because it is made under an employee share scheme. As a result,
you may not be given all the information usually required. You will also have fewer other legal protections for this investment. You are advised to ask
questions, read all documents carefully, and seek independent financial advice before committing.
The Stock is quoted on the New York Stock Exchange. This means that if you acquire Stock under the Plan, you may be able to sell the Stock on the
New York Stock Exchange if there are interested buyers. You may get less than you invested. The price will depend on the demand for the Stock.
For information on risk factors impacting the Company’s business that may affect the value of the Stock, you should refer to the risk factors discussion on
the Company’s Annual Report on Form 10-K and Quarterly Reports on Form 10-Q, which are filed with the U.S. Securities and Exchange Commission
and are available online at www.sec.gov, as well as on the Company’s “Investor Relations” website at https://investors.coca-colacompany.com/.
17. If you are subject to the laws of Peru
The grant of the Award is considered a private offering in Peru; therefore, it is not subject to registration in Peru. For more information concerning the
offer, please refer to the Plan Documents and any other materials or documentation made available by the Company. For more information regarding the
Company, please refer to the Company’s Annual Report on Form 10-K and Quarterly Reports on Form 10-Q, which are filed with the U.S. Securities and
Exchange Commission and are available at www.sec.gov, as well as the Company’s “Investor Relations” website at https://investors.coca-
colacompany.com/.
By accepting the Award, you acknowledge that the Award is being granted ex gratia with the purpose of rewarding you.
18. If you are subject to the laws of Philippines
The following wording is hereby made a part of the Plan Documents:

-- 116 of 156 --

The securities being offered or sold under the Plan have not been registered with the Philippine Securities and Exchange Commission under the
Philippine Securities Regulation Code. Any future offer or sale of the securities in the Philippines is subject to registration requirements under the
Securities Regulation Code unless such offer or sale qualifies as an exempt transaction.
This applies if your Award Notification specifies that your Award is an Option:
Notwithstanding any terms or conditions of the Plan Documents, you acknowledge and agree that you will be restricted to the cashless sell-all
method of exercise. To complete a cashless sell-all exercise, you must to instruct the broker to (i) sell all of the Stock issued upon exercise of the
Option; (ii) use the proceeds to pay the exercise price, any applicable Liabilities and brokerage fees or commissions; and (iii) remit the balance in
cash to you. You will not be permitted to hold the Stock after exercise. Depending on the development of local laws, the Company reserves the right
to modify the methods of exercising the Option and, in its sole discretion, to permit cash exercise, cashless sell-to cover exercise or any other method
of exercise and payment of Liabilities permitted under the Plan.
19. If you are subject to the laws of Russia
Information contained in the Plan Documents does not constitute an advertisement of any securities in Russia and must not be passed on to third parties
or otherwise be made publicly available in Russia. The Awards and the Stock to be granted under the Plan have not been and will not be registered in
Russia and are not intended for 'placement' or 'circulation' in Russia.
20. If you are subject to the laws of Singapore
You acknowledge that the Plan Documents have not been registered as a prospectus with the Monetary Authority of Singapore. Accordingly, the Plan
Documents and any other document or material in connection with the offer or sale, or invitation for subscription or purchase of the Stock may not be
circulated or distributed, nor may the Stock be offered or sold, or be made the subject of an invitation for subscription or purchase, whether directly or
indirectly, to persons in Singapore other than pursuant to, and in accordance with the conditions of, an exemption under any provision (other than Section
280) of Subdivision (4) of Division 1 of Part XIII of the Securities and Futures Act, Chapter 289 of Singapore.
The Awards under the Plan are prescribed capital markets products (as defined in the Securities and Futures (Capital Markets Products) Regulations
2018) and Excluded Investment Products (as defined in MAS Notices SFA 04-N12 and FAA-N16).
21. If you are subject to the laws of South Africa
By accepting the Award, you agree to immediately notify your employer of the amount of any income realized upon exercise or vesting of the Award. If
you fail to advise your employer of the income realized upon exercise or vesting of the Award, then you may be liable for a fine. You personally will be
responsible for paying the difference between the actual tax liability and the amount withheld by the Company or your employer.

-- 117 of 156 --

The documents listed below are available for your review on the Company’s website at https://investors.coca-colacompany.com/ and the Company’s
intranet:
1. The Company’s most recent annual financial statements; and
2. The Company’s most recent Plan prospectus.
A copy of the above-listed documents will be sent to you free of charge on written request to Global Equity, The Coca-Cola Company, at One Coca-Cola
Plaza, Atlanta, Georgia 30313, USA. You should read these materials carefully before making a decision whether to participate in the Plan.
22. If you are subject to the laws of Spain
By accepting the Award, you acknowledge that you consent to participation in the Plan and have received a copy of the Plan Documents. Except as
otherwise provided in the Plan Documents, termination of your employment for any reason (including for the reasons listed below) will automatically result
in the forfeiture of any unvested Awards; in particular, you understand and agree that such Awards will be forfeited without entitlement to the underlying
Stock or to any amount as indemnification in the event of a termination of your employment prior to vesting by reason of, including, but not limited to,
resignation, disciplinary dismissal with or without cause, individual or collective layoff with or without cause, material modification of employment under
Article 41 of the Worker’s Statute, relocation under Article 40 of the Worker’s Statute, Article 50 of the Worker’s Statute, Article 10.3 of Royal Decree
1382/1985 and unilateral withdrawal by your employer.
Furthermore, you understand that the Company has unilaterally, gratuitously, and in its sole discretion decided to grant Awards under the Plan to
individuals who may be employees of the Company's group throughout the world. The decision is a limited decision that is entered into upon the express
assumption and condition that any grant will not bind the Company or any Subsidiary (as defined in the Plan) or Affiliate, other than to the extent set forth
in the Plan Documents. Consequently, you understand that the Awards are offered on the assumption and condition that the Awards and any Stock
acquired under the Plan are not part of any employment contract (either with the Company or any Subsidiary or Affiliate), and shall not be considered a
mandatory benefit, salary for any purposes (including severance compensation), or any other right whatsoever. In addition, you understand that this offer
would not be made but for the assumptions and conditions referred to above; thus, you acknowledge and freely accept that, should any or all of the
assumptions be mistaken or should any of the conditions not be met for any reason, then any grant of or right to the Award shall be null and void.
23. If you are subject to the laws of Sweden
The following provision supplements section 5 (Tax) of the Additional Terms:
Without limiting the authority of any Withholding Person to satisfy their withholding obligations for Tax as set forth in section 5 (Tax) of the Additional
Terms, by accepting the grant of the Award, you authorize any Withholding Person to withhold or to sell Stock otherwise deliverable to you to satisfy
Tax, regardless of whether the Withholding Person has an obligation to withhold such Tax.

-- 118 of 156 --

24. If you are subject to the laws of Switzerland
The offering of the Plan in Switzerland is exempt from the requirement to prepare and publish a prospectus under the Swiss Financial Services Act
(FinSA) because such offering by the Company is made exclusively to current or former members of the board of directors, members of the
management board or employees of the Company, the employer and its Affiliates. The Plan Documents do not constitute a prospectus pursuant to
FinSA, and no such prospectus has been or will be prepared for or in connection with the offering of the Plan.
25. If you are subject to the laws of Turkey
Under Turkish law, you are not permitted to sell any Stock acquired under the Plan in Turkey. The shares are currently traded on the New York Stock
Exchange, which is located outside of Turkey, under the ticker symbol “KO” and the Stock may be sold through this exchange.
You acknowledge that any activity related to investments in foreign securities (e.g. the sale of Stock) should be conducted through a bank or financial
intermediary institution licensed by the Turkey Capital Markets Board and should be reported to the Turkish Capital Markets Board. You are solely
responsible for complying with this requirement and should consult with a personal legal advisor for further information regarding any obligations in this
respect.
26. If you are subject to the laws of the United Arab Emirates
The Awards are granted under the Plan only to select employees of the Company's group and are in the nature of providing employee equity incentives
in the United Arab Emirates. The Plan Documents are intended for distribution only to such employees and must not be delivered to, or relied on by, any
other person. Prospective purchasers of the securities offered should conduct their own due diligence on the securities. If you do not understand the
contents of the Plan Documents, you should consult an authorized financial adviser. The Emirates Securities and Commodities Authority has no
responsibility for reviewing or verifying any documents in connection with the Plan. Neither the Ministry of Economy nor the Dubai Department of
Economic Development has approved the Plan Documents nor taken steps to verify the information set out herein, and has no responsibility for such
documents.
27. If you are subject to the laws of the United Kingdom
This offer is being made to selected employees as part of an employee incentive program in order to provide an additional incentive and to encourage
employee share ownership and to increase your interest in the success of the Company. The company offering these rights is The Coca-Cola Company.
The Stock which is the subject of these rights is new or existing par value common stock in the Company. More information in relation to the Company
including the stock price can be found at the following web address: https://investors.coca-colacompany.com/.
The obligation to publish a prospectus does not apply because of Section 86(aa) of the Financial Services and Markets Act 2000 (as amended,
supplemented or substituted by any UK legislation enacted in connection with the UK’s exit from the European Union). The total maximum number of
Stock which is the subject of this offer is 240,000,000.

-- 119 of 156 --

28. If you are subject to the laws of Cambodia, Morocco, Myanmar, Nepal, Pakistan, or Vietnam
The Company reserves the right to restrict you from acquiring Stock at exercise or vesting of your Award. Instead, the Company reserves the right to
make a payment to you in cash upon exercise or vesting of your Award. Any references to the issuance of shares or Stock in any documents related to
the Award shall not be applicable in these circumstances.

-- 120 of 156 --

Exhibit 10.8
Award Notification – Stock Option
Congratulations [INSERT FULL NAME]! On [INSERT GRANT DATE], The Coca-Cola Company (the Company) granted you an award (your Award) under The
Coca-Cola Company 2024 Equity Plan, as amended from time to time (the Plan). Your Award is a great opportunity to share in the long-term success of the
Company and contribute to its future growth.
This document provides details of the key terms of your Award. Your Award is subject to the formal rules of the Plan, plus the additional terms and conditions
(including country specific terms) as set out in a document called the “Additional Terms”. The Additional Terms is available to review as part of the Award
acceptance process. The Plan is available in the Documents section of the Morgan Stanley at Work® website. This Award Notification (including the
appendices), the Plan and the Additional Terms together form your Award Agreement. You are being asked to confirm that you understand and agree to be
bound by these documents as part of the Award acceptance process, so we recommend you read them carefully.
Details of Award
Type of Award 	Option - This is a conditional right to purchase $0.25 par value common stock of the Company (Stock) in the future, at the
exercise price specified below. For tax purposes, this is a nonqualified stock option.
BELGIUM ONLY -
Option offer date [INSERT DATE]
BELGIUM ONLY - If you accept your Award within 60 days of this date, the Award is taxable on the 60th day following the
offer date. If you do not accept within the 60-day period, your Award is taxed at exercise.
Number of shares of
Stock subject to your
Award
[INSERT]
Exercise price 	[INSERT]
This is the price you will pay per share of Stock.
Continuing employment Your Award is subject to your continuing employment, as set out in the Employment Events Appendix to this document and
the Plan.
Date your Award
normally vests
25% per year over 4 years, as follows:
[INSERT DATE] - 25% of your Award vests
[INSERT DATE] - a further 25% of your Award vests
[INSERT DATE] - a further 25% of your Award vests
[INSERT DATE] - the final 25% of your Award vests
When your Award vests, you become entitled to exercise your Award.
Remember: your Award will only vest if and to the extent that all of the terms and conditions of your Award are satisfied. To
the extent that your Award does not vest, it will be forfeited.

-- 121 of 156 --

Details of Award
Exercise of your Award ‘Exercising’ your Award simply means exercising your right to buy the vested Stock subject to your Award.
In order to exercise your Award, you must submit any required documentation, pay the exercise price (see above), arrange to
pay any tax, fees and costs (which may be withheld), and take any other steps that might be required from you. You will be
informed of the acceptable form(s) and method(s) of paying the exercise price when you exercise your Award.
Expiration
date [INSERT]
This is the date your Award will normally expire (unless it expires earlier under the Plan or the Award terms and conditions).
When your Award expires, you lose your right to buy the Stock.
Prohibited Activities 	If you engage in certain activities (called Prohibited Activities), your Award will be forfeited and you will be required to pay
back any gain from your Award. Refer to the Prohibited Activities Appendix to this document.
Finally, certain data privacy provisions apply to you in connection with your Award, as set out in the Data Privacy Appendix to this document.
In the event of any conflict between this Award Notification (including the appendices), the Additional Terms and the Plan, the Plan takes precedence.
Action required!
If you wish to accept your Award, you must accept it using the Shareworks by Morgan Stanley® website by [Insert Date]. If you fail to do so by this deadline,
then the Company may declare your Award grant null and void at any time. If this happens, your Award will be forfeited, and you will have no right to the
underlying Stock. Acceptance of this award will constitute acknowledgement of and consent to the updated Annual Incentive and Long-Term Incentive design
and mix of awards.
Interpretation
The appendices below form part of your Award Notification. The singular includes the plural and defined terms have the meaning given in the Plan, unless otherwise specified. For the purposes of the
Prohibited Activities Appendix, references to your employer include your former employer, and for the purposes of the Data Privacy Appendix, references to your employer include your current local
employing entity or former local employing entity and the Company (where applicable). References to the Committee mean The Talent and Compensation Committee of the Board of Directors of the
Company, unless otherwise specified.

-- 122 of 156 --

Employment Events Appendix – Performance Share
The table below sets out the impact to your Award (if any) upon certain employment events. The terms of the table below apply to vested and unvested portions
of an Award equally, unless otherwise stated. Except as otherwise specified herein, all other terms and conditions of your Award continue to apply.
Event 	Impact to your Award
Disability 	If your employment with the Company or a Subsidiary terminates because of Disability, your Award immediately vests.
Otherwise, if you remain employed, there is no impact to your Award.
Death 	Any Award that has not been accepted terminates immediately upon your death and may not be transferred to your heirs.
If you die while employed with the Company or a Subsidiary, your Award immediately vests, however, it expires on the earlier
of (1) one year from your date of death, or (2) the expiration date in the Award Notification.
If you die after your termination of employment (but before your Award has expired), your Award expires on the earlier of (1)
one year from your date of death, or (2) the expiration date that applied to your Award at your date of death.
Leave of absences 	If you are on (1) US military leave, (2) a Company-paid leave of absence (meaning paid under Company payroll), or (3) an
unpaid leave of absence (approved pursuant to a published Company policy available to all employees covered under the
policy) of 12 months or less, there is no impact to your Award.
For all other leaves of absence not specified in the paragraph above, including all approved unpaid leaves that extend
beyond 12 months, your Award will be treated in accordance with the general termination provision at (C) below , except
that if the Committee identifies a valid business interest in doing otherwise, it may specify what provisions it deems
appropriate at its sole discretion (provided that the Committee shall have no obligation to consider any such matters).
Transfer 	If you transfer (1) between the Company and any Subsidiary or, (2) at the Committee’s discretion, to an Affiliate that is not a
Subsidiary, there is no impact to your Award.
If an approved unpaid leave of absence extends beyond 12 months, the terms of the general termination provision (C) will apply at the end of the 12 month.
1
1
1 	th

-- 123 of 156 --

Event 	Impact to your Award
Termination 	A. If your employment with the Company or a Subsidiary terminates after attaining age 60:
• 	Awards held less than 12 months are immediately forfeited, and
• 	Awards held at least 12 months immediately vest.
B. If your employment with the Company or a Subsidiary terminates involuntarily for any reason other than for cause within one
year after a Change in Control, your Award will be treated as described in the Plan.
C. If your employment with the Company or a Subsidiary terminates prior to attaining age 60 because of (1) an involuntarily
termination due to a reduction in workforce, internal reorganization, or job elimination and you sign a release of all claims
and, if requested, an agreement on confidentiality and competition, or (2) you participate in a Company or Subsidiary-
sponsored voluntary separation program:
• 	any unvested portion of the Award is immediately forfeited, and
• 	any vested portion of the Award will be forfeited upon the earlier of (1) 12 months from your termination date, or (2) the
expiration date in the Award Notification.
D. If your employment (1) with the Company or a Subsidiary terminates for any other reason, or (2) with an Affiliate (that is not
a Subsidiary) terminates for any reason :
• 	any unvested portion of the Award is immediately forfeited, and
• 	any vested portion of the Award will be forfeited upon the earlier of (1) six months from your termination date, or (2) the
expiration date in the Award Notification.
Notwithstanding anything herein, if your employment with an Affiliate terminates and you immediately become employed by
the Company or a Subsidiary, there is no impact on your Award.
For the purposes of your Award, you are deemed to have terminated employment on the date you are no longer actively providing services to the relevant entity
or entities, regardless of the reasons for termination and whether or not later found to be invalid or in breach of your employment agreement, if any, or
employment laws in the jurisdiction where you are employed. The Committee has exclusive discretion to decide when you are considered to be no longer
actively providing services for the purposes of your Award. However, you will not be considered to be actively providing services during any contractual notice
period or any period of “garden leave” or similar period mandated under employment laws in the jurisdiction where you are employed or in your employment
agreement, if any, unless the Committee decides otherwise.
This also would apply in the case where the Committee determined that your transfer to the Affiliate would not impact your Award. If your employer no longer meets the definition of “Affiliate”, you are
deemed to have terminated employment for the purposes of the Plan.
2
2
2

-- 124 of 156 --

Prohibited Activities Appendix
1. 	Engaging in Prohibited Activity
1.1 Timing
Section 1.2 (Implications) applies if you engage in a Prohibited Activity (as defined in section 5 (Types of Prohibited Activity) below) at any time during
the term of your Award or within one year after the later of:
1.1.1 the termination of your employment with the Company, your employer or any Affiliate; and
1.1.2 the last date of vesting or exercise of all or any portion of your Award.
1.2 Implications
If this section 1.2 applies:
1.2.1 your Award will immediately terminate, be forfeited and (if relevant) cease to be exercisable; and
1.2.2 within 10 days after receiving written notice from the Company that this section applies, you must pay in cash to the Company:
(i) any and all gains associated with any previous vesting or exercise of all or any portion of your Award; and
(ii) interest calculated from the time of the notice until the date of repayment to the Company.
2. 	Implications for settled Awards
2.1 Calculation of gain
For the purposes of section 1.2.2, each gain associated with the vesting or exercise of all or any portion of your Award will be calculated as:
2.1.1 where your Award is in the form of an Option, the closing price per share of Stock on the date of exercise as reported on the New York Stock
Exchange Composite Transactions listing minus the exercise price per share of Stock, multiplied by the number of shares of Stock over which
the Award was exercised;
2.1.2 where your Award is in the form of Restricted Stock Units or Performance Share Units, the closing price per share of Stock on the date of
vesting as reported on the New York Stock Exchange Composite Transactions listing, multiplied by the number of shares of Stock that vested;
and
2.1.3 where your Award is in the form of Performance Cash, the gross amount of the cash payment that vested.

-- 125 of 156 --

3. 	Alternative payment
3.1 Return of Stock
If all or any part of this Prohibited Activities Appendix is held to be invalid, illegal or unenforceable for any reason by any court with jurisdiction:
3.1.1 you will transfer to the Company all of the shares of Stock that you acquired on vesting or exercise of your Award that you still hold (and if your
Award is an Option, the Company will pay to you the exercise price you paid for that Stock in exchange); and
3.1.2 where you have already sold, transferred or disposed of any shares of Stock you acquired on vesting or exercise of your Award, you must pay
to the Company:
(i) any and all gains associated with each sale, transfer or disposal; and
(ii) interest calculated from the date of each sale, transfer or disposal until the date of repayment to the Company.
3.2 Calculation of gain
For the purposes of section 3.1.2, the gain associated with the sale, transfer or disposal will in each case be calculated as the closing price per share of
Stock on the date of the sale, transfer or disposal as reported on the New York Stock Exchange Composite Transactions listing (minus, where your
Award is an Option, the exercise price per share of Stock), multiplied by the number of shares of Stock sold, transferred or disposed of.
4. Interest
Any interest payable under this Prohibited Activities Appendix will be calculated using the weighted prime rate at SunTrust Bank, Atlanta.
5. Types of Prohibited Activity
The term Prohibited Activity includes any and all of the following:
5.2 Disparagement
Making any statement, written or verbal, in any forum or media, or taking any action in disparagement of the Company, your employer and/or any
Affiliate, including but not limited to negative references to the Company or its products, services, corporate policies, or current or former officers or
employees, customers, suppliers, or business partners or associates.
5.2 Publicity
Publishing any opinion, fact, or material, delivering any lecture or address, participating in the making of any film, radio broadcast or television
transmission, or communicating with any representative of the media relating to confidential matters regarding the business or affairs of the Company,
your employer and/or any Affiliate which you were involved with during your employment.

-- 126 of 156 --

5.3 Disclosure of a Trade Secret
Failure to hold in confidence any and all Trade Secrets of the Company that came into your knowledge during your employment with the Company,
your employer and/or any Affiliate, or disclosing, publishing, or making use of, at any time, such Trade Secrets.
For these purposes, Trade Secret means any technical or non-technical data, formula, pattern, compilation, program, device, method, technique,
drawing, process, financial data, financial plan, product plan, list of actual or potential customers or suppliers or other information similar to any of the
foregoing, which:
5.3.1 derives economic value, actual or potential, from not being generally known to and not being readily ascertainable by proper means by other
persons who can derive economic value from its disclosure or use; and
5.3.2 is the subject of efforts that are reasonable under the circumstances to maintain its secrecy.
5.4 Disclosure of Confidential Information
Failure to hold in confidence all Confidential Information of the Company, your employer and/or any Affiliate that came into your knowledge during your
employment with the Company, your employer or any Affiliate, or disclosing, publishing, or making use of such Confidential Information.
For these purposes, Confidential Information means any data or information, other than Trade Secrets (as defined in section 5.3 (Disclosure of a
Trade Secret)), that is valuable to the Company and not generally known to the public or to competitors of the Company.
5.5 Failing to return materials
Your failure, in the event of your termination of employment for any reason, promptly to deliver to the Company all memoranda, notes, records, manuals
or other documents, including all copies of such materials and all documentation prepared or produced in connection therewith, containing Trade
Secrets (as defined in section 5.3 (Disclosure of a Trade Secret)) or Confidential Information (as defined in section 5.4 (Disclosure of Confidential
Information)) regarding the Company’s business, whether made or compiled by you or furnished to you by virtue of your employment with the
Company, your employer or any Affiliate, or failure promptly to deliver to the Company all vehicles, computers, credit cards, telephones, handheld
electronic devices, office equipment, and other property furnished to you by virtue of your employment with the Company, your employer or any Affiliate.
5.6 Competing
Rendering services for any organization which, or engaging directly or indirectly in any business which, in the sole judgment of the Committee or the
Chief Executive Officer of the Company or any senior officer designated by the Committee, is or becomes competitive with the Company.
Notwithstanding the preceding sentence, this Section 5.6 will not be applicable for any employee living or working in California.

-- 127 of 156 --

5.7 Solicitation
Soliciting or attempting to solicit for employment, for or on behalf of any corporation, partnership, or other business entity, any employee of the
Company, your employer or an Affiliate with whom you had professional interaction during the last twelve months of your employment with the
Company, your employer or the Affiliate.
5.8 Violation of Company policies
Violating any written policies of the Company or your employer applicable to you, including, without limitation, The Coca-Cola Company Global Insider
Trading Compliance Policy.
6. Release
You may be released from the effects of this Prohibited Activities Appendix if the Committee determines in its sole discretion that such action is in the
best interest of the Company and its stockholders.
7. Other rights apply
Nothing in this Prohibited Activities Appendix is intended to or will be interpreted as diminishing or otherwise limiting the Company’s right under
applicable state or local law or any prior agreement you have signed or made with the Company regarding trade secrets, confidential information, or
intellectual property.

-- 128 of 156 --

Data Privacy Appendix
1. 	General
1.1 Introduction
This Data Privacy Appendix sets out certain data privacy provisions that apply to you in connection with your Award.
1.2 Meaning of Data
For the purposes of this Data Privacy Appendix, Data means personal information that directly or indirectly identifies you, including: your name, home
address and telephone number, your date of birth, your government identification number, your salary information, nationality, job title and employment
location, any shares or directorships you hold or held in the Company or any Affiliate, details of your Award and any equity or cash awards or any other
entitlements to stock or cash granted (regardless of whether or not exercised, vested or settled, and including any cancelled or forfeited awards), any
information necessary to process your Award or any other award (e.g. your mailing address for a check payment or bank account wire transfer
information), any other information necessary to process mandatory tax withholding and reporting and/or, where applicable, your employment or service
termination date and the reason for the termination.
2. For Award recipients not located in the EEA or UK
This section applies if you reside anywhere in the world except the European Economic Area (EEA) or the United Kingdom (UK). By accepting your
Award, you confirm the following:
2.1 Consent
You voluntarily consent to the collection, use and transfer, in electronic or other form, of your Data by and between the Company, your employer or any
Affiliate for the purpose of implementing, administering, and managing your participation in the Plan.
2.2 Data collected
You understand that the Company and its Affiliates may hold Data for the exclusive purpose of implementing, administering, and managing the Plan.
2.3 Purposes of collection
You understand that Data will be transferred to one or more stock or incentive plan service providers selected by the Company, which may assist the
Company with the implementation, administration, and/or management of the Plan.
2.4 Recipients of Data
You understand that the recipients of Data may be located in the United States or elsewhere. The Company also uses third party service providers who
may assist with the implementation, administration or management of the Plan. These service providers are bound by contract to handle Data in a way
that aligns with this Data Privacy Appendix and applicable law. If you have

-- 129 of 156 --

any questions about the local entities or services providers who may access or handle your Data, please contact your local human resources
representative.
By consenting at section 2.1 (Consent) above, you authorize the Company and any other possible recipients that do or may assist the Company with
implementing, administering or managing the Plan to receive, possess, use, retain and transfer the Data, in electronic or other form, for the sole
purpose of implementing, administering and/or managing your participation in the Plan.
2.5 Data retention
You understand that Data will be held only as long as is necessary to implement, administer and manage your participation in the Plan. In some cases,
your information will be retained for the Company or your employer to comply with a legal or tax obligation.
2.6 Your rights
You understand that if you reside in certain jurisdictions, to the extent required by applicable laws, you may, at any time and without cost:
2.6.1 request access to Data;
2.6.2 request additional information about the storage and processing of Data;
2.6.3 require any necessary amendments to Data; or
2.6.4 refuse or withdraw the consents you give by accepting the Award,
by contacting your local human resources representative in writing.
2.7 Implications of not consenting or withdrawing consent
You understand that you provide these consents on a purely voluntary basis. If you do not consent, or if you later withdraw your consent, your
employment or service contract with the Company or an Affiliate will not be adversely affected. Refusing or withdrawing your consent will mean that the
Company will not be able to grant new awards or administer or maintain any existing awards (including this Award) under the Plan. You understand that
refusing or withdrawing your consent may affect your ability to participate in the Plan (including the right to retain an award, such as this Award). You
understand that you may contact a local human resources representative for more information on the consequences of refusal to consent or withdrawal
of consent.
3. For Award recipients located in the EEA and/or UK
This section applies if you reside inside the United Kingdom (UK) and/or the European Economic Area (EEA). By accepting your Award, you confirm
the following:
3.1 Data collected
You understand that the your employer (acting as controller) and the Company may collect, to the extent permissible under applicable law, Data for the
exclusive purpose of implementing, administering, and managing the Plan. The Data is collected from you, the employer, and the

-- 130 of 156 --

Company for the exclusive purpose of implementing, administering, and managing the Plan in accordance with the terms of your Award.
3.2 Purposes of collection/processing
You acknowledge the legal basis for Data processing is performance of the contract comprising your Award. The Data must be provided in order for you
to participate in the Plan and for the parties to your Award to perform their respective obligations as set out in your Award documents. If you do not
provide Data, you will not be able to participate in the Plan or continue to hold your Award.
3.3 Transfers and retention of Data
You understand that your employer will transfer Data to the Company for Plan administration purposes. The Company and your employer may also
transfer your Data to other service providers (such as accounting firms, payroll processing firms or tax firms), as may be selected by the Company now
or in the future, to assist the Company and your employer with the implementation, administration and/or management of your Award. You understand
that recipients of the Data may be located in a country that does not benefit from an adequacy decision issued by the European Commission. When
your information is transferred outside the EEA or the UK (as applicable), it is done in accordance with data protection laws and regulations requiring
adequate transfer mechanisms. For further information as to the transfer of your Data, please contact privacy@coca-cola.com. Your Data will be held
only as long as is necessary to implement, administer and manage your rights and obligations under the terms of your Award documents, as well as in
compliance with other laws requiring a longer retention period.
3.4 Accuracy
You understand the Company and your employer will take steps in accordance with applicable legislation to keep Data accurate, complete and up to
date.
3.5 Your rights
You understand you are entitled to:
3.5.1 have any inadequate, incomplete or incorrect Data corrected;
3.5.2 request access to your Data and additional information about the processing of that Data;
3.5.3 object to the processing of Data or have your Data erased, under certain circumstances; and
3.5.4 subject to applicable law:
(i) restrict the processing of your Data so that it is stored but not actively processed (e.g. while the Company assesses whether you are
entitled to have Data erased); and
(ii) receive a copy of the Data provided in connection with your Award or generated by you, in a common machine-readable format,
and you may exercise these rights by contacting a local human resources representative.

-- 131 of 156 --

3.6 Other contacts
You understand you have the right to contact, and may lodge a complaint with, the relevant data protection supervisory authority.
You may also contact the EU Data Protection Officer:
Coca-Cola Italia s.r.l.
Viale Edison 110
Building B
20099 Sesto San Giovanni (Milan)
Italy
DPO-Europe@coca-cola.com
4. Country specific provisions
The provisions below supplement section 2 (For Award recipients not located in the EEA or UK) of this Data Privacy Appendix. By accepting your
Award, you confirm the following:
4.1 If you are subject to the laws of Canada
You authorize the Company, your employer, and your employer’s representatives to discuss with and obtain all relevant information from all personnel
(professional or not) involved in the administration and operation of the Plan. You authorize your employer, the Company, any Affiliates and any stock or
incentive plan service provider that may be selected by the Company to assist with the Plan to disclose and discuss the Plan with their respective
advisors. You further authorize your employer, the Company and any Affiliates to record this information and to keep it in your employee file.
4.2 If you are subject to the laws of Russia
You acknowledge that you have read, understood and agree to the terms regarding the collection, processing and transfer of data described in section
2 (For Award recipients not located in the EEA or UK) of this Data Privacy Appendix. Upon request of the Company or your employer, you agree to
provide an executed data privacy consent form or any similar agreements or consents that the Company or your employer may deem necessary to
obtain under the data privacy laws in Russia, either now or in the future. You understand that you will not be able to participate in the Plan if you fail to
execute any such consent or agreement that may be requested.

-- 132 of 156 --

Awards made under
The Coca-Cola Company 2024 Equity Plan
Additional Terms
By accepting your Award you:
1. 	Plan Documents
Agree that you have been given all relevant information and materials regarding the terms and conditions of your Award, which are set out in the rules
of The Coca-Cola Company 2024 Equity Plan, as amended from time to time (the Plan), your Award Notification (including any appendices attached to
it) and these Additional Terms (including the Global Appendix set out below) (collectively, the Plan Documents).
2. 	Employment
2.1 Acknowledge that the grant of your Award does not form part of and does not affect or change your employment contract or your employment relationship
with your employer (which is entirely separate from the Plan). The grant of your Award and your participation in the Plan does not create a right to
employment or continued service and will not be interpreted as forming an employment or service contract with The Coca-Cola Company (the
Company), your employer or any Affiliate (as defined in the Plan). The Award does not impact the ability of the Company, your employer or any
Affiliate to terminate that employment or service relationship. All benefits granted by your Award will constitute an occasional extraordinary payment and
may not, in any way or for any purpose, be considered part of your normal remuneration or constitute consideration for any services you provide to the
Company, your employer or any Affiliate, including when calculating any other benefits.
2.2 	Acknowledge that the Company’s decision to grant your Award is voluntary and discretionary, and that you have no right to participate in the Plan.
Acceptance of your Award and participation in the Plan does not create any right to, or expectation of, future employment or service, future participation
in the Plan or the grant of future awards (on the same basis, or at all). The Company may at any time decide to cease offering awards under the Plan,
or amend, modify, suspend, cancel or terminate the Plan and any benefits under it.
2.3 	Acknowledge that you are not entitled to the exercise of any discretion under the Plan in your favor, that decisions with respect to your Award and any
future awards are at the sole discretion of the Company and are final, binding and conclusive, and that you do not have any claim or right of action in
respect of any decision, omission, or discretion, which may in each case operate to your disadvantage.
2.4 Agree, in consideration for and as a condition of your Award, to waive all rights which might arise in connection with the Plan, including:
2.4.1 the right to institute any claim against the Company, your employer or any Affiliate; and
2.4.2 the right to pursue any claim that is allowed by a court,
other than the right to acquire, as relevant, $0.25 par value shares of common stock of the Company (Stock) or cash (subject to and in accordance
with the Plan).

-- 133 of 156 --

2.5 Acknowledge that you do not have any right to compensation or damages for any loss (actual or potential) in relation to the Plan or your Award, including
where it is forfeited on termination of employment or cessation of services for any reason, whether or not lawful or in breach of employment laws or the
terms of your employment or service agreement, if any.
3. 	No transfer
Accept that you must not pledge, encumber, assign, transfer, charge or otherwise dispose of your Award or any rights in respect of it, whether
voluntarily or involuntarily (other than to your personal representatives on death).
4. 	Modifications and additional requirements
4.1 Agree that the Company may modify any of the terms of your Award to be consistent with any applicable law or applicable government agency regulation
where, in the opinion of the Company, that term might otherwise conflict or be inconsistent.
4.2 Agree that the Company may impose additional conditions, requirements and restrictions on your Award, your participation in the Plan and any Stock or
cash you acquire on vesting or exercise of your Award, and that you will comply with them, including signing any additional agreements or
undertakings.
4.3 	Agree to any amendment made to the Plan or any term of your Award (including an amendment with retroactive effect) where the amendment is
necessary or advisable to ensure the Plan or your Award complies with any future law relating to plans of this nature or their administration (including
Section 409A of the U.S. Internal Revenue Code of 1986, as amended).
4.4 	Agree to any amendment made to any of the terms of your Award (including rescinding your Award entirely) to correct any error that occurred in
connection with the grant or documentation of your Award.
4.5 	Acknowledge that your Award may be adjusted to reflect a change in capital structure, in accordance with the terms of the Plan, and agree that, where
your Award is over Stock and an adjustment results in a fractional share, the fractional share may be disregarded at the Company’s discretion.
5. 	Tax
5.1 Acknowledge that participating in the Plan will probably have tax consequences for you and that all payments made with respect to your Award (including
payments in Stock or cash) may be subject to tax, social security and any similar charges in any country where you are employed, reside, or are
otherwise subject to tax (Tax).
5.2 	Agree that you (or your personal representative) are ultimately responsible for and will bear any liability for any Tax in respect of your Award and your
participation in the Plan, and understand that this liability may exceed any amounts withheld and paid on your behalf.
5.3 	Acknowledge that the Company, your employer, an Affiliate, any trustee of any employee benefit trust and any third party service provider (each, a
Withholding Person) is entitled to do any, all or a combination of the following methods (where relevant) to enable a Withholding Person to raise an
amount it considers necessary or desirable to recover the Liabilities:

-- 134 of 156 --

5.3.1 sell or procure the sale on your behalf of a sufficient number of the Stock you acquire on vesting or exercise of your Award;
5.3.2 reduce the number of Stock you acquire on vesting or exercise of your Award accordingly and settle the balance in cash; and
5.3.3 withhold amounts from:
(i) proceeds of sale under section 5.3.1;
(ii) the balance settled in cash under section 5.3.2; and
(iii) any other cash payments of any kind owed to you.
For these purposes, Liabilities means any obligation on the Withholding Person to pay or account for Tax, any unpaid exercise price, any associated
costs (including under section 7 (Costs)) and any amount you owe to the Company, your employer or any Affiliate due to any obligation of any nature
whatsoever (including under a loan, the Company’s tax equalization program or any travel or expenses policy) to the extent that the Company, the
employer or any Affiliate in its reasonable judgement determines you owe them that amount.
5.4 Agree that, for tax purposes, and where allowed by applicable law, you are deemed to have received the full number of Stock where the number of Stock
you acquire is reduced under section 5.3.2.
5.5 Agree that, where permitted by the Company, you may elect to satisfy Tax and/or pay any exercise price by delivering (including by attestation) Stock to
the Company.
5.6 Agree that if a Withholding Person’s obligation to pay or account for Tax cannot or has not been fully satisfied by the above methods, you must pay to the
Withholding Person an amount sufficient to enable them to discharge that obligation.
5.7 Agree to enter any tax elections for particular tax and/or social security treatment, execute any documents, give any directions and take any action as may
be requested by the Company, your employer or any Affiliate in relation to any Liabilities.
5.8 	Acknowledge that the Company, your employer and any Affiliate do not guarantee or warrant any particular Tax treatment in relation to your Award, the
cash or Stock you acquire in connection with your Award (including any dividends on Stock), or your participation in the Plan and that they are not
under any obligation to structure the Award in a Tax favorable way or avoid adverse Tax treatment in any jurisdiction.
5.9 	Acknowledge that neither the Company, your employer nor any Affiliate will be liable for any Tax, interest, penalties or other amounts owed by any
taxpayer as a consequence of the Plan or an Award and that any Tax information provided is for guidance purposes only.
5.10 Accept that the cash or Stock subject to your Award may only vest or be exercised (as applicable) if satisfactory arrangements are in place to enable all
Withholding Persons to obtain the funds needed to satisfy any Liabilities.
5.11 	Acknowledge that the vested (and, if applicable, exercised) Stock or cash subject to your Award may not be delivered or paid to you unless you have
complied with your obligation to pay the Liabilities.

-- 135 of 156 --

6. 	Internationally mobile employees
6.1 Acknowledge that if you are a mobile employee, meaning that you are based in different jurisdictions during the course of your employment or service that
you are or may be subject to Tax in more than one country, you are strongly encouraged to inform the Company and your employer, and to speak with
your personal tax adviser regarding the tax treatment of your participation in the Plan.
6.2 Accept that, if you are a mobile employee, the Company or your employer may be required to withhold for Tax in more than one jurisdiction.
6.3 	Accept that if you are a “Global Mobility Associate” as defined in the Company’s Global Mobility Policy (or the equivalent under any applicable
international service policy from time to time), you remain responsible for all Tax except where expressly stated otherwise in that policy and/or the
Company’s tax equalization program. A copy of the Company’s Global Mobility Policy is available on the Company’s intranet.
7. 	Costs
Agree that you are responsible for the payment of any fees, dealing, commission or currency conversion costs or any other costs associated with your
Award, including costs associated with the payment of any cash and the sale of any Stock.
8. 	Notices
8.1 Agree that any notice or other communication required in relation to your Award will be given in writing, which may include electronic means.
8.2 Agree that any notice or other communication to be given to you in connection with your Award may be delivered by electronic means (including by email,
or through the Company or your employer’s intranet or a share plan portal), personally delivered, or sent by ordinary post to the principal address on file
for you from time to time with the Company, your employer, an Affiliate or the Company’s agents.
8.3 	Agree that any notice or other communication to be given to the Company or its agents in connection with your Award may be delivered or sent to its
registered office or to such other place and by such means as communicated to you by or on behalf of the Company from time to time.
8.4 Accept that notices or other communications:
8.4.1 	sent electronically will be deemed to have been received immediately (if sent during usual business hours) or at the opening of
business on the next business day (if sent outside usual business hours);
8.4.2 	that are personally delivered will be deemed to have been received when left at the relevant address (if left during usual business
hours) or at the opening of business on the next business day (if left outside usual business hours); and
8.4.3 	sent by post will be deemed to have been received 24 hours after posting to a U.S. address or 3 days after posting to an address
outside the U.S.,
unless there is evidence to the contrary.

-- 136 of 156 --

8.5 Agree that all notices or communications to be given to you are given and sent at your risk and that neither the Company, your employer nor any Affiliate
has any liability in respect of any notice or communication given or sent, nor need they be concerned to see that you actually receive it.
9. 	Insider trading and market abuse
9.1 	Acknowledge that rules on insider trading, dealing notification requirements, and market abuse laws may apply in relation to any actions or decisions
taken relating to your Award, including in relation to the acceptance, vesting, exercise or settlement of your Award, the delivery or payment of any Stock
or cash, and the sale of any Stock. These rules, requirements and laws:
9.1.1 	are separate from and in addition to the requirements that apply to you under The Coca-Cola Company Global Insider Trading Compliance
Policy; and
9.1.2 may prohibit or delay your actions or decisions.
9.2 Agree that it is your responsibility to comply with the rules, requirements and laws referred to in section 9.1. You should consult with your personal legal
adviser on these matters.
10. 	Currency risk
10.1 Acknowledge that if any Stock relating to your Award is traded in a currency that is not the currency in your jurisdiction, the value of the Stock may also
be affected by movements in the exchange rate.
10.2 Agree that neither the Company, your employer nor any Affiliate is liable for any loss due to movements in the exchange rate nor any charges imposed in
relation to the conversion or transfer of money.
11. 	No advice
11.1 	Confirm you are accepting your Award and participating in the Plan voluntarily and understand that the Company is not making any recommendations
regarding your Award or any Stock or cash relating to your Award.
11.2 Agree that neither the Company, your employer, any Affiliate nor any person or entity acting on their behalf has provided you with any legal, investment,
tax (including reporting) or financial advice with respect to your participation in the Plan, your Award or any Stock or cash acquired upon vesting or
exercise of your Award. You should consult with your own suitably qualified advisers before taking any action under the Plan.
11.3 	Acknowledge that the information and materials provided do not take into account your objectives, financial situation or needs and that if you do not
understand the contents of the Plan Documents, or you are in any doubt, you should consult an independent authorized financial adviser.
11.4 Agree you will have no remedies for any statement, representation, assurance or warranty that is not set out in your Plan Documents.
12. 	No guarantee
12.1 Acknowledge that neither the Company, your employer nor any Affiliate guarantees a specified level of return in respect of your Award or any Stock.

-- 137 of 156 --

12.2 Acknowledge that there is a risk that any Stock relating to your Award may fall as well as rise in value, that the future value of Stock cannot be predicted
with certainty and that market forces will impact the price of any Stock relating to your Award and, in the worst case, the market value of the Stock may
become zero. More information in relation to the Company, including its share price, can be found at https://www.coca-colacompany.com/.
13. No public offer
13.1 Acknowledge that your Award is being offered to you in your capacity as an employee of the Company’s group and that the offer is not intended for the
general public and may not be used for any public offer.
13.2 Acknowledge that the Company is not required to deliver any Stock or cash on settlement of your Award before it completes, on terms to its satisfaction,
any registration, listing, exemption or qualification or other legal requirements or obtains any clearance or approval that the Company considers is
necessary or desirable, and you agree to provide any information, make any agreements and give any representations that the Company requests as
part of this process.
13.3 	Agree that the Company may (whether under Section 17.7(b) of the Plan or otherwise) refuse to deliver any Stock or cash where the Company
considers the delivery of Stock or cash may conflict or be inconsistent with applicable law or applicable government agency regulation.
13.4 	Acknowledge that neither the Company, your employer nor any Affiliate is under any obligation to register, exempt or qualify, or seek clearance or
approval for, your Award or any Stock or cash that you may acquire in connection with your Award.
13.5 Acknowledge that your Award may not have been authorized or approved by any applicable securities authorities and may have been offered pursuant
to an exemption from registration in your local jurisdiction.
13.6 Acknowledge that the regulatory bodies in your jurisdiction accept no responsibility for the accuracy and completeness of the statements and information
contained in the Plan Documents and take no liability whatsoever for any loss arising from reliance upon the whole or any part of the contents of those
documents.
13.7 	Acknowledge that a prospectus or similar offering or registration document may not have been prepared, authorized or approved by any applicable
authority in any jurisdiction outside the United States.
14. Exchange controls and any reporting requirements
14.1 	Accept that exchange control regulations and/or foreign asset reporting requirements may apply to you in respect of your Award and/or any Stock or
cash acquired in connection with your Award, and that you are solely responsible for complying with those regulations and requirements.
14.2 Agree that neither the Company, your employer nor any Affiliate are responsible for obtaining exchange control approval or making any reports on your
behalf, nor for monitoring compliance with those regulations and requirements and that if you fail to obtain any required exchange control approval or
make the necessary reports, neither the Company, your employer nor any Affiliate will be liable in any way for any resulting fines or penalties. You
should seek independent professional advice if you are unsure about the obligations that apply to you as a result of your participation in the Plan.

-- 138 of 156 --

14.3 Accept that you are solely responsible for complying with any filing, notification or reporting requirements in respect of:
14.3.1 your participation in the Plan and/or
14.3.2 benefits received under the Plan,
as required by the local law in any jurisdiction. The Company accepts no responsibility for your failure or delay in complying with such requirements. If
you are in any doubt as to what actions you should take, you should consult a duly authorized independent adviser.
15. General
15.1 Consent to the use of electronic communications in connection with the Plan.
15.2 Confirm that references to “employer” throughout these Additional Terms include your former employer, where applicable.
15.3 	Agree that all determinations and decisions on questions of interpretation in respect of your Award and the Plan Documents will be made by the
Company (or any committee on its behalf) in its sole and absolute discretion. Those determinations and decisions will be final, binding and conclusive.
Any references to determinations or decisions made, or actions taken, by the “Company” as referred to in these Additional Terms include any
committee acting on its behalf.
15.4 Agree that if any provision of your Plan Documents is held to be invalid, illegal or unenforceable for any reason by any court in any jurisdiction then, for
the purposes of that jurisdiction only:
15.4.1 such provision will be deleted; and
15.4.1 the remaining provisions will continue in full force and effect.
15.5 Agree that if the Company waives a breach of one or more provisions in the Plan Documents, this does not constitute a waiver of any other provision of
the Plan Documents, or a waiver of any subsequent breach of the Plan Documents (by you or anyone else).
15.6 Accept that:
15.6.1 	the federal laws of the United States of America and the state laws of the State of Delaware, United States of America, govern your Plan
Documents and your Award without regard to the conflict of law provisions; and
15.6.2 	the courts of the United States District Court for the District of Delaware or the Delaware Superior Court, New Castle County have exclusive
jurisdiction in respect of disputes arising under or in connection with the Plan or your Award,
and you waive any current or future objection you may have to this choice of law and jurisdiction.
16. English language (this applies if you have received an English language version only of any Plan Document)
16.1 Accept that you fully understand the contents of the English language version of the Plan Documents.

-- 139 of 156 --

16.2 Acknowledge that you do not need a translation of the Plan Documents and that you are fluent and regularly conduct business in the English language
as part of your duties and responsibilities to your employer.
17. Translations (this applies if you have received a Plan Document in a language other than English)
17.1 	Agree that if there is any conflict between the terms of the English language version of the Plan Documents and a version in any other language, the
English language version will prevail.
18. Options (this applies if your Award Notification specifies that your Award is an Option)
18.1 Understand that, in order to exercise your Award, you will need to pay the exercise price.
18.2 Acknowledge that you will be informed of the acceptable forms and methods of paying the exercise price when you come to exercise your Award.
19. Restricted resale (this applies if your Award is over Stock)
Acknowledge that any Stock you may acquire upon settlement of your Award may be subject to restrictions on transfer and resale in your local
jurisdiction and you agree that you will comply with those restrictions, including that you will not offer, sell, advertise or otherwise market the Stock (or
cause any of these to occur) in circumstances which constitute any type of public offering of securities, unless an exemption applies.
20. Performance conditions (this applies if your Award Notification specifies that your Award is subject to performance conditions)
20.1 	Accept that the vesting of your Award is conditional on the satisfaction of one or more performance conditions as set out in the Performance Criteria
Appendix to your Award Notification (the Performance Criteria) and, to the extent the Performance Criteria are not satisfied, your Award may be
forfeited.
20.2 Accept that the Performance Criteria may be altered in the circumstances specified in Section 10.2 of the Plan.
21. Malus and clawback (this applies if your Award Notification specifies that your Award is subject to “Malus and clawback”)
21.1 Agree that any benefits you may receive with respect to your Award will be subject to reduction, cancellation, repayment, forfeiture or recoupment if there
is a determination that the vesting of, or amount realized from, your Award was based on:
21.1.1 materially inaccurate financial statements; or
21.1.2 any other materially inaccurate performance metric criteria,
and you acknowledge that this applies regardless of whether you caused or contributed to the material inaccuracy.
21.2 	Agree that the Company may also seek to recover your Award where required by the provisions of the Dodd-Frank Wall Street Reform and Consumer
Protection Act or any other “clawback”

-- 140 of 156 --

provision required by applicable law, regulation or listing standards, including the listing standards of the New York Stock Exchange, and you authorize
such recovery.
22. Stock ownership guidelines (this only applies if you are subject to the Company’s stock ownership guidelines)
22.1 Accept that if you have not met the Company’s stock ownership guidelines before the applicable compliance deadline but you are a “Section 16 officer”
under the U.S. Securities Exchange Act of 1934, you are prohibited from selling 50% of any Stock you obtain upon vesting or exercise of your Award
until you meet the relevant guidelines, except for any Stock that is sold or cash settled to cover Tax and any exercise price.
22.2 Accept that if you have not met the guidelines by the applicable compliance deadline, you are prohibited at all times after that compliance deadline from
selling any Stock you obtain on vesting or exercise of your Award, except for any Stock that is sold or cash settled to cover Tax, commissions and fees
and any exercise price. Once you meet the guidelines, you can sell Stock in excess of the guidelines.

-- 141 of 156 --

Global Appendix – Equity Awards
1. 	If you are subject to the laws of the European Union
This offer is being made to selected employees as part of an employee incentive program in order to provide an additional incentive and to encourage
employee share ownership and to increase your interest in the success of the Company. The company offering these rights is The Coca-Cola Company.
The Stock which is the subject of these rights is new or existing par value common stock in the Company. More information in relation to the Company
including the stock price can be found at the following web address: https://investors.coca-colacompany.com/.
The obligation to publish a prospectus does not apply because of Article 1(4)(i) of the EU Prospectus Regulation. The total maximum number of Stock
which is the subject of this offer is 240,000,000.
2. 	If you are subject to the laws of Argentina
Neither the Award nor the underlying Stock are publicly offered or listed on any stock exchange in Argentina.
This provision applies if your Award Notification specifies that your Award is an Option:
Depending upon the method of exercise chosen for the Option, you may be subject to restrictions with respect to the purchase and/or remittance of
U.S. dollars pursuant to Argentine currency exchange regulations. The Company reserves the right to restrict the methods of exercise if required or
advisable to comply with Argentine laws.
3. 	If you are subject to the laws of Australia
The grant of Awards under the Plan is intended to comply with the provisions of the Corporations Act 2001, ASIC Regulatory Guide 49 and ASIC Class
Order CO 14/1000. Additional details are set forth in the Australia Offer Document, which is available on the Morgan Stanley at Work® website.
The offer is intended to receive tax deferred treatment under Subdivision 83A-C of the Income Tax Assessment Act 1997(Cth). The conditions to receive
such treatment are contained in the Award Agreement.
4. 	If you are subject to the laws of Belgium
If your Award Notification specifies that your Award is an Option, you confirm you have read and understood the information regarding the Belgian
taxation of Options which has been separately made available to you by email and/or on the Morgan Stanley at Work® website. You should review this
information thoroughly before accepting your Option grant.
__________________________
If your are subject to the laws of any of the following countries, there are no country-specific provisions for your country in this appendix: Bangladesh, Costa Rica, Dominican Republic, Ecuador,
Egypt, Japan, Kenya, Korea, Malaysia, Nigeria, Puerto Rico, Serbia, Sri Lanka, Swaziland, Taiwan, Thailand and Ukraine.
3
3.

-- 142 of 156 --

5. 	If you are subject to the laws of Brazil
By accepting the Award, you agree that you are (i) making an investment decision, and (ii) the value of the underlying Stock is not fixed and may increase
or decrease in value over the vesting or exercise period without compensation to you.
6. 	If you are subject to the laws of Canada
For purposes of your Award, your employment will be considered terminated and your right (if any) to vest in any Award or exercise any Option after such
termination (regardless of the reason for such termination and whether or not later found to be invalid, unlawful or in breach of the employment laws in
the jurisdiction where you are employed or the terms of your employment agreement, if any) will be measured as of the earlier of: (a) the date your
employment with the Company or one of its Subsidiaries (as defined in the Plan) or Affiliates is terminated, (b) the date you receive written notice of
termination from the Company or a Subsidiary or Affiliate, regardless of any notice period or period of pay in lieu of such notice mandated under the
employment laws in the jurisdiction where you are employed or the terms of your employment agreement, if any, or (c) the date you are no longer
employed by the Company or any of its Subsidiaries or Affiliates. You will not be entitled to a pro-rata portion of the Award for any time before the date on
which your right to vest terminates, nor will you be entitled to any compensation for lost vesting. In the event the date on which you are no longer actively
providing services cannot be reasonably determined under the terms of your Award, the Company, in its sole discretion, shall determine when you are no
longer employed for purposes of the Award (including whether you may still be considered employed or actively providing services while on a leave of
absence).
Notwithstanding the foregoing, if applicable employment standards legislation explicitly requires continued entitlement to vesting during a statutory notice
period, your right to vest in the Award under the Plan, if any, will terminate effective as of the last day of your minimum statutory notice period, but you will
not earn or be entitled to pro-rated vesting if the vesting date falls after the end of your statutory notice period, nor will you be entitled to any
compensation for lost vesting.
In addition to any restrictions on resale and transfer noted in the Plan Documents, Stock acquired pursuant to the Plan will be subject to certain
restrictions on resale imposed by Canadian provincial securities laws (in general, you may not resell your Stock to Canadian purchasers). Accordingly,
you are encouraged to seek legal advice prior to any resale of the Stock.
Furthermore, notwithstanding anything to the contrary in the Plan or the Award Agreement, Awards granted to Canadian residents shall only be settled in
Stock and shall not be settled in cash.
The following terms and conditions apply if you are resident in Quebec:
You agree that you wish the Plan Documents to be drawn up in English.
Vous confirmez que vous souhaitiez que les Documents du Plan soient rédigés en anglais
7. 	If you are subject to the laws of Chile
Neither the Company, the Plan nor the Stock have been registered in the Registro de Valores (Securities Registry) or in the Registro de Valores
Extranjeros (Foreign Securities Registry) of the

-- 143 of 156 --

Comisión para el Mercado Financiero de Chile (Chilean Commission for the Financial market or CMF) and they are not subject to the control of the CMF.
The Plan is governed by General Regulation 336. As the Stock is not registered, the Company has no obligation under Chilean law to deliver public
information regarding the Stock in Chile. Shares of Stock cannot be publicly offered in Chile unless they are registered with the CMF.
Ni The Coca-Cola Company, ni el Plan ni las Acciones han sido registradas en el Registro de Valores o en el Registro de Valores Extranjeros que
lleva la Comisión para el Mercado Financiero de Chile (CMF) y ninguno de ellos está sujeto a la fiscalización de la CMF. Esta oferta de Acciones se
acoge a la Norma de Carácter General 336. Por tratarse de valores no inscritos, el emisor de las Acciones no tiene obligación bajo la ley chilena de
entregar en Chile información pública acerca de las Acciones. Las Acciones no pueden ser ofrecidas públicamente en Chile en tanto éstas no se
inscriban en el Registro de Valores correspondiente.
8. 	If you are subject to exchange control restrictions imposed by the China State Administration of Foreign Exchange (SAFE), as
determined by the Company in its sole discretion, or you are subject to mandatory retirement in China
Notwithstanding any other provision in the Plan Documents, the following provisions apply in the event of the termination of your employment (as
interpreted in accordance with the Employment Events Appendix) with the Company or a Subsidiary (as defined in the Plan) (1) because of your
Disability, or (2) after attaining age 55:
Awards that are Options and Awards held at least 12 months will immediately vest and will be settled in cash. The cash amount will be determined
based on the closing price of the Stock on the date of your termination of employment (or, if a non-trading day, the next trading day) or the exercise of
your Option (if applicable) within the post-termination exercise period stated below. Awards that are not Options and that are held less than 12
months from the date of grant are forfeited.
Where Performance Criteria apply, the Performance Criteria will be measured over a shortened performance period, ending at the end of the year
prior to your termination of employment.
If your Award is an Option, the period over which you may exercise your Option expires upon earlier of (1) six months from your termination of
employment or (2) the Option expiration date provided in the Plan Documents.
The Company has the discretion to arrange for the sale of any Stock issued upon settlement of your Award, either immediately upon settlement or at any
time thereafter. In any event, if you terminate employment, you will be required to sell all Stock acquired upon settlement of the Award within such time
period as required by the Company in accordance with SAFE requirements. Any Stock remaining in your brokerage account at the end of this period shall
be sold by the broker (on your behalf pursuant to this authorization and without further consent). In addition, any Award that has not vested by the end of
this period will then immediately be forfeited. The Company shall have the exclusive discretion to determine when your employment has been terminated
for the purposes of the Award.

-- 144 of 156 --

You agree to sign any additional agreements, forms and/or consents that reasonably may be requested by the Company (or the Company’s designated
broker) to effectuate the sale of the Stock (including, without limitation, as to the transfer of the sale proceeds and other exchange control matters noted
below) and shall otherwise cooperate with the Company with respect to such matters. You acknowledge that neither the Company nor the designated
broker is under any obligation to arrange for the sale of Stock at any particular price (it being understood that the sale will occur in the market) and that
broker’s fees and similar expenses may be incurred in any such sale. In any event, when the Stock is sold, the sale proceeds, less any withholding for
applicable taxes, any broker’s fees or commissions, and any similar expenses of the sale will be remitted to you in accordance with applicable exchange
control laws and regulations.
By accepting the Award, you acknowledge that you understand and agree that you are not permitted to transfer any Stock acquired under the Plan out of
your account established with the Company’s designated broker until the Stock is sold. The limitation applies to all Stock issued to you under the Plan,
whether or not you remained employed with the Company or a Subsidiary.
You understand and agree that you will be required to immediately repatriate to China the proceeds from the sale of any Stock acquired under the Plan
and any such dividends paid on such shares. You further understand that such repatriation proceeds may need to be effected through a special bank
account established by the Company (or a Subsidiary or Affiliate in China), and you hereby consent and agree that any sale proceeds and cash
dividends may be transferred to such special account by the Company (or a Subsidiary or Affiliate in China) on your behalf prior to being delivered to you
and that no interest shall be paid with respect to funds held in such account.
The proceeds may be paid to you in U.S. dollars or local currency at the Company’s discretion. If the proceeds are paid to you in U.S. dollars, you
understand that a U.S. dollar bank account in China must be established and maintained so that the proceeds may be deposited into such account. If
the proceeds are paid to you in local currency, you acknowledge that the Company (and its Subsidiaries and Affiliates) are under no obligation to secure
any particular exchange conversion rate and that the Company (and its Subsidiaries and Affiliates) may face delays in converting the proceeds to local
currency due to exchange control restrictions. You agree to bear any currency fluctuation risk between the time the Stock is sold and the net proceeds
are converted into local currency and distributed to you. You further agree to comply with any other requirements that may be imposed by the Company
in the future in order to facilitate compliance with exchange control requirements in China.
In addition to the vesting schedule for your Award, settlement of the Award is also conditioned on the continued effectiveness of the Company’s
registration of the Plan with SAFE (the SAFE Registration Requirement). If or to the extent the Company is unable to maintain the registration, no
Stock for which a registration cannot be maintained shall be issued. In this case, the Company retains the discretion to settle any Award for which the
vesting schedule, but not the SAFE Registration Requirement, has been met in cash paid through local payroll in an amount equal to the market value of
the Stock subject to the Award less any withholding for applicable taxes.
The Company (and its Subsidiaries and Affiliates) shall not be liable for any costs, fees, lost interest or dividends or other losses that you may incur or
suffer resulting from the enforcement of the foregoing terms or otherwise from the Company’s operation and enforcement of the Plan, the

-- 145 of 156 --

Award Agreement, and the Award in accordance with any applicable laws, rules, regulations and requirements.
9. If you are subject to the laws of Colombia
You acknowledge that pursuant to Article 128 of the Colombian Labor Code, the Plan and related benefits do not constitute a component of “salary” for
any legal purpose.
10. If you are subject to the laws of France
By accepting the Award, you confirm that you have read and understood the Plan Documents, which were provided in English. You accept the terms of
those Plan Documents and confirm that you have a good knowledge of the English language.
En acceptant ce paiement, vous confirmez avoir lu et compris les documents relatifs à ce plan d’incitation à long terme (qui vous ont été fournis en
anglais) et que vous acceptez les termes de ce plan.
11. If you are subject to the laws of Hong Kong
WARNING:
The contents of the Plan Documents have not been reviewed by any regulatory authority in Hong Kong. You are advised to exercise caution in relation to
the offer. If you are in any doubt about any of the contents of the Plan Documents, you should obtain independent professional advice.
This offer to receive an Award under the Plan (the Offer) is strictly private and only available to eligible employees of Coca-Cola China Limited. The Offer
has also not been approved by the Securities and Futures Commission in Hong Kong and it should not be made in whole or in part to the public or any
third-party.
No Awards granted under the Plan may be transferred or assigned, except as expressly permitted by the Company in writing.
Sale of Stock. Any Stock received at vesting is accepted as a personal investment. In the event that any portion of this Award vests within six months of
the grant date, you agree that you will not offer to the public or otherwise dispose of the Stock acquired prior to the six-month anniversary of the grant
date.
12. If you are subject to the laws of India
You must repatriate to India all funds resulting from the sale of Stock acquired in relation to your Award within 90 days, and all proceeds from the receipt
of any dividends within 180 days. You should receive a foreign inward remittance certificate (FIRC) from your bank where you deposit the foreign
currency. You should maintain the FIRC as evidence of the repatriation of funds in the event that the Reserve Bank of India or your employer requests
proof of repatriation.

-- 146 of 156 --

13. If you are subject to the laws of Indonesia
A translation of the documents relating to this grant into Bahasa Indonesia can be provided to you upon request to your local human resources
representative. By accepting the grant of the Award, you (i) confirm having read and understood the documents relating to this grant which were provided
in the English language, (ii) accept the terms of those documents accordingly, and (iii) agree not to challenge the validity of this document based on Law
No. 24 of 2009 on National Flag, Language, Coat of Arms and National Anthem or the implementing Presidential Regulation (when issued).
Terjemahan dari dokumen-dokumen terkait dengan pemberian ini ke Bahasa Indonesia dapat disediakan bagi anda berdasarkan permintaan kepada
perwakilan sumber daya manusia lokal anda. Dengan menerima pemberian Award, anda (i) mengkonfirmasi bahwa dirinya telah membaca dan
mengerti dokumen-dokumen yang terkait dengan pemberian ini yang disediakan dalam Bahasa Inggris, (ii) menerima syarat-syarat dari dokumen-
dokumen tersebut, dan (iii) setuju untuk tidak mengajukan keberatan atas keberlakuan dokumen ini berdasarkan Undang-Undang No. 24 Tahun
2009 tentang Bendera, Bahasa, dan Lambang Negara, Serta Lagu Kebangsaan atau Peraturan Presiden pelaksananya (ketika diterbitkan).
14. If you are subject to the laws of Italy
By accepting the grant of the Award, you acknowledge that you have received a copy of the Plan Documents, you have reviewed the Plan Documents in
their entirety and you fully understand and accept all provisions of the Plan Documents. You further acknowledge that you have read and expressly
approve the following sections of the Additional Terms: section 2 (Employment); section 4 (Modifications and additional requirements); section 5 (Tax);
and section 15 (General).
15. If you are subject to the laws of Mexico
By participating in the Plan, you acknowledge that you have received a copy of the Plan, reviewed the Plan in its entirety and fully understand and accept
all provisions of the Plan. You further acknowledge that you have read and expressly approve the terms and conditions set forth in section 2
(Employment) of the Additional Terms, in which the following is clearly described and established: (i) your participation in the Plan does not constitute an
acquired right; (ii) the Plan and your participation in the Plan are offered by the Company on a wholly discretionary basis; (iii) your participation in the Plan
is voluntary; and (iv) the Company and its Subsidiaries (as defined in the Plan) are not responsible for any decrease in the value of the underlying Stock.
By participating in the Plan, you expressly recognize that The Coca Cola Company, with registered offices at One Coca-Cola Plaza, Atlanta, Georgia
30313, USA, is solely responsible for the administration of the Plan and that your participation in the Plan and acquisition of Stock does not constitute an
employment relationship between you and the Company since you are participating in the Plan on a wholly commercial basis. Based on the foregoing,
you expressly recognize that the Plan and the benefits that you may derive from participation in the Plan do not establish any rights between you and the
Company and do not form part of the employment conditions and/or benefits provided by the Company and any modification of the Plan or its termination
shall not constitute a change or impairment of the terms and conditions of your employment.

-- 147 of 156 --

You further understand that your participation in the Plan is as a result of a unilateral and discretionary decision of the Company; therefore, the Company
reserves the absolute right to amend and/or discontinue your participation at any time without any liability to you.
Finally, you hereby declare that you do not reserve any action or right to bring any claim against the Company for any compensation or damages
regarding any provision of the Plan or the benefits derived under the Plan, and you therefore grant a full and broad release to the Company, its
Subsidiaries, branches, representation offices, its shareholders, officers, agents or legal representatives with respect to any claim that may arise.
Al participar en el Plan, usted reconoce que ha recibido una copia del Plan, que ha revisado el Plan en su totalidad, y que entiende y acepta en su
totalidad, todas y cada una de las disposiciones del Plan. Asimismo reconoce que ha leído y aprueba expresamente los términos y condiciones
señalados en el párrafo titulado Naturaleza de la Oferta en el Convenio, en lo que claramente se describe y establece lo siguiente: (i) su
participación en el Plan no constituye un derecho adquirido; (ii) el Plan y su participación en el Plan son ofrecidos por la Compañía sobre una base
completamente discrecional; (iii) su participación en el Plan es voluntaria; y (iv) la Compañía y sus Afiliadas no son responsables de ninguna por la
disminución en el valor de las Acciones subyacentes.
Al participar en el Plan, usted reconoce expresamente que The Coca-Cola Company, con oficinas registradas en One Coca-Cola Plaza, Atlanta,
Georgia 30313, Estados Unidos de América, es la única responsable por la administración del Plan, y que su participación en el Plan, así como la
adquisición de las Acciones, no constituye una relación laboral entre usted y la Compañía, debido a que usted participa en el plan sobre una base
completamente mercantil. Con base en lo anterior, usted reconoce expresamente que el Plan y los beneficios que pudiera obtener por su
participación en el Plan, no establecen derecho alguno entre usted y la Compañía, y no forman parte de las condiciones y/o prestaciones laborales
que la Compañía ofrece, y que las modificaciones al Plan o su terminación, no constituirán un cambio ni afectarán los términos y condiciones de su
relación laboral.
Asimismo usted entiende que su participación en el Plan es el resultado de una decisión unilateral y discrecional de la Compañía; por lo tanto, la
Compañía se reserva el derecho absoluto de modificar y/o suspender su participación en cualquier momento, sin que usted incurra en
responsabilidad alguna.
Finalmente, usted declara que no se reserva acción o derecho alguno para interponer reclamación alguna en contra de la Compañía, por concepto
de compensación o daños relacionados con cualquier disposición del Plan o de los beneficios derivados del Plan, y por lo tanto, usted libera total y
ampliamente de toda responsabilidad a la Compañía, a sus Afiliadas, sucursales, oficinas de representación, sus accionistas, funcionarios, agentes
o representantes legales, con respecto a cualquier reclamación que pudiera surgir.
The Stock underlying your Award has not been registered with the National Register of Securities maintained by the Mexican Banking and Securities
Commission and may not be offered or sold publicly in Mexico. The Plan Documents may not be publicly distributed in Mexico. These materials are
addressed to you only because of your existing relationship with the Company and its Subsidiaries and may not be reproduced or copied in any form.
The offer contained in these

-- 148 of 156 --

materials is addressed solely to the present employees of the Company and its Subsidiaries in Mexico and any rights under the Plan may not be
assigned or transferred. The Stock underlying your Award will be offered pursuant to a private placement exception under the Mexican Securities Law.
16. If you are subject to the laws of New Zealand
You are being offered an Award which, if vested, will entitle you to acquire Stock in accordance with the terms of the Plan Documents. The Stock, if
issued, will give you a stake in the ownership of the Company. You may receive a return if dividends are paid.
If the Company runs into financial difficulties and is wound up, you will be paid only after all creditors and holders of preference shares (if any) have been
paid. You may lose some or all of your investment, if any.
New Zealand law normally requires people who offer financial products to give information to investors before they invest. This information is designed to
help investors to make an informed decision. The usual rules do not apply to this offer because it is made under an employee share scheme. As a result,
you may not be given all the information usually required. You will also have fewer other legal protections for this investment. You are advised to ask
questions, read all documents carefully, and seek independent financial advice before committing.
The Stock is quoted on the New York Stock Exchange. This means that if you acquire Stock under the Plan, you may be able to sell the Stock on the
New York Stock Exchange if there are interested buyers. You may get less than you invested. The price will depend on the demand for the Stock.
For information on risk factors impacting the Company’s business that may affect the value of the Stock, you should refer to the risk factors discussion on
the Company’s Annual Report on Form 10-K and Quarterly Reports on Form 10-Q, which are filed with the U.S. Securities and Exchange Commission
and are available online at www.sec.gov, as well as on the Company’s “Investor Relations” website at https://investors.coca-colacompany.com/.
17. If you are subject to the laws of Peru
The grant of the Award is considered a private offering in Peru; therefore, it is not subject to registration in Peru. For more information concerning the offer,
please refer to the Plan Documents and any other materials or documentation made available by the Company. For more information regarding the
Company, please refer to the Company’s Annual Report on Form 10-K and Quarterly Reports on Form 10-Q, which are filed with the U.S. Securities and
Exchange Commission and are available at www.sec.gov, as well as the Company’s “Investor Relations” website at https://investors.coca-
colacompany.com/.
By accepting the Award, you acknowledge that the Award is being granted ex gratia with the purpose of rewarding you.
18. If you are subject to the laws of Philippines
The following wording is hereby made a part of the Plan Documents:

-- 149 of 156 --

The securities being offered or sold under the Plan have not been registered with the Philippine Securities and Exchange Commission under the
Philippine Securities Regulation Code. Any future offer or sale of the securities in the Philippines is subject to registration requirements under the
Securities Regulation Code unless such offer or sale qualifies as an exempt transaction.
This applies if your Award Notification specifies that your Award is an Option:
Notwithstanding any terms or conditions of the Plan Documents, you acknowledge and agree that you will be restricted to the cashless sell-all
method of exercise. To complete a cashless sell-all exercise, you must to instruct the broker to (i) sell all of the Stock issued upon exercise of the
Option; (ii) use the proceeds to pay the exercise price, any applicable Liabilities and brokerage fees or commissions; and (iii) remit the balance in
cash to you. You will not be permitted to hold the Stock after exercise. Depending on the development of local laws, the Company reserves the right
to modify the methods of exercising the Option and, in its sole discretion, to permit cash exercise, cashless sell-to cover exercise or any other method
of exercise and payment of Liabilities permitted under the Plan.
19. If you are subject to the laws of Russia
Information contained in the Plan Documents does not constitute an advertisement of any securities in Russia and must not be passed on to third parties
or otherwise be made publicly available in Russia. The Awards and the Stock to be granted under the Plan have not been and will not be registered in
Russia and are not intended for 'placement' or 'circulation' in Russia.
20. If you are subject to the laws of Singapore
You acknowledge that the Plan Documents have not been registered as a prospectus with the Monetary Authority of Singapore. Accordingly, the Plan
Documents and any other document or material in connection with the offer or sale, or invitation for subscription or purchase of the Stock may not be
circulated or distributed, nor may the Stock be offered or sold, or be made the subject of an invitation for subscription or purchase, whether directly or
indirectly, to persons in Singapore other than pursuant to, and in accordance with the conditions of, an exemption under any provision (other than Section
280) of Subdivision (4) of Division 1 of Part XIII of the Securities and Futures Act, Chapter 289 of Singapore.
The Awards under the Plan are prescribed capital markets products (as defined in the Securities and Futures (Capital Markets Products) Regulations
2018) and Excluded Investment Products (as defined in MAS Notices SFA 04-N12 and FAA-N16).
21. If you are subject to the laws of South Africa
By accepting the Award, you agree to immediately notify your employer of the amount of any income realized upon exercise or vesting of the Award. If
you fail to advise your employer of the income realized upon exercise or vesting of the Award, then you may be liable for a fine. You personally will be
responsible for paying the difference between the actual tax liability and the amount withheld by the Company or your employer.

-- 150 of 156 --

The documents listed below are available for your review on the Company’s website at https://investors.coca-colacompany.com/ and the Company’s
intranet:
1. The Company’s most recent annual financial statements; and
2. The Company’s most recent Plan prospectus.
A copy of the above-listed documents will be sent to you free of charge on written request to Global Equity, The Coca-Cola Company, at One Coca-Cola
Plaza, Atlanta, Georgia 30313, USA. You should read these materials carefully before making a decision whether to participate in the Plan.
22. If you are subject to the laws of Spain
By accepting the Award, you acknowledge that you consent to participation in the Plan and have received a copy of the Plan Documents. Except as
otherwise provided in the Plan Documents, termination of your employment for any reason (including for the reasons listed below) will automatically result
in the forfeiture of any unvested Awards; in particular, you understand and agree that such Awards will be forfeited without entitlement to the underlying
Stock or to any amount as indemnification in the event of a termination of your employment prior to vesting by reason of, including, but not limited to,
resignation, disciplinary dismissal with or without cause, individual or collective layoff with or without cause, material modification of employment under
Article 41 of the Worker’s Statute, relocation under Article 40 of the Worker’s Statute, Article 50 of the Worker’s Statute, Article 10.3 of Royal Decree
1382/1985 and unilateral withdrawal by your employer.
Furthermore, you understand that the Company has unilaterally, gratuitously, and in its sole discretion decided to grant Awards under the Plan to
individuals who may be employees of the Company's group throughout the world. The decision is a limited decision that is entered into upon the express
assumption and condition that any grant will not bind the Company or any Subsidiary (as defined in the Plan) or Affiliate, other than to the extent set forth
in the Plan Documents. Consequently, you understand that the Awards are offered on the assumption and condition that the Awards and any Stock
acquired under the Plan are not part of any employment contract (either with the Company or any Subsidiary or Affiliate), and shall not be considered a
mandatory benefit, salary for any purposes (including severance compensation), or any other right whatsoever. In addition, you understand that this offer
would not be made but for the assumptions and conditions referred to above; thus, you acknowledge and freely accept that, should any or all of the
assumptions be mistaken or should any of the conditions not be met for any reason, then any grant of or right to the Award shall be null and void.
23. If you are subject to the laws of Sweden
The following provision supplements section 5 (Tax) of the Additional Terms:
Without limiting the authority of any Withholding Person to satisfy their withholding obligations for Tax as set forth in section 5 (Tax) of the Additional
Terms, by accepting the grant of the Award, you authorize any Withholding Person to withhold or to sell Stock otherwise deliverable to you to satisfy
Tax, regardless of whether the Withholding Person has an obligation to withhold such Tax.

-- 151 of 156 --

24. If you are subject to the laws of Switzerland
The offering of the Plan in Switzerland is exempt from the requirement to prepare and publish a prospectus under the Swiss Financial Services Act
(FinSA) because such offering by the Company is made exclusively to current or former members of the board of directors, members of the
management board or employees of the Company, the employer and its Affiliates. The Plan Documents do not constitute a prospectus pursuant to
FinSA, and no such prospectus has been or will be prepared for or in connection with the offering of the Plan.
25. If you are subject to the laws of Turkey
Under Turkish law, you are not permitted to sell any Stock acquired under the Plan in Turkey. The shares are currently traded on the New York Stock
Exchange, which is located outside of Turkey, under the ticker symbol “KO” and the Stock may be sold through this exchange.
You acknowledge that any activity related to investments in foreign securities (e.g. the sale of Stock) should be conducted through a bank or financial
intermediary institution licensed by the Turkey Capital Markets Board and should be reported to the Turkish Capital Markets Board. You are solely
responsible for complying with this requirement and should consult with a personal legal advisor for further information regarding any obligations in this
respect.
26. If you are subject to the laws of the United Arab Emirates
The Awards are granted under the Plan only to select employees of the Company's group and are in the nature of providing employee equity incentives
in the United Arab Emirates. The Plan Documents are intended for distribution only to such employees and must not be delivered to, or relied on by, any
other person. Prospective purchasers of the securities offered should conduct their own due diligence on the securities. If you do not understand the
contents of the Plan Documents, you should consult an authorized financial adviser. The Emirates Securities and Commodities Authority has no
responsibility for reviewing or verifying any documents in connection with the Plan. Neither the Ministry of Economy nor the Dubai Department of
Economic Development has approved the Plan Documents nor taken steps to verify the information set out herein, and has no responsibility for such
documents.
27. If you are subject to the laws of the United Kingdom
This offer is being made to selected employees as part of an employee incentive program in order to provide an additional incentive and to encourage
employee share ownership and to increase your interest in the success of the Company. The company offering these rights is The Coca-Cola Company.
The Stock which is the subject of these rights is new or existing par value common stock in the Company. More information in relation to the Company
including the stock price can be found at the following web address: https://investors.coca-colacompany.com/.
The obligation to publish a prospectus does not apply because of Section 86(aa) of the Financial Services and Markets Act 2000 (as amended,
supplemented or substituted by any UK legislation enacted in connection with the UK’s exit from the European Union). The total maximum number of
Stock which is the subject of this offer is 240,000,000.

-- 152 of 156 --

28. If you are subject to the laws of Cambodia, Morocco, Myanmar, Nepal, Pakistan, or Vietnam
The Company reserves the right to restrict you from acquiring Stock at exercise or vesting of your Award. Instead, the Company reserves the right to
make a payment to you in cash upon exercise or vesting of your Award. Any references to the issuance of shares or Stock in any documents related to
the Award shall not be applicable in these circumstances.

-- 153 of 156 --

Exhibit 31.1
CERTIFICATIONS
I, Henrique Braun, Chief Executive Officer of The Coca-Cola Company, certify that:
1. 	I have reviewed this quarterly report on Form 10-Q of The Coca-Cola Company;
2. 	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in
light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3. 	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition,
results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4. 	The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act
Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
(a) 	Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that
material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during
the period in which this report is being prepared;
(b) 	Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to
provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance
with generally accepted accounting principles;
(c) 	Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the
disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d) 	Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter
(the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s
internal control over financial reporting; and
5. 	The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s
auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
(a) 	All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to
adversely affect the registrant’s ability to record, process, summarize and report financial information; and
(b) 	Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial
reporting.
Date: 	April 30, 2026
/s/ Henrique Braun
Henrique Braun
Chief Executive Officer of The Coca-Cola Company

-- 154 of 156 --

Exhibit 31.2
CERTIFICATIONS
I, John Murphy, President and Chief Financial Officer of The Coca-Cola Company, certify that:
1. 	I have reviewed this quarterly report on Form 10-Q of The Coca-Cola Company;
2. 	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in
light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3. 	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition,
results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4. 	The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act
Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
(a) 	Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that
material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during
the period in which this report is being prepared;
(b) 	Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to
provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance
with generally accepted accounting principles;
(c) 	Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the
disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d) 	Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter
(the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s
internal control over financial reporting; and
5. 	The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s
auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
(a) 	All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to
adversely affect the registrant’s ability to record, process, summarize and report financial information; and
(b) 	Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial
reporting.
Date: 	April 30, 2026
/s/ John Murphy
John Murphy
President and Chief Financial Officer of The Coca-Cola Company

-- 155 of 156 --

Exhibit 32.1
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the quarterly report of The Coca-Cola Company (“Company”) on Form 10-Q for the period ended April 3, 2026 (“Report”), I, Henrique Braun, Chief
Executive Officer of the Company and I, John Murphy, President and Chief Financial Officer of the Company, each certify, pursuant to 18 U.S.C. Section 1350, as adopted
pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
(1) 	to my knowledge, the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2) 	the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
/s/ HENRIQUE BRAUN
Henrique Braun
Chief Executive Officer of The Coca-Cola Company
April 30, 2026
/s/ JOHN MURPHY
John Murphy
President and Chief Financial Officer of The Coca-Cola Company
April 30, 2026

-- 156 of 156 --